EXECUTION
COPY

     

    
      


      
        

        

      

       

      


    

    ASSET
PURCHASE AGREEMENT

     

    BY
AND AMONG

     

    HEALTH
DIAGNOSTICS OF NEW JERSEY, L.L.C.,

     

    MODERN
MEDICAL MODALITIES CORPORATION,

     

    UNION
IMAGING ASSOCIATES, INC.,

     

    UNION
IMAGING CENTER, LLC,

     

    AND

     

    PET
SCAN AT UNION IMAGING, LLC

     

     

    DATED
AS OF JANUARY 30, 2009

     

    
      


      
        

        

      

       

      
        
           

        

        
           

          
            

          

        

        
           

        

      

      
        TABLE
OF CONTENTS

         

        Page

      

    

    
      
        
          
            
              
                
                  
                    
                      
                        
                          
                            
                              
                                
                                  
                                    
                                      
                                        
                                          
                                            
                                              
                                                
                                                  
                                                    
                                                      
                                                        
                                                          
                                                            
                                                              
                                                                
                                                                  
                                                                    
                                                                      
                                                                         

                                                                        
                                                                          
                                                                            
                                                                              
                                                                                
                                                                                  
                                                                                    
                                                                                      
                                                                                        
                                                                                          
                                                                                            
                                                                                              
                                                                                                
                                                                                                  
                                                                                                    
                                                                                                      
                                                                                                        
                                                                                                          
                                                                                                            
                                                                                                              
                                                                                                                
                                                                                                                  
                                                                                                                    
                                                                                                                      
                                                                                                                        
                                                                                                                          
                                                                                                                            
                                                                                                                              
                                                                                                                                
                                                                                                                                  
                                                                                                                                    
                                                                                                                                      
                                                                                                                                        
                                                                                                                                          
                                                                                                                                            
                                                                                                                                              
                                                                                                                                                
                                                                                                                                                  	1.	PURCHASE
      OF ACQUIRED ASSETS	2
	 	 	 
	 	
                                                                                                                                                          1.1

                                                                                                                                                        	
                                                                                                                                                          Purchase
      and Sale of Acquired Assets

                                                                                                                                                        	
                                                                                                                                                          2

                                                                                                                                                        
	 	
                                                                                                                                                          1.2

                                                                                                                                                        	
                                                                                                                                                          Assumed
      Obligations

                                                                                                                                                        	
                                                                                                                                                          2

                                                                                                                                                        
	 	
                                                                                                                                                          1.3

                                                                                                                                                        	
                                                                                                                                                          Method
      of Conveyance

                                                                                                                                                        	
                                                                                                                                                          3

                                                                                                                                                        
	 	
                                                                                                                                                          1.4

                                                                                                                                                        	
                                                                                                                                                          Purchase
      Price

                                                                                                                                                        	
                                                                                                                                                          3

                                                                                                                                                        
	 	
                                                                                                                                                          1.5

                                                                                                                                                        	
                                                                                                                                                          Allocation
      of Purchase Price

                                                                                                                                                        	
                                                                                                                                                          3

                                                                                                                                                        
	 	
                                                                                                                                                          1.6

                                                                                                                                                        	
                                                                                                                                                          Assumed
      Indebtedness

                                                                                                                                                        	
                                                                                                                                                          4

                                                                                                                                                        
	 	
                                                                                                                                                          1.7

                                                                                                                                                        	
                                                                                                                                                          Escrow
      Amount

                                                                                                                                                        	
                                                                                                                                                          4

                                                                                                                                                        
	 	
                                                                                                                                                          1.8

                                                                                                                                                        	
                                                                                                                                                          Purchase
      Price Adjustments

                                                                                                                                                        	
                                                                                                                                                          6

                                                                                                                                                        
	 	 	 
	2.	
                                                                                                                                                          REPRESENTATIONS
      AND WARRANTIES OF PARENT AND SELLER COMPANIES

                                                                                                                                                        	
                                                                                                                                                          7

                                                                                                                                                        
	 	 	 
	 	
                                                                                                                                                          2.1

                                                                                                                                                        	
                                                                                                                                                          Corporate
      Organization, Etc.

                                                                                                                                                        	
                                                                                                                                                          8

                                                                                                                                                        
	 	
                                                                                                                                                          2.2

                                                                                                                                                        	
                                                                                                                                                          Ownership

                                                                                                                                                        	
                                                                                                                                                          8

                                                                                                                                                        
	 	
                                                                                                                                                          2.3

                                                                                                                                                        	
                                                                                                                                                          Subsidiaries

                                                                                                                                                        	
                                                                                                                                                          8

                                                                                                                                                        
	 	
                                                                                                                                                          2.4

                                                                                                                                                        	
                                                                                                                                                          Books
      and Records

                                                                                                                                                        	
                                                                                                                                                          8

                                                                                                                                                        
	 	
                                                                                                                                                          2.5

                                                                                                                                                        	
                                                                                                                                                          Authorization,
      Etc

                                                                                                                                                        	
                                                                                                                                                          9

                                                                                                                                                        
	 	
                                                                                                                                                          2.6

                                                                                                                                                        	
                                                                                                                                                          Title
      and Related Matters

                                                                                                                                                        	
                                                                                                                                                          9

                                                                                                                                                        
	 	
                                                                                                                                                          2.7

                                                                                                                                                        	
                                                                                                                                                          Financial
      Statements

                                                                                                                                                        	
                                                                                                                                                          11

                                                                                                                                                        
	 	
                                                                                                                                                          2.8

                                                                                                                                                        	
                                                                                                                                                          Absence
      of Certain Changes

                                                                                                                                                        	
                                                                                                                                                          12

                                                                                                                                                        
	 	
                                                                                                                                                          2.9

                                                                                                                                                        	
                                                                                                                                                          Accounts
      Receivable

                                                                                                                                                        	
                                                                                                                                                          13

                                                                                                                                                        
	 	
                                                                                                                                                          2.10

                                                                                                                                                        	
                                                                                                                                                          Agreements
      and Commitments

                                                                                                                                                        	
                                                                                                                                                          13

                                                                                                                                                        
	 	
                                                                                                                                                          2.11

                                                                                                                                                        	
                                                                                                                                                          Government
      Contracts

                                                                                                                                                        	
                                                                                                                                                          15

                                                                                                                                                        
	 	
                                                                                                                                                          2.12

                                                                                                                                                        	
                                                                                                                                                          Litigation

                                                                                                                                                        	
                                                                                                                                                          16

                                                                                                                                                        
	 	
                                                                                                                                                          2.13

                                                                                                                                                        	
                                                                                                                                                          Taxes

                                                                                                                                                        	
                                                                                                                                                          17

                                                                                                                                                        
	 	
                                                                                                                                                          2.14

                                                                                                                                                        	
                                                                                                                                                          Banking
      Arrangements

                                                                                                                                                        	
                                                                                                                                                          19

                                                                                                                                                        
	 	
                                                                                                                                                          2.15

                                                                                                                                                        	
                                                                                                                                                          Liens;
      Indebtedness; Collateral

                                                                                                                                                        	
                                                                                                                                                          19

                                                                                                                                                        
	 	
                                                                                                                                                          2.16

                                                                                                                                                        	
                                                                                                                                                          Licenses

                                                                                                                                                        	
                                                                                                                                                          19

                                                                                                                                                        
	 	
                                                                                                                                                          2.17

                                                                                                                                                        	
                                                                                                                                                          Compliance
      with Law

                                                                                                                                                        	
                                                                                                                                                          20

                                                                                                                                                        
	 	
                                                                                                                                                          2.18

                                                                                                                                                        	
                                                                                                                                                          Rates
      and Reimbursement Policies

                                                                                                                                                        	
                                                                                                                                                          21

                                                                                                                                                        
	 	
                                                                                                                                                          2.19

                                                                                                                                                        	
                                                                                                                                                          Physicians

                                                                                                                                                        	
                                                                                                                                                          21

                                                                                                                                                        
	 	
                                                                                                                                                          2.20

                                                                                                                                                        	
                                                                                                                                                          Improper
      and Other Payments

                                                                                                                                                        	
                                                                                                                                                          23

                                                                                                                                                        
	 	
                                                                                                                                                          2.21

                                                                                                                                                        	
                                                                                                                                                          Intellectual
      Property

                                                                                                                                                        	
                                                                                                                                                          23

                                                                                                                                                        
	 	
                                                                                                                                                          2.22

                                                                                                                                                        	
                                                                                                                                                          Employee
      Benefit Plans

                                                                                                                                                        	
                                                                                                                                                          25

                                                                                                                                                        
	 	
                                                                                                                                                          2.23

                                                                                                                                                        	
                                                                                                                                                          Employees

                                                                                                                                                        	
                                                                                                                                                          28

                                                                                                                                                        
	 	
                                                                                                                                                          2.24

                                                                                                                                                        	
                                                                                                                                                          Insurance
      Coverage

                                                                                                                                                        	
                                                                                                                                                          29

                                                                                                                                                        
	 	
                                                                                                                                                          2.25

                                                                                                                                                        	
                                                                                                                                                          Appraisal
      Reports and Surveys

                                                                                                                                                        	
                                                                                                                                                          29

                                                                                                                                                        
	 	
                                                                                                                                                          2.26

                                                                                                                                                        	
                                                                                                                                                          Consents

                                                                                                                                                        	
                                                                                                                                                          30

                                                                                                                                                        
	 	
                                                                                                                                                          2.27

                                                                                                                                                        	
                                                                                                                                                          Environmental
      Matters

                                                                                                                                                        	
                                                                                                                                                          30

                                                                                                                                                        
	 	
                                                                                                                                                          2.28

                                                                                                                                                        	
                                                                                                                                                          Medical
      Waste

                                                                                                                                                        	
                                                                                                                                                          31

                                                                                                                                                        
	 	
                                                                                                                                                          2.29

                                                                                                                                                        	
                                                                                                                                                          Federal
      Health Care Programs

                                                                                                                                                        	
                                                                                                                                                          31

                                                                                                                                                        
	 	
                                                                                                                                                          2.30

                                                                                                                                                        	
                                                                                                                                                          Capital
      Expenditures and Investments

                                                                                                                                                        	
                                                                                                                                                          31

                                                                                                                                                        
	 	
                                                                                                                                                          2.31

                                                                                                                                                        	
                                                                                                                                                          Dealings
      with Affiliates

                                                                                                                                                        	
                                                                                                                                                          32

                                                                                                                                                        
	 	
                                                                                                                                                          2.32

                                                                                                                                                        	
                                                                                                                                                          Confidential
      Information

                                                                                                                                                        	
                                                                                                                                                          32

                                                                                                                                                        


                                                                                                                                                

                                                                                                                                              

                                                                                                                                               

                                                                                                                                               

                                                                                                                                              
                                                                                                                                                
                                                                                                                                                   

                                                                                                                                                

                                                                                                                                                
                                                                                                                                                  -i-

                                                                                                                                                  
                                                                                                                                                    

                                                                                                                                                  

                                                                                                                                                

                                                                                                                                                
                                                                                                                                                   

                                                                                                                                                

                                                                                                                                              

                                                                                                                                               

                                                                                                                                              
                                                                                                                                                TABLE
OF CONTENTS

                                                                                                                                                (continued)

                                                                                                                                                Page

                                                                                                                                              

                                                                                                                                               

                                                                                                                                              
                                                                                                                                                
                                                                                                                                                  	 	
                                                                                                                                                          2.33

                                                                                                                                                        	
                                                                                                                                                          Brokerage

                                                                                                                                                        	
                                                                                                                                                          32

                                                                                                                                                        
	 	
                                                                                                                                                          2.34

                                                                                                                                                        	
                                                                                                                                                          Solvency

                                                                                                                                                        	
                                                                                                                                                          32

                                                                                                                                                        
	 	
                                                                                                                                                          2.35

                                                                                                                                                        	
                                                                                                                                                          Power
      of Attorney

                                                                                                                                                        	
                                                                                                                                                          32

                                                                                                                                                        
	 	
                                                                                                                                                          2.36

                                                                                                                                                        	
                                                                                                                                                          Disclosures

                                                                                                                                                        	
                                                                                                                                                          32

                                                                                                                                                        
	 	 	 
	3.
      	
                                                                                                                                                          REPRESENTATIONS
      AND WARRANTIES OF PURCHASER

                                                                                                                                                        	
                                                                                                                                                          33

                                                                                                                                                        
	 	 	 
	 	
                                                                                                                                                          3.1

                                                                                                                                                        	
                                                                                                                                                          Corporate
      Organization, Etc

                                                                                                                                                        	
                                                                                                                                                          33

                                                                                                                                                        
	 	
                                                                                                                                                          3.2

                                                                                                                                                        	
                                                                                                                                                          Authorization,
      Etc

                                                                                                                                                        	
                                                                                                                                                          33

                                                                                                                                                        
	 	
                                                                                                                                                          3.3

                                                                                                                                                        	
                                                                                                                                                          Brokerage

                                                                                                                                                        	
                                                                                                                                                          34

                                                                                                                                                        
	 	 	 
	4.
      	
                                                                                                                                                          COVENANTS
      OF SELLER COMPANIES AND PARENT

                                                                                                                                                        	
                                                                                                                                                          34

                                                                                                                                                        
	 	 	 
	 	
                                                                                                                                                          4.1

                                                                                                                                                        	
                                                                                                                                                          Regular
      Course of Business

                                                                                                                                                        	
                                                                                                                                                          34

                                                                                                                                                        
	 	
                                                                                                                                                          4.2

                                                                                                                                                        	
                                                                                                                                                          Ownership
      Changes

                                                                                                                                                        	
                                                                                                                                                          34

                                                                                                                                                        
	 	
                                                                                                                                                          4.3

                                                                                                                                                        	
                                                                                                                                                          Capital
      and Other Expenditures

                                                                                                                                                        	
                                                                                                                                                          35

                                                                                                                                                        
	 	
                                                                                                                                                          4.4

                                                                                                                                                        	
                                                                                                                                                          Borrowing

                                                                                                                                                        	
                                                                                                                                                          35

                                                                                                                                                        
	 	
                                                                                                                                                          4.5

                                                                                                                                                        	
                                                                                                                                                          Other
      Commitments

                                                                                                                                                        	
                                                                                                                                                          35

                                                                                                                                                        
	 	
                                                                                                                                                          4.6

                                                                                                                                                        	
                                                                                                                                                          Interim
      Financial Information and Audit

                                                                                                                                                        	
                                                                                                                                                          35

                                                                                                                                                        
	 	
                                                                                                                                                          4.7

                                                                                                                                                        	
                                                                                                                                                          Full
      Access and Disclosure

                                                                                                                                                        	
                                                                                                                                                          35

                                                                                                                                                        
	 	
                                                                                                                                                          4.8

                                                                                                                                                        	
                                                                                                                                                          Fulfillment
      of Conditions Precedent

                                                                                                                                                        	
                                                                                                                                                          36

                                                                                                                                                        
	 	
                                                                                                                                                          4.9

                                                                                                                                                        	
                                                                                                                                                          Minimum
      Account Balance

                                                                                                                                                        	
                                                                                                                                                          36

                                                                                                                                                        
	 	
                                                                                                                                                          4.10

                                                                                                                                                        	
                                                                                                                                                          SEC
      Matters

                                                                                                                                                        	
                                                                                                                                                          36

                                                                                                                                                        
	 	 	 
	5.	
                                                                                                                                                          CLOSING
      CONDITIONS

                                                                                                                                                        	
                                                                                                                                                          36

                                                                                                                                                        
	 	 	 
	 	
                                                                                                                                                          5.1

                                                                                                                                                        	
                                                                                                                                                          Conditions
      to the Obligations of Purchaser

                                                                                                                                                        	
                                                                                                                                                          36

                                                                                                                                                        
	 	
                                                                                                                                                          5.2

                                                                                                                                                        	
                                                                                                                                                          Conditions
      to Obligations of Seller Companies and Parent

                                                                                                                                                        	
                                                                                                                                                          38

                                                                                                                                                        
	 	 	 	 
	6.
      	
                                                                                                                                                          CLOSING

                                                                                                                                                        	
                                                                                                                                                           
      

                                                                                                                                                        	
                                                                                                                                                          39

                                                                                                                                                        
	 	 	 	 
	 	
                                                                                                                                                          6.1

                                                                                                                                                        	
                                                                                                                                                          Closing

                                                                                                                                                        	
                                                                                                                                                          39

                                                                                                                                                        
	 	
                                                                                                                                                          6.2

                                                                                                                                                        	
                                                                                                                                                          Deliveries
      by Seller Companies and Parent

                                                                                                                                                        	
                                                                                                                                                          39

                                                                                                                                                        
	 	
                                                                                                                                                          6.3

                                                                                                                                                        	
                                                                                                                                                          Deliveries
      by Purchaser

                                                                                                                                                        	
                                                                                                                                                          40

                                                                                                                                                        
	 	 	 	 
	7.
      	
                                                                                                                                                          COVENANTS

                                                                                                                                                        	
                                                                                                                                                          41

                                                                                                                                                        
	 	 	 	 
	 	
                                                                                                                                                          7.1

                                                                                                                                                        	
                                                                                                                                                          No
      Solicitation or Negotiation

                                                                                                                                                        	
                                                                                                                                                          41

                                                                                                                                                        
	 	
                                                                                                                                                          7.2

                                                                                                                                                        	
                                                                                                                                                          Transfer
      Tax

                                                                                                                                                        	
                                                                                                                                                          42

                                                                                                                                                        
	 	
                                                                                                                                                          7.3

                                                                                                                                                        	
                                                                                                                                                          Agreement
      to Defend

                                                                                                                                                        	
                                                                                                                                                          42

                                                                                                                                                        
	 	
                                                                                                                                                          7.4

                                                                                                                                                        	
                                                                                                                                                          Further
      Acts and Assurances

                                                                                                                                                        	
                                                                                                                                                          42

                                                                                                                                                        
	 	
                                                                                                                                                          7.5

                                                                                                                                                        	
                                                                                                                                                          Deliveries
      After Closing.

                                                                                                                                                        	
                                                                                                                                                          42

                                                                                                                                                        
	 	
                                                                                                                                                          7.6

                                                                                                                                                        	
                                                                                                                                                          No
      Termination of Seller Companies’ and Parent’s Obligations by Dissolution,
      Etc.

                                                                                                                                                        	
                                                                                                                                                          43

                                                                                                                                                        
	 	
                                                                                                                                                          7.7

                                                                                                                                                        	
                                                                                                                                                          Confidentiality

                                                                                                                                                        	
                                                                                                                                                          43

                                                                                                                                                        
	 	
                                                                                                                                                          7.8

                                                                                                                                                        	
                                                                                                                                                          Public
      Announcements

                                                                                                                                                        	
                                                                                                                                                          43

                                                                                                                                                        
	 	
                                                                                                                                                          7.9

                                                                                                                                                        	
                                                                                                                                                          Non-Competition

                                                                                                                                                        	
                                                                                                                                                          44

                                                                                                                                                        
	 	
                                                                                                                                                          7.10

                                                                                                                                                        	
                                                                                                                                                          Employees

                                                                                                                                                        	
                                                                                                                                                          45

                                                                                                                                                        
	 	
                                                                                                                                                          7.11

                                                                                                                                                        	
                                                                                                                                                          Schedules

                                                                                                                                                        	
                                                                                                                                                          45

                                                                                                                                                        
	 	
                                                                                                                                                          7.12

                                                                                                                                                        	
                                                                                                                                                          Exhibits

                                                                                                                                                        	
                                                                                                                                                          46

                                                                                                                                                        


                                                                                                                                                

                                                                                                                                              

                                                                                                                                               

                                                                                                                                               

                                                                                                                                              
                                                                                                                                                
                                                                                                                                                   

                                                                                                                                                

                                                                                                                                                
                                                                                                                                                  -ii-

                                                                                                                                                  
                                                                                                                                                    

                                                                                                                                                  

                                                                                                                                                

                                                                                                                                                
                                                                                                                                                   

                                                                                                                                                

                                                                                                                                              

                                                                                                                                              
                                                                                                                                                TABLE
OF CONTENTS

                                                                                                                                                (continued)

                                                                                                                                                Page

                                                                                                                                              

                                                                                                                                               

                                                                                                                                               

                                                                                                                                              
                                                                                                                                                
                                                                                                                                                  	 	 	 	 
	8.
      	
                                                                                                                                                          INDEMNIFICATION

                                                                                                                                                        	
                                                                                                                                                          46

                                                                                                                                                        
	 	 	 	 
	 	
                                                                                                                                                          8.1

                                                                                                                                                        	
                                                                                                                                                          Survival

                                                                                                                                                        	
                                                                                                                                                          46

                                                                                                                                                        
	 	
                                                                                                                                                          8.2

                                                                                                                                                        	
                                                                                                                                                          Limitations

                                                                                                                                                        	
                                                                                                                                                          47

                                                                                                                                                        
	 	
                                                                                                                                                          8.3

                                                                                                                                                        	
                                                                                                                                                          Indemnification
      by Seller Companies and Parent

                                                                                                                                                        	
                                                                                                                                                          47

                                                                                                                                                        
	 	
                                                                                                                                                          8.4

                                                                                                                                                        	
                                                                                                                                                          Indemnification
      by Purchaser

                                                                                                                                                        	
                                                                                                                                                          49

                                                                                                                                                        
	 	
                                                                                                                                                          8.5

                                                                                                                                                        	
                                                                                                                                                          Third-Party
      Claims

                                                                                                                                                        	
                                                                                                                                                          49

                                                                                                                                                        
	 	
                                                                                                                                                          8.6

                                                                                                                                                        	
                                                                                                                                                          Payment
      of Indemnification Amounts

                                                                                                                                                        	
                                                                                                                                                          51

                                                                                                                                                        
	 	
                                                                                                                                                          8.7

                                                                                                                                                        	
                                                                                                                                                          Security
      for the Indemnification Obligation; Right of Set-Off

                                                                                                                                                        	
                                                                                                                                                          51

                                                                                                                                                        
	 	
                                                                                                                                                          8.8

                                                                                                                                                        	
                                                                                                                                                          Adjustment
      to Purchase Price

                                                                                                                                                        	
                                                                                                                                                          51

                                                                                                                                                        
	 	
                                                                                                                                                          8.9

                                                                                                                                                        	
                                                                                                                                                          Breach

                                                                                                                                                        	
                                                                                                                                                          51

                                                                                                                                                        
	 	 	 
	9.
      	
                                                                                                                                                          TERMINATION,
      AMENDMENT AND WAIVER

                                                                                                                                                        	
                                                                                                                                                          52

                                                                                                                                                        
	 	 	 
	 	
                                                                                                                                                          9.1

                                                                                                                                                        	
                                                                                                                                                          Termination

                                                                                                                                                        	
                                                                                                                                                          52

                                                                                                                                                        
	 	
                                                                                                                                                          9.2

                                                                                                                                                        	
                                                                                                                                                          Effect
      of Termination

                                                                                                                                                        	
                                                                                                                                                          52

                                                                                                                                                        
	 	
                                                                                                                                                          9.3

                                                                                                                                                        	
                                                                                                                                                          Extension;
      Waiver

                                                                                                                                                        	
                                                                                                                                                          52

                                                                                                                                                        
	 	 	 
	10.
      	
                                                                                                                                                          DEFINITIONS

                                                                                                                                                        	
                                                                                                                                                          53

                                                                                                                                                        
	 	 	 
	11.
      	
                                                                                                                                                          MISCELLANEOUS

                                                                                                                                                        	
                                                                                                                                                          62

                                                                                                                                                        
	 	
                                                                                                                                                          11.1

                                                                                                                                                        	
                                                                                                                                                          Schedules
      and Other Instruments

                                                                                                                                                        	
                                                                                                                                                          62

                                                                                                                                                        
	 	
                                                                                                                                                          11.2

                                                                                                                                                        	
                                                                                                                                                          Additional
      Assurances

                                                                                                                                                        	
                                                                                                                                                          62

                                                                                                                                                        
	 	
                                                                                                                                                          11.3

                                                                                                                                                        	
                                                                                                                                                          Consented
      Assignment

                                                                                                                                                        	
                                                                                                                                                          62

                                                                                                                                                        
	 	
                                                                                                                                                          11.4

                                                                                                                                                        	
                                                                                                                                                          Legal
      Fees and Costs

                                                                                                                                                        	
                                                                                                                                                          63

                                                                                                                                                        
	 	
                                                                                                                                                          11.5

                                                                                                                                                        	
                                                                                                                                                          Benefit;
      Assignment

                                                                                                                                                        	
                                                                                                                                                          63

                                                                                                                                                        
	 	
                                                                                                                                                          11.6

                                                                                                                                                        	
                                                                                                                                                          Cost
      of Transactions

                                                                                                                                                        	
                                                                                                                                                          63

                                                                                                                                                        
	 	
                                                                                                                                                          11.7

                                                                                                                                                        	
                                                                                                                                                          Waiver
      of Breach

                                                                                                                                                        	
                                                                                                                                                          63

                                                                                                                                                        
	 	
                                                                                                                                                          11.8

                                                                                                                                                        	
                                                                                                                                                          Notice

                                                                                                                                                        	
                                                                                                                                                          63

                                                                                                                                                        
	 	
                                                                                                                                                          11.9

                                                                                                                                                        	
                                                                                                                                                          Performance

                                                                                                                                                        	
                                                                                                                                                          64

                                                                                                                                                        
	 	
                                                                                                                                                          11.10

                                                                                                                                                        	
                                                                                                                                                          Severability

                                                                                                                                                        	
                                                                                                                                                          64

                                                                                                                                                        
	 	
                                                                                                                                                          11.11

                                                                                                                                                        	
                                                                                                                                                          Gender
      and Number

                                                                                                                                                        	
                                                                                                                                                          65

                                                                                                                                                        
	 	
                                                                                                                                                          11.12

                                                                                                                                                        	
                                                                                                                                                          Divisions
      and Headings

                                                                                                                                                        	
                                                                                                                                                          65

                                                                                                                                                        
	 	
                                                                                                                                                          11.13

                                                                                                                                                        	
                                                                                                                                                          Entire
      Agreement; Amendment

                                                                                                                                                        	
                                                                                                                                                          65

                                                                                                                                                        
	 	
                                                                                                                                                          11.14

                                                                                                                                                        	
                                                                                                                                                          Counterpart

                                                                                                                                                        	
                                                                                                                                                          65

                                                                                                                                                        
	 	
                                                                                                                                                          11.15

                                                                                                                                                        	
                                                                                                                                                          No
      Third Party Beneficiaries

                                                                                                                                                        	
                                                                                                                                                          65

                                                                                                                                                        
	 	
                                                                                                                                                          11.16

                                                                                                                                                        	
                                                                                                                                                          Schedules

                                                                                                                                                        	
                                                                                                                                                          65

                                                                                                                                                        
	 	
                                                                                                                                                          11.17

                                                                                                                                                        	
                                                                                                                                                          Injunctive
      Relief

                                                                                                                                                        	
                                                                                                                                                          65

                                                                                                                                                        
	 	
                                                                                                                                                          11.18

                                                                                                                                                        	
                                                                                                                                                          Delays
      or Omissions

                                                                                                                                                        	
                                                                                                                                                          66

                                                                                                                                                        
	 	
                                                                                                                                                          11.19

                                                                                                                                                        	
                                                                                                                                                          Waiver
      of Jury Trial

                                                                                                                                                        	
                                                                                                                                                          66

                                                                                                                                                        
	 	
                                                                                                                                                          11.20

                                                                                                                                                        	
                                                                                                                                                          Choice
      of Law; Venue

                                                                                                                                                        	
                                                                                                                                                          66

                                                                                                                                                        
	 	
                                                                                                                                                          11.21

                                                                                                                                                        	
                                                                                                                                                          Tax
      Advice and Reliance

                                                                                                                                                        	
                                                                                                                                                          66

                                                                                                                                                        
	 	
                                                                                                                                                          11.22

                                                                                                                                                        	
                                                                                                                                                          No
      Strict Construction

                                                                                                                                                        	
                                                                                                                                                          67

                                                                                                                                                        
	 	
                                                                                                                                                          11.23

                                                                                                                                                        	
                                                                                                                                                          Interpretation

                                                                                                                                                        	
                                                                                                                                                          67

                                                                                                                                                        


                                                                                                                                                

                                                                                                                                              

                                                                                                                                            

                                                                                                                                          

                                                                                                                                        

                                                                                                                                      

                                                                                                                                    

                                                                                                                                  

                                                                                                                                

                                                                                                                              

                                                                                                                            

                                                                                                                          

                                                                                                                        

                                                                                                                      

                                                                                                                    

                                                                                                                  

                                                                                                                

                                                                                                              

                                                                                                            

                                                                                                          

                                                                                                        

                                                                                                      

                                                                                                    

                                                                                                  

                                                                                                

                                                                                              

                                                                                            

                                                                                          

                                                                                        

                                                                                      

                                                                                    

                                                                                  

                                                                                

                                                                              

                                                                            

                                                                          

                                                                        

                                                                      

                                                                    

                                                                  

                                                                

                                                              

                                                            

                                                          

                                                        

                                                      

                                                    

                                                  

                                                

                                              

                                            

                                          

                                        

                                      

                                    

                                  

                                

                              

                            

                          

                        

                      

                    

                  

                

              

            

          

        

      

    

    


     

    


    
      
         

      

      
        -iii-

        
          

        

      

      
         

      

    

     

    Exhibits

     

    
      
        
          	
                  1.2(a)

                	
                  Form
      Assumption Agreement

                
	
                  1.3(a)

                	
                  Form
      Bill of Sale

                
	
                  1.3(b)

                	
                  Form
      Assignment of Lease

                
	
                  1.3(d)

                	
                  Form
      Consent to Assignment

                
	
                  1.7.1

                	
                  Form
      Escrow Agreement

                
	
                  5.1.7

                	
                  Form
      Management Services Agreement

                
	
                  6.2.9

                	
                  Parent
      and Seller Companies’ Secretary’s Certificate

                
	
                  6.2.11(i)

                	
                  Parent
      and Seller Companies’ Officers’ Certificate - Bring Down or
      Representations and Warranties, No MAC, and No
  Litigation

                
	
                  6.2.11(ii)

                	
                  Parent
      and Seller Companies’ Officer’s Certificate – Indebtedness and Accuracy of
      Financial Statements

                
	
                  6.2.12

                	
                  Parent
      and Seller Companies’ Counsel Opinion

                
	
                  6.3.3

                	
                  Purchaser’s
      Secretary’s Certificate

                


        

      

    

     

    Schedules

     

    
      
        
          	
                  1.1

                	
                  Excluded
      Assets

                
	
                  1.2(a)

                	
                  Assumed
      Obligations

                
	
                  1.6

                	
                  Assumed
      Indebtedness

                
	
                  1.8.1

                	
                  Closing
      Date Working Capital Calculation Procedures

                
	
                  2.1(a)

                	
                  Jurisdictions
      of Qualification

                
	
                  2.1(b)

                	
                  Organizational
      Documents

                
	
                  2.4

                	
                  Directors,
      Officers and Managers

                
	
                  2.5.2

                	
                  No
      Violation

                
	
                  2.6.1

                	
                  Title
      Matters

                
	
                  2.6.2

                	
                  Lease
      Contracts and Liens

                
	
                  2.6.4

                	
                  Improvements

                
	
                  2.7.1

                	
                  Financial
      Statements

                
	
                  2.7.2

                	
                  Indebtedness

                
	
                  2.7.3

                	
                  Guarantees

                
	
                  2.9

                	
                  Accounts
      Receivable

                
	
                  2.10.1

                	
                  Material
      Contracts

                
	
                  2.10.4

                	
                  Bids
      and Proposals

                
	
                  2.10.5

                	
                  Termination
      Notices

                
	
                  2.10.6

                	
                  Required
      Consents

                
	
                  2.11

                	
                  Government
      Contracts

                
	
                  2.12

                	
                  Litigation

                
	
                  2.14

                	
                  Banking
      Arrangements

                
	
                  2.15

                	
                  Liens,
      Indebtedness and Collateral

                
	
                  2.16

                	
                  Licenses

                
	
                  2.17.2

                	
                  HIPAA
      Compliance

                
	
                  2.19

                	
                  Physicians

                


        

         

         

        
          
             

          

          
            -iv-

            
              

            

          

          
             

          

        

        
          
            TABLE
OF CONTENTS

            (continued)

            Page

          

           

           

        

        
          	
                  2.19.3

                	
                  Actions
      and Investigations

                
	
                  2.21.1

                	
                  Intellectual
      Property

                
	
                  2.21.2

                	
                  Intellectual
      Property Licenses

                
	
                  2.21.5

                	
                  Intellectual
      Property Claims

                
	
                  2.21.8

                	
                  General
      Public Licenses

                
	
                  2.22

                	
                  Employee
      Benefit Plans

                
	
                  2.23

                	
                  Employees

                
	
                  2.24

                	
                  Insurance
      Coverage

                
	
                  2.26

                	
                  Consents

                
	
                  2.27

                	
                  Environmental
      Matters

                
	
                  2.31

                	
                  Capital
      Expenditures and Investments

                
	
                  2.32

                	
                  Dealings
      with Affiliates

                
	
                  3.2.2

                	
                  No
      Violation

                


        

      

    

     

     

    
 

    
      
         

      

      
        -v-

        
          

        

      

      
         

      

    

    ASSET PURCHASE
AGREEMENT

     

    This
ASSET PURCHASE AGREEMENT
(the “Agreement”), is entered into
as of January 30, 2009, by and among HEALTH DIAGNOSTICS OF NEW JERSEY,
L.L.C., a New Jersey limited liability company (“Purchaser”), MODERN MEDICAL MODALITIES
CORPORATION, a New Jersey corporation (“Parent”), UNION IMAGING ASSOCIATES,
INC., a New Jersey corporation and wholly-owned subsidiary of Parent
(“UIA”), UNION IMAGING CENTER, LLC, a
New Jersey limited liability company and wholly-owned subsidiary of Parent
(“UIC”), and PET SCAN AT UNION IMAGING,
LLC, a New Jersey limited liability company and wholly-owned subsidiary
of Parent (“PET” and
together with UIA and UIC, individually a “Seller Company” and
collectively, “Seller
Companies”). Terms used herein and not otherwise defined shall have the
meanings set forth in Section 10
hereof.

     

    RECITALS

     

    WHEREAS, PET operates a
diagnostic imaging center (the “PET Center”) located at 418
Chestnut Street, Suite A, Union, New Jersey 07083 (the “PET Location”);

     

    WHEREAS, UIC and the JV
operate a diagnostic imaging center (the “UIC Center” and, together with
the PET Center, the “Imaging
Centers”) located at 441-445 Chestnut Street, Union, New Jersey 07083
(the “UIC
Location”);

     

    WHEREAS, Parent leases office
space and a storage facility located at 439 Chestnut Street, Union, New Jersey
(the “Storage Location”,
and together with the PET Location and the UIC Location, the “Locations”);

     

    WHEREAS, all of such business
operations and initiatives conducted at the Imaging Centers are collectively
referred to herein as the “Business”;

     

    WHEREAS, pursuant to the terms
of that certain Lease and Management Agreement dated as of July 30, 1991 by and
between UIA and Howard Kessler, M.D., P.A. d/b/a Union Imaging Associates, P.A.,
a New Jersey professional association (the “PA”), the PA provides certain
billing and professional reading services to each of the Imaging Centers (the
“Existing Services
Agreement”);

     

    WHEREAS, this Agreement is
entered into to enable Purchaser to (i) acquire all of the Acquired Assets,
except the Excluded Assets, used by or in connection with the Business, (ii)
assume the Assumed Obligations, except the Retained Liabilities, with respect to
the Business and (iii) assume the Assumed Indebtedness, subject to the terms
hereof; and

     

    WHEREAS, the Board of
Directors or Board of Managers, as applicable, of Parent and each Seller Company
have approved the sale of the Acquired Assets to, and the Assumption of the
Assumed Obligations and the Assumed Indebtedness by, Purchaser, upon the terms
and subject to the conditions set forth herein.

     

    
      
         

      

      
        - 1
-

        
          

        

      

      
         

      

    

    NOW, THEREFORE, in
consideration of the above premises, the representations and warranties,
covenants and agreements, and subject to the conditions contained herein, and
for other good and valuable consideration, the receipt and adequacy of which are
hereby conclusively acknowledged, Parent, Seller Companies and Purchaser,
intending to become legally bound, hereby agree as follows:

     

    1. Purchase Of Acquired
Assets

     

    1.1 Purchase
and Sale of Acquired Assets.  Subject to the terms and
conditions of this Agreement, Parent and each applicable Seller Company agrees
to sell, assign, convey and transfer to Purchaser, and Purchaser agrees to
purchase from each applicable Seller Company or Parent (as the case may be), at
the Closing, all of the assets used by or in connection with the Business,
wherever located, including, but not limited to, medical imaging equipment,
current inventory, accounts receivable, machinery, fixtures and other equipment,
leasehold improvements, intellectual property (to the extent transferable),
Contracts to which any Seller Company is a party, books and records, rights to
all of Seller Companies’ Claims against third parties (with the exception of any
Claims arising out of the Excluded Assets or Excluded Liabilities), prepaid
expenses, customer lists, Licenses (to the extent transferable), Seller
Companies’ corporate, financial and similar records, patient records, medical
licenses, other medical assets and other intangibles, free and clear of any
Liens, Claims and Orders (other than the Permitted Liens) (collectively, the
“Acquired Assets”),
except for the assets specifically set forth on Schedule 1.1 attached
hereto (collectively, the “Excluded
Assets”).

     

    1.2 Assumed
Obligations.  At the Closing, Purchaser shall assume and agree
to pay, satisfy, perform and discharge as the same shall become due only the
liabilities of Seller Companies, including all post-Closing obligations under
(i) existing Contracts that are included among the Acquired Assets (other than
obligations or liabilities as the result of the breach of any such Contract
prior to the Closing Date), (ii) capital leases of Seller Companies set forth on
Schedule 1.2(a)
attached hereto and (iii) operating leases of Seller Companies set forth on
Schedule 1.2(a)
attached hereto (other than obligations relating to defaults thereunder that
arose prior to the Closing) (the “Assumed Obligations”),
pursuant to an Assumption Agreement substantially in the form of Exhibit 1.2(a)
attached hereto (the “Assumption Agreement”). Each
of the Contracts assumed hereunder is independently assumed subject to the
representations, warranties (including that such Contract is not in default on
the Closing Date), covenants and conditions made herein as to that
Contract.  Except as expressly set forth in this Section 1.2 and
Schedule 1.2(a)
attached hereto, Purchaser shall not assume or otherwise be responsible at any
time for any liability, obligation, debt or commitment of any Seller Company or
Parent, whether absolute or contingent, accrued or unaccrued, asserted or
unasserted, or otherwise, including, but not limited to, any liabilities,
obligations, debts or commitments of Seller Companies or Parent (a) incident to,
arising out of or incurred with respect to this Agreement and the agreements,
documents, instruments, and transactions contemplated hereby, (b) which
otherwise arise or are asserted or incurred by reason of events, acts or
transactions occurring, or the operation of the Business, prior to or on the
Closing Date, (c) for outstanding checks and other similar obligations, (d)
relating to the employee benefit plans, employee policies, employee Contracts,
employee programs and/or arrangements of Seller Companies or any of their
Subsidiaries and Affiliates with Employees (including, but not limited to, any
severance or bonus payments payable to any Employee of any Seller Company), (e)
relating to Product Liability Claims, (f) relating to Taxes, (i) attributable to
the Acquired Assets or the Business with respect to any taxable period or
portion thereof that ends on or prior to the Closing Date or (ii) imposed on any
Seller Company or Parent; or (g) relating to medical malpractice (collectively,
the “Excluded
Liabilities”).  Parent and Seller Companies agree to satisfy
and discharge each of the Excluded Liabilities as the same shall become
due.  Purchaser’s assumption of the Assumed Obligations shall in no
way expand the rights or remedies of third parties against Purchaser as compared
to the rights and remedies that such parties would have had against Parent or
any Seller Company had this Agreement not been consummated.

     

    
      
         

      

      
        - 2
-

        
          

        

      

      
         

      

    

    1.3 Method of
Conveyance.  The sale, transfer, conveyance and assignment by
the applicable Seller Companies of the Acquired Assets to Purchaser in
accordance with Section 1.1 hereof
shall be effected on the Closing Date at the Closing by the applicable Seller
Companies’ execution and delivery to Purchaser of instruments of transfer
including: (a) the bill of sale in substantially the form of Exhibit 1.3(a)
attached hereto (the “Bill of
Sale”), (b) an assignment of each of Seller Company’s facility leases
used in connection with the Business in substantially the form of Exhibit 1.3(b)
attached hereto (each, an “Assignment of Lease”), and (c)
consents to the assignment of Contracts by third parties thereto in the form of
Exhibit 1.3(d)
attached hereto.  On the Closing Date, all of the Acquired Assets
shall be transferred by the applicable Seller Companies to Purchaser free and
clear of any and all Liens, Claims and Orders.

     

    1.4 Purchase
Price.  In consideration for the conveyance of the Acquired
Assets, and in reliance on the representations and warranties, covenants and
agreements of Parent and Seller Companies contained herein and the agreements,
documents, instruments, and transactions contemplated hereby, Purchaser agrees
to assume the Assumed Obligations and shall pay to Seller Companies an aggregate
cash amount equal to (i) Eight Million Eight Hundred Thousand Dollars
($8,800,000.00); minus (ii) the
aggregate amount of Seller Companies’ Assumed Indebtedness calculated as of the
Closing Date; minus (iii) the
Imaging Centers Capital Expenditures; minus (iv) the Escrow
Amount; plus or
minus (v) the
Purchase Price adjustments set forth in Section 1.8.1 (such net amount being
referred to as the “Purchase
Price”).  The Purchase Price shall be paid to Seller Companies
by wire transfer of immediately available funds on the Closing
Date.

     

    1.5 Allocation
of Purchase Price.  Parent, Seller Companies and Purchaser
agree to allocate the aggregate Purchase Price and, to the extent required, the
Assumed Liabilities and relevant transaction costs, among the Acquired Assets in
accordance with Section 1060 of the Code.  Parent, Seller Companies
and Purchaser agree that Purchaser shall prepare and provide to a draft
allocation of the of the purchase price among the Acquired Assets within five
(5) days before the Closing Date, which shall be mutually agreed to by
Purchaser, Parent and Seller Companies in good faith within ninety (90) days
after the Closing Date. Parent or Seller Companies shall notify Purchaser within
thirty (30) days of receipt of such draft allocation of any objection Parent or
Seller Companies may have thereto.  Parent, Seller Companies and
Purchaser agree to resolve any disagreement with respect to such allocation in
good faith.  Parent, Seller Companies and Purchaser (i) hereby
undertake and agree to file timely any information that may be required to be
filed pursuant to Treasury Regulations promulgated under Section 1060(b) of the
Code, and shall use the allocation determined pursuant to this Section 1.5 in
connection with the preparation of Internal Revenue Service Form 8594 as such
form relates to the transactions contemplated by this Agreement and (ii) shall
each timely report the federal, state and local income and other Tax
consequences of the transactions contemplated by this Agreement in a manner
consistent with such allocation, including the preparation and filing of Form
8594 under Section 1060 of the Code (or any successor form or successor
provision of any future Tax law, and any comparable provision of state, or local
Tax law) with their respective federal, state and local income Tax returns for
the taxable year that includes the Closing Date.  Neither Purchaser
nor any Seller Company shall file any Tax Return inconsistent with the
allocation determined pursuant to this Section 1.5 except as
may be adjusted by subsequent agreement following an audit by the IRS or by
court decision.

     

    
      
         

      

      
        - 3
-

        
          

        

      

      
         

      

    

    1.6 Assumed
Indebtedness.  In addition to the Assumed Obligations, and
subject to the Purchase Price adjustments set forth in Section 1.4, Purchaser
shall assume Seller Companies’ outstanding Indebtedness as of the Closing Date
specifically set forth on Schedule 1.6 attached
hereto (“Assumed
Indebtedness”); provided, that such
Assumed Indebtedness is properly and accurately reflected in the Financial
Statements and shall not exceed an aggregate amount of One Million Six Hundred
Thousand Dollars ($1,600,000) (“Indebtedness
Cap”).  In the event the calculation of the Assumed
Indebtedness is greater than the Indebtedness Cap, Parent and Seller Companies
shall be liable and responsible, jointly and severally, for such Indebtedness in
excess of the Indebtedness Cap.

     

    1.7 Escrow
Amount.

     

    1.7.1 On the
Closing Date, Purchaser shall deposit with the Escrow Agent an aggregate cash
amount equal to Six Hundred Fifty Thousand Dollars ($650,000) (the “Escrow Amount”) for the
purpose of securing the indemnification obligations of Seller Companies and
Parent and the post-closing adjustments of the Purchase Price set forth in this
Agreement, of which (i) Five Hundred Thousand Dollars ($500,000) (the “Indemnification Escrow
Amount”) may be used by Purchaser, in its sole and absolute discretion,
to satisfy any indemnification Claim under this Agreement or any agreement or
instrument contemplated by this Agreement, and (ii) One Hundred Fifty Thousand
Dollars ($150,000) (the “Working Capital Escrow
Amount”) may be used by Purchaser, in its sole and absolute discretion,
to satisfy the post-Closing adjustments of the Purchase Price pursuant to
Section 1.8.  The Escrow Amount shall be held by the Escrow Agent
pursuant to the terms of the escrow agreement substantially in the form of Exhibit 1.7.1
attached hereto (the “Escrow
Agreement”).  The Escrow Amount shall be held as a trust fund
and shall not be subject to any Lien, attachment, trustee process or any other
judicial process of any creditor of any party, and shall be held and disbursed
solely for the purposes and in accordance with the terms of the Escrow
Agreement.

     

    1.7.2 Subject
to the terms and conditions of the Escrow Agreement, not later than six (6)
months after the Closing Date, Purchaser and Parent will cause the Escrow Agent
to remit to Parent Two Hundred Fifty Thousand Dollars ($250,000) of the
Indemnification Escrow Amount, less the sum of any amounts which are owed to or
have been retained by Purchaser from the Indemnification Escrow Amount in
satisfaction of any indemnification Claims of Purchaser, any pending, unresolved
Claims of Purchaser, or any other obligations of any of the Seller Companies or
Parent under this Agreement or any agreements, documents, instruments, and
transactions contemplated hereby.

     

    
      
         

      

      
        - 4
-

        
          

        

      

      
         

      

    

    1.7.3 Subject
to the terms and conditions of the Escrow Agreement, not later than twelve (12)
months after the Closing Date, Purchaser and Parent will cause the Escrow Agent
to remit to Seller the remaining Indemnification Escrow Amount held by
Purchaser, less the sum of any amounts which are owed to or have been retained
by Purchaser from the Indemnification Escrow Amount in satisfaction of any
indemnification Claims of Purchaser, any pending, unresolved Claims of
Purchaser, or any other obligations of any of Seller Companies or Parent under
this Agreement or any agreements, documents, instruments, and transactions
contemplated hereby (other than any amounts retained under Section
1.7.2).

     

    1.7.4 Upon the
final resolution of any unresolved Claims of Purchaser, if it is determined that
all, or any portion of the remaining Indemnification Escrow Amount, is due to
Parent, Purchaser and Parent shall cause the Escrow Agent to make such payment
to Parent, less any amount due to Purchaser.

     

    1.7.5 Purchaser
shall have the right, in its sole and absolute discretion, to satisfy any amount
owed to Purchaser in satisfaction of any indemnification Claim or any other
obligations of any of the Seller Companies or Parent under this Agreement or any
agreements, documents, instruments, and transactions contemplated hereby from
the Indemnification Escrow Amount or to recover such amounts directly from any
of the Seller Companies and Parent, jointly and severally, or recover such
amount from any remaining portion of the Working Capital Escrow Amount, or any
combination of the foregoing.

     

    1.7.6 None of
the indemnification Claims of Purchaser under this Agreement or any agreements,
documents, instruments, and transactions contemplated hereby shall be limited by
the amount of the Indemnification Escrow Amount or limit Purchaser’s rights and
remedies under this Agreement or any agreements, documents, instruments, and
transactions contemplated hereby, including, but not limited to, Section
8.

     

    1.7.7 Subject
to the terms and conditions of the Escrow Agreement, the Working Capital Escrow
Amount shall be held by the Escrow Agent and released on the applicable
Settlement Date.

     

    1.7.8 Purchaser
shall have the right, in its sole and absolute discretion, to satisfy any amount
owed to Purchaser in satisfaction of any Working Capital Shortfall, which shall
not be subject to the Hurdle Rate, determined in accordance with Section 1.8
from the Working Capital Escrow Amount or to recover such amounts directly from
any of the Seller Companies and Parent, jointly and severally, or recover such
amount from any remaining portion of the Indemnification Escrow Amount, or any
combination of the foregoing.

     

    1.7.9 None of
the Working Capital Shortfall Purchase Price adjustments under this Agreement
shall be limited by the amount of the Working Capital Escrow Amount or limit
Purchaser’s rights and remedies under this Agreement, including, but not limited
to, Section 1.8.

     

    1.7.10 The
adoption of this Agreement and the approval of the transactions hereby by the
board of directors of Parent and the stockholders (or members, as applicable)
and board of directors (or similar managing body) of each Seller Company shall
each constitute approval of the Escrow Agreement and of all of the arrangements
relating thereto, including without limitation the placement in escrow of the
Escrow Amount.

     

    
      
         

      

      
        - 5
-

        
          

        

      

      
         

      

    

    1.8 Purchase
Price Adjustments.

     

    1.8.1 Post-Closing
Adjustments.  No later than ninety (90) days following the
Closing Date, Purchaser shall cause its accountants to prepare and deliver to
Parent an unaudited balance sheet (the “Closing Date Balance Sheet”)
and a calculation of the Closing Date Working Capital, each as of the Closing
Date, which shall be prepared by Purchaser in accordance with GAAP and the
procedures set forth on Schedule 1.8.1
attached hereto. Purchaser shall also make available to Parent copies of all
work papers and other documents and data as was used to calculate the Closing
Date Balance Sheet.  Parent shall have the right to dispute the
Closing Date Balance Sheet (and any items therein) and the Closing Date Working
Capital calculation and make any proposed adjustments thereto as provided in
Section 1.8.2.

     

    (a) If it is
determined there is a Working Capital Shortfall, the amount of such Working
Capital Shortfall shall be paid by Parent or released from the Escrow Amount, as
determined by Purchaser in it sole and absolute discretion, to Purchaser on the
applicable Settlement Date.

     

    (b) If it is
determined that there is a Working Capital Surplus, the amount of such Working
Capital Surplus shall be paid by Purchaser to Parent on the applicable
Settlement Date.

     

    (c) In the
event a Working Capital Shortfall is not paid to Purchaser on the Settlement
Date pursuant to Section 1.8.1(a) (unless due to the fault of Purchaser), Parent
shall also pay to Purchaser interest on the amount of the Working Capital
Shortfall at a rate of fifteen percent (15%) per annum, which shall accrue from
the Closing Date to the date of actual payment.  In the event a
Working Capital Surplus is not paid to Parent on the Settlement Date pursuant to
Section 1.8.1(b) (unless due to the fault of Parent), Purchaser shall also pay
to Parent interest on the amount of the Working Capital Surplus at a rate of
fifteen percent (15%) per annum, which shall accrue from the Closing Date to the
date of actual payment.

     

    1.8.2 Dispute
Resolution Procedures.  Parent shall
have until five (5) days after the delivery of the Closing Date Working Capital
calculation, to review such calculation and propose any adjustments
thereto.  All adjustments proposed by Parent shall be set out in
detail in a written statement delivered to Purchaser (the “Adjustment Statement”) and
shall be incorporated into the Closing Date Balance Sheet, unless Purchaser
shall object in writing to such proposed adjustments (the proposed adjustment or
adjustments to which Purchaser objects are referred to herein as the “Contested Adjustments” and
Purchaser’s objection notice is referred to herein as the “Contested Adjustment Notice”)
within five (5) days of delivery by Parent to Purchaser of the Adjustment
Statement.  If Purchaser delivers a Contested Parent Adjustment Notice
to Parent, Purchaser and Parent shall attempt in good faith to resolve their
dispute regarding the Contested Adjustments, but if a final resolution thereof
is not obtained within five (5) days after Purchaser delivers to Parent said
Contested Adjustment Notice, either Purchaser or Parent may retain for the
benefit of all the parties hereto a nationally recognized independent accounting
firm acceptable to both Parent and Purchaser (the “Independent Accountant”) to
resolve any remaining disputes concerning the Contested
Adjustments.  If the Independent Accountant is retained, then (i)
Parent and Purchaser shall each submit to the Independent Accountant in writing
not later than five (5) days after the Independent Accountant is retained their
respective positions with respect to the Contested Adjustments, together with
such supporting documentation as they deem necessary or as the Independent
Accountant requests, and (ii) the Independent Accountant shall, within thirty
(30) days after receiving the positions of both Parent and Purchaser and all
supplementary supporting documentation requested by the Independent Accountant,
render its decision as to the Contested Adjustments, which decision shall be
final and binding on, and nonappealable by, Parent and Purchaser.  The
fees and expenses of the Independent Accountant shall be paid by the party whose
estimate of the Closing Date Working Capital is furthest from the Independent
Accountant’s calculation of the Closing Date Working Capital.  The
decision of the Independent Accountant shall also include a certificate of the
Independent Accountant setting forth the final Closing Date Working Capital
calculation (the “Settlement
Amount Certificate”).  The Closing Date Balance Sheet shall be
deemed to include all proposed adjustments not disputed by Purchaser and those
adjustments accepted or made by the decision of the Independent Accountant in
resolving the Contested Adjustments.

     

    
      
         

      

      
        - 6
-

        
          

        

      

      
         

      

    

    1.8.3 There
shall be a “Settlement
Date” after the calculation of the Closing Date Working Capital which
shall mean the following, as applicable:

     

    (a) If Parent
has not timely delivered an Adjustment Statement to Purchaser, fifteen (15) days
after the date Parent receives the Closing Date Working Capital
calculation;

     

    (b) If Parent
has timely delivered an Adjustment Statement and Purchaser has not timely
delivered a Contested Adjustment Notice, five (5) days after the date Purchaser
receives the Adjustment Statement;

     

    (c) If Parent
and Purchaser have any disputes regarding Contested Adjustments and they resolve
those disputes without the Independent Accountant, five (5) business days after
such resolution;

     

    (d) Five (5)
business days after the Independent Accountant delivers the Settlement Amount
Certificate, if applicable; or

     

    (e) Such
other date as shall be agreed between Parent and Purchaser.

     

    2. Representations
And Warranties of Parent and Seller Companies.  Parent and each
Seller Company, jointly and severally, represents and warrants to Purchaser as
of the date hereof and as of the Closing Date as set forth below in this Section
2.  Each of the representations and warranties shall be deemed
material and Purchaser, in executing, delivering and consummating the
transactions under this Agreement, has relied and will rely upon the correctness
and completeness of each representation and warranty notwithstanding any
independent investigation and all the representations and warranties are
provided by Parent and Seller Companies to induce Purchaser to enter into this
Agreement and consummate the transactions contemplated hereby.

     

    
      
         

      

      
        - 7
-

        
          

        

      

      
         

      

    

    2.1 Corporate
Organization, Etc..  Parent and each Seller Company is an
entity duly organized, validly existing and in good standing under the laws of
its jurisdiction of incorporation with full corporate or limited liability
company power and authority to carry on its business as it is now being
conducted and to own, operate and lease its properties and
assets.  Parent and each Seller Company is duly qualified or licensed
to do business and is in corporate and Tax good standing in every jurisdiction
in which the conduct of its business, the ownership or lease of its properties,
require it to be so qualified or licensed. Such jurisdictions are set forth in
Schedule 2.1(a)
attached hereto. True, complete and correct copies of Parent’s and each Seller
Company’s charter, articles of organization and bylaws (or similar documents, as
the case may be) as presently in effect are set forth in Schedule 2.1(b)
attached hereto. As of the date hereof, neither UIC nor PET has an operating
agreement, limited liability company agreement or other similar governance
document presently existing or in effect.

     

    2.2 Ownership. All of the authorized,
issued and outstanding equity interests, Options, and securities that are
convertible into, or exchangeable for, equity interests of each of Seller
Companies on a fully diluted basis as of the date hereof (the “Equity Interests”), and
without giving effect to any of the transactions contemplated hereby, are held
beneficially and of record by Parent.  All of the Equity Interests are
duly authorized, validly issued, fully paid and nonassessable, are free and
clear of any and all Liens, Orders, Contracts or other limitations whatsoever,
other than the Permitted Liens, and have been issued in compliance with all
applicable securities laws.  Parent is the record and beneficial owner
and holder of, and has good and marketable title to, the Equity Interests, free
and clear of any and all Liens, Orders, Contracts or other limitations
whatsoever, other than the Permitted Liens.  All of the Equity
Interests were acquired from third parties or Seller Companies in compliance
with all applicable Regulations, free and clear of any rescission and Contract
rights.  There are no existing agreements, Options, warrants, rights,
calls or commitments of any character to which any Seller Company is a party, or
by which any Seller Company is bound, providing for the issuance of any
additional Equity Interests, or for the repurchase or redemption of Equity
Interests, the voting, transfer, encumbrance of the Equity Interests or any
aspect of any Seller Company’s governance or dividends or distributions. There
are no outstanding Options or other instruments convertible into or exchangeable
for Equity Interests and no commitments to issue or sell such Equity
Interests.  No Seller Company has redeemed any Equity Interests in
violation of any Contract, Order or Regulation and there are no existing
Contracts or Options between Parent on the one hand, and any other Person, on
the other hand, regarding the Equity Interests.  No Seller Company has
any Contracts containing any profit participation features, stock appreciation
rights or phantom stock options, or similar Contracts that allow any Person to
participate in the equity of any Seller Company.  The equity ownership
record books of Seller Companies that have been delivered to Purchaser for
inspection prior to the date hereof are complete and correct in all material
respects.

     

    2.3 Subsidiaries.  No Seller Company
owns or is obligated, or has a right to, purchase any equity interest in or any
other security convertible into or exchangeable for an equity interest in any
entity.

     

    2.4 Books and
Records.  The minute books
of Seller Companies that have been made available to Purchaser for inspection
are complete and correct in all material respects and contain all of the
proceedings of the directors and managers of each Seller Company, as
applicable.  A true and complete list of the incumbent managers,
directors and officers of each Seller Company, as applicable, is set forth in
Schedule 2.4
attached hereto.  No Seller Company has any of its records, systems,
controls, data or information recorded, stored, maintained, operated or
otherwise wholly or partly dependent upon or held by any means (including any
electronic, mechanical or photographic process, whether computerized or not)
that (including all means of access thereto and therefrom) are not under the
exclusive ownership and direct control of Seller Companies.

     

    
      
         

      

      
        - 8
-

        
          

        

      

      
         

      

    

    2.5 Authorization,
Etc.  

     

    2.5.1 Each
Seller Company and Parent have full power and authority to enter into this
Agreement and the agreements, documents and transactions contemplated hereby to
which Seller Companies or Parent are parties and to consummate the transactions
contemplated hereby and thereby.  The execution, delivery and
performance of this Agreement and all other agreements and transactions
contemplated hereby have been duly authorized by Parent and the Board of
Directors or the Board of Managers, as applicable, of each Seller Company, and
no other corporate proceedings on their part are necessary to authorize this
Agreement or any of the agreements, documents and transactions contemplated
hereby and thereby, except as provided in Section 4.10 hereto.  This
Agreement and all other agreements contemplated hereby to be entered into by
Seller Companies and/or Parent each constitutes a legal, valid and binding
obligation of Seller Companies and/or Parent enforceable against each Seller
Company and/or Parent in accordance with its terms, except as the same may be
limited by applicable bankruptcy, insolvency, rehabilitation, moratorium or
similar laws, now or hereafter in effect, of general application relating to or
affecting creditors’ rights, including, without limitation, the effect of
statutory or other laws regarding fraudulent conveyances and preferential
transfers, and for the limitations imposed by general principles of
equity.

     

    2.5.2 Except as
set forth in Schedule 2.5.2
attached hereto, the execution, delivery and performance by Seller Companies and
Parent of this Agreement, and all other agreements contemplated hereby, and the
fulfillment of and compliance with the respective terms hereof and thereof by
Seller Companies and Parent, do not and will not (a) conflict with or result in
a breach of the terms, conditions or provisions of, (b) constitute a default or
event of default under (whether with or without due notice, the passage of time
or both), (c) result in the creation of any Lien upon the Acquired Assets
pursuant to, (d) give any third party the right to modify, terminate or
accelerate any obligation under, (e) result in a violation of, or (f) require
any authorization, consent, approval, exemption or other action by, notice to,
or filing with any third party or Authority pursuant to, the charter, articles
of organization, bylaws or operating agreement (or similar constating documents)
of any Seller Company or Parent, as the case may be, or any applicable
Regulation, Order or Contract to which any Seller Company, Parent or their
respective assets and properties (including the Acquired Assets) or the Equity
Interests are subject.  Parent and each Seller Company have complied
with all applicable Regulations and Orders in connection with the execution,
delivery and performance of this Agreement and the agreements and transaction
contemplated hereby.

     

    2.6 Title and
Related Matters.  

     

    2.6.1 Except as
set forth in Schedule 2.6.1
attached hereto, Seller Companies have good and marketable title to all real and
personal, tangible and intangible, property and other assets reflected in the
Financial Statements or acquired after the Financial Statement Date, free and
clear of all Liens, Claims and Orders except Permitted Liens.  All
properties used in the Business for the periods covered by the Financial
Statements are reflected in the Financial Statements in accordance with and to
the extent required on an accrual accounting basis.  Schedule 2.6.1
attached hereto sets forth a complete and accurate summary of all leased assets
that have annual rental payments in excess of $10,000, describing the expiration
date of such lease, the name of the lessor, the annual rental payment and
whether a consent is required from the lessor to consummate the transactions
contemplated hereby.

     

    
      
         

      

      
        - 9
-

        
          

        

      

      
         

      

    

    2.6.2 All
Parent’s and Seller Companies’ leases that are part of the Acquired Assets are
in full force and effect, and valid and enforceable in accordance with their
respective terms.  Neither Parent nor any Seller Company has received
any notice of, and there exists no event of default or event which constitutes
or would constitute (with notice or lapse of time or both), any default by
Parent, any Seller Company or any other Person under any lease.  All
rent and other amounts due and payable with respect to Parent’s and Seller
Companies’ leases that are part of the Acquired Assets have been paid through
the date of this Agreement, and all rent and other amounts due and payable with
respect to Parent’s and Seller Companies’ leases that are part of the Acquired
Assets and are due and payable on or prior to the Closing Date will have been
paid prior to the Closing Date.  All lessors under the leases that are
part of the Acquired Assets have consented (where such consent is necessary) or
prior to the Closing will have consented (where such consent is necessary) to
the transactions contemplated pursuant to this Agreement and the agreements,
documents and transactions contemplated hereby and thereby without requiring
material modification in the rights or obligations
thereunder.  Neither Parent nor any Seller Company has received any
written notice that the landlord with respect to any real property lease that is
part of the Acquired Assets would refuse to renew such lease upon expiration of
the period thereof upon substantially the same terms, except for rent increases
consistent with past experience or market rentals.

     

    2.6.3 None of
the Acquired Assets belonging to Parent or Seller Companies is or will be on the
Closing Date subject to any (i) Contracts of sale or lease except as set forth
in Schedule
2.6.3 attached hereto, except Contracts for the sale of inventory in the
ordinary and regular course of business or (ii) Liens, except for Permitted
Liens and the Liens set forth in Schedule 2.6.3
attached hereto.

     

    2.6.4 Except as
set forth in Schedule
2.6.4 attached hereto, the buildings, structures and improvements
included within the Acquired Assets’ real property (collectively, the “Improvements”) have complied
and comply in all material respects with all applicable Regulations, including
building and zoning ordinances and no material alteration, repair, improvement
or other work that could give rise to a Lien has been performed in respect to
such Improvements within the last 120 days.  The Improvements and the
mechanical systems situated therein, including without limitation the heating,
electrical, air conditioning and plumbing systems, are in good operating
condition and repair, ordinary wear and tear excepted, and are adequate and
suitable for the purposes for which they are presently being used, and the roof
of each Improvement is in satisfactory condition and is not in need of current
repair or replacement.  The Acquired Assets’ real property and its
continued use, occupancy and operation as currently used, occupied and operated
does not constitute a nonconforming use under any Regulation or Order affecting
the real property (other than possible set back violations, none of which will
have a Material Adverse Effect on the Business’s real property or its continued
use, occupancy and operation as currently used, occupied and operated), and the
continued existence, use, occupancy and operation of each Improvement, and the
right and ability to repair and/or rebuild such Improvements in the event of
casualty, is not dependent on any special Permit, exception, approval or
variance.  There is no pending or, to the knowledge of Parent and
Seller Companies, threatened or proposed proceeding or governmental action to
modify the zoning classification of, or to take by the power of eminent domain
(or to purchase in lieu thereof), or to classify as a landmark, or to impose
special assessments on, or otherwise to take or restrict in any way the right to
use, develop or alter, all or any part of the Business’ real property that would
have a Material Adverse Effect.  To the knowledge of Parent and Seller
Companies, there are no encroachments upon any of the Business’ real property,
and no portion of any Improvement owned by Parent or Seller Companies encroaches
upon any property not included within the Business’ real property or upon the
area of any easement affecting the Business’ real property.  Each
Improvement has direct access, adequate for the Business, in the ordinary
course, to a public street adjoining the Business’ real property on which such
Improvement is situated, and, to the knowledge of Parent and Seller Companies,
no existing way of access to any Improvement crosses or encroaches upon any
property or property interest not included in the Acquired Assets.

     

    
      
         

      

      
        - 10
-

        
          

        

      

      
         

      

    

    2.6.5 There has
not been since the Financial Statement Date, and will not be prior to the
Closing Date, any sale, lease, or any other disposition or distribution by
Parent or any Seller Company of any Acquired Assets, now or hereafter owned by
it, except transactions in the ordinary and regular course of business or as
otherwise consented to by Purchaser.  Immediately after the Closing,
Purchaser will own, or have the unrestricted right to use, all properties and
assets that are used (or necessary) in connection with the Business, except for
the Excluded Assets, on the same economic basis as before the
Closing.

     

    2.6.6 The
Acquired Assets constitute all of the assets necessary or appropriate for the
continued operation of the Business.

     

    2.6.7 All of
the Acquired Assets consisting of tangible assets are located at the Locations
and are in good working condition, except for reasonable wear and tear, and are
sufficient for the purposes for which such Acquired Assets are currently used
and for the purpose proposed to be used in the operations of the Business
pursuant to the transactions contemplated pursuant to this Agreement and the
agreements, documents and transactions contemplated hereby and
thereby.  No Seller Company nor Parent is aware of the need to replace
or purchase any material equipment for use in the operation of the Business
prior to Closing or after the Closing pursuant to the transactions contemplated
pursuant to this Agreement and the agreements, documents and transactions
contemplated hereby and thereby, except as related to the Imaging Centers
Capital Expenditures.  All such Acquired Assets are reflected in the
Financial Statements at net book value.

     

    2.7 Financial
Statements.  

     

    2.7.1 Attached
hereto as Schedule
2.7.1 are (i) unaudited profit and loss statements and balance sheets of
each Seller Company for each twelve (12) month period ended September 30, 2008
and December 31, 2007 and (ii) a detailed calculation of the billings,
collections and scans performed in connection with the Business for the four (4)
month period ended January 31, 2009 (collectively herein referred to as the
“Financial Statements”
and September 30, 2008 is herein referred to as the “Financial Statement
Date”).  The balance sheets fairly present the financial
position of each Seller Company as of the dates set forth therein, in accordance
with accrual accounting methods.  The Financial Statements were
prepared from the books and records of Seller Companies.  Seller
Companies do not utilize any percentage of completion or similar method of
accounting for revenue, income or cost recognition purposes.  No
Seller Company has in the past three (3) fiscal years written off any research
and development costs, incurred any reorganization, restructuring or similar
costs or changed the book value of any assets, liabilities or goodwill of any
business acquired by such Seller Company.  No Seller Company has any
obligation to make any Investments in any Person.  All properties used
in the Business during the period covered by the Financial Statements are
reflected in the Financial Statements in accordance with and to the extent
required by accrual accounting methods.

     

    
      
         

      

      
        - 11
-

        
          

        

      

      
         

      

    

    2.7.2 Except as
set forth in Schedule 2.7.2
attached hereto, no Seller Company has any Indebtedness, obligation or liability
(whether accrued, absolute, contingent, unliquidated or otherwise, known or
unknown to Seller Companies, whether due or to become due) arising out of
transactions entered into at or prior to the Closing Date, or any state of facts
existing at or prior to the Closing Date, other than:  (i) liabilities
set forth in the September 30, 2008 balance sheets of Seller Companies, or (ii)
liabilities and obligations that have arisen after September 30, 2008 in the
ordinary course of business (none of which is a liability resulting from breach
of a Contract, Regulation, Order or warranty, tort, infringement or
Claim).

     

    2.7.3 Except as
set forth in Schedule 2.7.3
attached hereto, there is no Person that has Guaranteed, or provided any
financial accommodation of, any Indebtedness, obligation or liability of any
Seller Company or for the benefit of any Seller Company for the periods covered
by the Financial Statements other than as set forth in the Financial
Statements.  Seller Companies’ accounting systems and controls are
sufficient to detect material fraud and inaccuracies in the financial reporting
processes and reports.

     

    2.8 Absence
of Certain Changes.  Except as set forth on Schedule 2.8 attached
hereto, since the Financial Statement Date, there has not been any (a) Material
Adverse Change in the business, operations, properties, assets, condition
(financial or otherwise), results, plans, strategies or prospects of any Seller
Company; (b) damage, destruction or loss, whether covered by insurance or
not, having a cost of $10,000 or more, with regard to Seller Companies’ property
and business; (c) declaration, setting aside or payment of any dividend or
distribution (whether in cash, ownership interest or property) with respect to
any of the Equity Interests; (d) redemption or other acquisition of any of the
Equity Interests; (e) increase in the compensation payable to or to become
payable by any Seller Company to its officers or employees working in the
Business or any adoption of or increase in any bonus, insurance, pension or
other employee benefit plan, payment or arrangement made to, for or with any
such officers or employees or any Affiliate of any Seller Company; (f) entry
into any material Contract not in the ordinary course of business, including
without limitation, any borrowing from any new lender or in excess of the
existing credit limits or capital expenditure (except for the capital
expenditures set forth in Schedule 2.30
attached hereto); (g) change by any Seller Company in accounting methods or
principles or any write-down, write-up or revaluation of any Acquired Assets of
any Seller Company, except depreciation accounted for in the ordinary course of
business and write downs of inventory which reflect the lower of cost or market
and which are in the ordinary course of business and in accordance with accrual
accounting methods; (h) failure to promptly pay and discharge current
liabilities or agree with any party to extend the payment of any current
liability; (i) Lien placed on any of the Acquired Assets other than Permitted
Liens; (j) sale, assignment, transfer, lease, license or otherwise placement of
a Lien on any of the Acquired Assets, except in the ordinary course of business
consistent with past practice, or canceled any material debts or Claims;
(k) sale, assignment, transfer, lease, license or otherwise placement of a
Lien on any Intellectual Property rights or other intangible assets, disclosure
of any material confidential information to any Person or abandoned or permitted
to lapse any Intellectual Property rights; (l) making of, or commitment to make,
any charitable contributions or pledges exceeding in the aggregate $25,000; or
(m) agreement, whether orally or in writing, to do any of the
foregoing.

     

    
      
         

      

      
        - 12
-

        
          

        

      

      
         

      

    

    2.9 Accounts
Receivable.  The gross amount of the accounts receivable and
notes receivable of Seller Companies reflected in the Financial Statements and
the gross amount of such additional accounts receivable as are reflected on the
books of Seller Companies on the date hereof represent the gross amount of all
outstanding accounts and notes receivable of Seller Companies and are current,
good and collectible against account debtors for services rendered in accordance
with the usual business practices and historical collection experience of Seller
Companies and are subject to no counterclaims, and have been outstanding for the
periods indicated in the aging analysis at Schedule 2.9 attached
hereto.  The gross amount of all outstanding accounts and notes
receivable of Seller Companies are due, valid, genuine and subsisting Claims
against account debtors arising out of bona fide services rendered in accordance
with the usual business practices and historical collection experience of Seller
Companies and are subject to no counterclaims, defenses, deductions or set-offs
and have been outstanding for the periods indicated in the aging analysis at
Schedule 2.9
attached hereto. No Seller Company nor Parent knows of any reason why such
accounts receivable would not be collectible by Seller Companies according to
approximately the same ratios as accounts receivable have been historically
collectible by Seller Companies.  The gross amount of all outstanding
accounts and notes receivable included on Schedule 2.9 attached
hereto and generated through the Closing Date arose in the ordinary course of
business.  No Seller Company has incurred any liabilities to patients
for discounts except as provided in the Financial Statements.

     

    2.10 Agreements
and Commitments.  

     

    2.10.1 Except as
set forth in Schedule 2.10.1
attached hereto, in connection with the Business, neither Parent nor any Seller
Company is a party to any written or oral:

     

    (a) pension,
profit sharing, Option, employee ownership purchase, stock appreciation right,
phantom stock option or other plan providing for deferred or other compensation
to employees of Seller Companies or any other employee benefit plan (other than
as set forth in Schedule 2.22
attached hereto), or any Contract with any labor union or labor
group;

     

    (b) Contract
relating to loans to officers, directors, managers, Parent or any Affiliates
thereof;

     

    
      
         

      

      
        - 13
-

        
          

        

      

      
         

      

    

    (c) Contract
relating to the borrowing of money or the mortgaging, pledging or otherwise
placing a Lien on any Acquired Asset;

     

    (d) Guarantee
that will be an Assumed Obligation;

     

    (e) Contract
that will be an Acquired Asset under which Parent or any Seller Company has
advanced or loaned or agreed to advance or loan, any Person amounts in the
aggregate exceeding $10,000;

     

    (f) Contract
pursuant to which Parent or any Seller Company is (and Purchaser will become)
lessor of or permits any third party to hold or operate any property, real or
personal, owned or controlled by Parent or Seller Companies;

     

    (g) Contract
pursuant to which any Parent or any Seller Company is (and Purchaser will
become) lessee of any property, real or personal, owned or controlled by another
Person;

     

    (h) warranty
Contract with respect to its services rendered or its products sold or
leased;

     

    (i) Contract
or non-competition provision in any Contract prohibiting it from freely engaging
in any business or competing anywhere in the world;

     

    (j) Contract
for the purchase, acquisition or supply of inventory and other property and
assets, whether for resale or otherwise in excess of $10,000;

     

    (k) Contracts
with independent  agents, brokers, dealers or distributors which
provide for annual payments in excess of $10,000;

     

    (l) employment,
consulting, sales, commissions, advertising or marketing Contracts;

     

    (m) Contract
with Physicians;

     

    (n) Contracts
providing for “take or pay” or similar unconditional purchase or payment
obligations;

     

    (o) Contracts
with Persons with which, directly or indirectly, an Affiliate or Parent also has
a Contract;

     

    (p) Contract
that requires the consent of any Person, or contains any provision that would
result in a modification of any rights or obligation of any Person thereunder
upon a change in control of any Seller Company or the sale of the Acquired
Assets by Seller Companies or that would provide any Person any remedy
(including rescission or liquidated damages), in connection with the execution,
delivery or performance of this Agreement and the agreements, documents and the
consummation of the transactions contemplated hereby and thereby;

     

    
      
         

      

      
        - 14
-

        
          

        

      

      
         

      

    

    (q) nondisclosure
or confidentiality Contracts;

     

    (r) power of
attorney or other similar Contract or grant of agency;

     

    (s) third
party payor Contract or other Contract from which any Seller Company is
reimbursed or otherwise paid for the provision of healthcare services;
or

     

    (t) Any other
Contract that is material to any Seller Company’s operations or business
prospects or involves consideration in excess of $25,000 annually, excluding any
purchase orders in the ordinary course of business.

     

    2.10.2 Parent
and each Seller Company has performed in all material respects all obligations
required to be performed by it and is not in default in any respect under or in
breach of nor in receipt of any Claim of default or breach under any material
Contract that is an Acquired Asset or to which Parent or such Seller Company is
subject (including without limitation all performance bonds, warranty
obligations or otherwise); no event has occurred that with the passage of time
or the giving of notice or both would result in a default, breach or event of
non-compliance under any material Contract that is an Acquired Asset to which
Parent or any Seller Company is subject (including without limitation all
performance bonds, warranty obligations or otherwise); neither Parent nor any
Seller Company has any present expectation or intention of fully performing all
such obligations; neither Parent nor any Seller Company has any knowledge of any
breach or anticipated breach by the other Persons to any such Contract to which
it is a party.

     

    2.10.3 Parent
and Seller Companies have delivered to Purchaser true and complete copies of all
the Contracts and documents listed in the schedules to this
Agreement.

     

    2.10.4 Schedule 2.10.4
attached hereto sets forth a complete and accurate list of each outstanding bid
or proposal for business submitted by Seller Companies in excess of
$10,000.

     

    2.10.5 Except as
set forth on Schedule
2.10.5 attached hereto, no party to any Contract has, within the twelve
(12) months preceding the date hereof, given Parent or any Seller Company
written notice repudiating any provision thereof or indicating an intention to
exercise any right of cancellation, termination or non-renewal
thereof.

     

    2.10.6 Except as
set forth on Schedule
2.10.6 attached hereto, each Contract is assignable to Purchaser without
the consent of any third party or any increase in any payment or change in any
term provided for thereunder, and no Contract requires the consent of any other
party, any increase in any payment or change in any term provided for
thereunder, in connection with the transactions contemplated
hereby.

     

    2.11 Government
Contracts.  Except as set forth on Schedule 2.11
attached hereto:

     

    2.11.1 Neither
Parent nor any Seller Company is a party to any Contract or subject to any
Regulation that would result in the termination of any Government Contract that
is part of the Business or that would impose any limitation on Seller Companies’
ability to perform a Government Contract that is part of the Business or to
continue the Business (whether as the Business is conducted prior to Closing or
as the Business is contemplated to be conducted pursuant to the transactions
contemplated pursuant to this Agreement and the agreements, documents and
transactions contemplated hereby and thereby).

     

    
      
         

      

      
        - 15
-

        
          

        

      

      
         

      

    

    2.11.2 No
payment has been made by Parent, any Seller Company or by any Person authorized
to act on its behalf, to any Person in connection with any Government Contract
of any Seller Company or Parent in violation of applicable United States or
foreign procurement Regulations, including without limitation any criminal or
civil Regulations relating to bribes or gratuities, or in violation of the
Foreign Corrupt Practices Act.

     

    2.11.3 With
respect to each Government Contract that is part of the Business to which any
Seller Company or Parent is a party:  (i) all representations and
certifications executed, acknowledged or set forth in or pertaining to such
Government Contract were complete and correct as of their effective date, and
each Seller Company and Parent have complied with all such representations and
certifications; (ii) neither the United States government nor any prime
contractor, subcontractor or other Person has notified a Seller Company or
Parent, either orally or in writing, that such Seller Company or Parent has
breached or violated any Regulation, or any certificate, representation, clause,
provision or requirement pertaining to such Government Contract; and (iii) no
termination for convenience or termination for default has occurred within the
last three (3) years, and no cure notice or show cause notice is currently in
effect pertaining to, such Government Contract.

     

    2.11.4 Neither
Parent, any Seller Company nor any of their directors, managers, officers,
employees or owners is (or during the last five (5) years has been) under
administrative, civil or criminal investigation or indictment by any
Governmental Entity with respect to any alleged irregularity, misstatement or
omission arising under or relating to any Government Contract that is part of
the Business.  During the last five (5) years, neither Parent, nor any
Seller Company has conducted or initiated any internal investigation or made a
voluntary disclosure to the United States government related to the
same.

     

    2.11.5 There
exist (i) no outstanding Claims against any Seller Company or Parent, either by
the United States government or by any prime contractor, subcontractor, vendor
or other third party, arising under or relating to any Government Contract that
is part of the Business, and (ii) no disputes between any Seller Company or
Parent, on the one hand, and the United States government, on the other hand,
under the Contract Disputes Act or any other federal Regulation or between any
Seller Company or Parent on the one hand, and any prime contractor,
subcontractor or vendor, on the other hand, arising under or relating to any
Government Contract that is part of the Business.

     

    2.11.6 No Seller
Company, nor any of their directors, managers, officers, employees or owners is
(or during the last five (5) years has been) suspended or debarred from doing
business with the United States government or other Authority or is (or during
such period was) the subject to a finding of nonresponsibility or ineligibility
for United States government contracting.

     

    2.12 Litigation.  Schedule 2.12
attached hereto sets forth a true and complete list of all Claims and Orders
involving any Seller Company, Parent and/or, to the knowledge of Seller
Companies and Parent, the PA since January 1, 2005 relating to the
Business.  Except as set forth in Schedule 2.12
attached hereto, to the best knowledge of Seller Companies and Parent, there is
no Claim or Order relating to the Business threatened against or affecting
Parent, any Seller Company, the PA, the Acquired Assets, the Business or the
Equity Interests, nor is there any reasonable basis therefor.  Neither
Parent, any Seller Company nor, to the knowledge of Seller Companies and Parent,
the PA is in default under or with respect to any Order described in Schedule 2.12
attached hereto.  Except as set forth on Schedule 2.12
attached hereto, Parent, each Seller Company and, to the knowledge of Seller
Companies and Parent, the PA are fully insured with respect to each of the
matters set forth on Schedule 2.12
attached hereto and neither Parent, any Seller Company nor, to the knowledge of
Seller Companies and Parent, the PA has received any opinion or a memorandum or
advice from legal counsel to the effect that it is exposed, from a legal
standpoint, to any liability or obligations that could have an adverse effect in
excess of $10,000.  In connection with the Business, no Authorities
are currently conducting investigations, and there are no proceedings, against
any Seller Company, Parent or, to the knowledge of Seller Companies and Parent,
the PA and, to Seller Companies’ and Parent’s knowledge, no such investigation
or proceeding is being threatened.

     

    
      
         

      

      
        - 16
-

        
          

        

      

      
         

      

    

    2.13 Taxes.  

     

    2.13.1 Tax
Returns.  Seller Companies
have timely filed or caused to be timely filed or will timely file or cause to
be timely filed (taking into account any applicable extension of time within
which to file) with the appropriate Taxing Authorities all Federal, state,
foreign and local Tax returns, statements, forms, reports and other documents
(including elections, declarations, disclosures, schedules, estimates and
information tax returns) for Taxes (“Tax Returns”) that are
required to be filed by, or with respect to, the income or operations of the
Business or the ownership of the Acquired Assets on or prior to the Closing
Date.  Such Tax Returns are and will be true, correct and complete in
all material respects.  Other than as set forth on Schedule 2.13.1
attached hereto, Seller Companies have not requested any extension of time
within which to file any Tax Return.  The Tax Returns that covered or
will cover periods prior to the Closing Date have accurately reflected and will
accurately reflect all liability for Taxes of Seller Companies for the periods
covered thereby.

     

    2.13.2 Payment
of Taxes.  Except as set
forth on Schedule 2.13.2, all Taxes and Tax liabilities due by or with respect
to the income, assets or operations of the Business and the ownership of the
Acquired Assets for all taxable years or other taxable periods that end on or
before the Closing Date and, with respect to any taxable year or other taxable
period beginning on or before and ending after the Closing Date, the portion of
such taxable year or period ending on and including the Closing Date have been
or will be timely paid in full.

     

    2.13.3 Other Tax
Matters.

     

    (a) Except as
set forth on Schedule 2.13.3(a), since January 1, 2004, no Seller Company has
been, nor to its knowledge will be, the subject of an audit or other examination
of Taxes by the Taxing Authorities of any nation, state or locality with respect
to the income or operations of the Business or the ownership of the Acquired
Assets; and, to the knowledge of Parent, Seller Companies or any officer or
employee of Seller Companies, no such audit is contemplated or pending; and
neither Parent nor any Seller Company has received any written notices from any
Taxing Authority relating to any issue that could affect any Tax liability with
respect to the income or operations of the Business or the ownership of the
Acquired Assets.

     

    
      
         

      

      
        - 17
-

        
          

        

      

      
         

      

    

    (b) No Seller
Company nor Parent has entered into an agreement or waiver or been requested to
enter into an agreement or waiver extending any statute of limitations relating
to the payment or collection of Taxes with respect to the income or operations
of the Business or the ownership of the Acquired Assets that has not expired and
is not presently contesting the Tax liability with respect to the income or
operations of the Business or the ownership of the Acquired Assets before any
Taxing Authority or court, tribunal or agency.

     

    (c) All Taxes
that Seller Companies are required by law to withhold or collect with respect to
the income or operations of the Business or the ownership of the Acquired Assets
in connection with amounts paid or owing to any employee, independent
contractor, creditor, member or other third party have been duly withheld or
collected, and have been timely paid over to the proper Taxing Authorities to
the extent due and payable.

     

    (d) There are
no existing or, to Parent’s and Seller’s Companies’ knowledge, threatened Liens
for Taxes upon the Acquired Assets or the Equity Interests except for Liens for
current Taxes not yet due and payable.

     

    (e) Neither
Parent nor any Seller Company has received a written notice of a Claim made by
any Taxing Authority in a jurisdiction where a Seller Company does not file Tax
Returns with respect to the income or operations of the Business or the
ownership of the Acquired Assets that a Seller Company is or may be subject to
taxation by that jurisdiction with respect to the income or operations of the
Business or the ownership of the Acquired Assets.

     

    (f) There are
no material security interests on any of the Acquired Assets that arose in
connection with any failure (or alleged failure) to pay any Taxes.

     

    (g) No Seller
Company has been included in any “consolidated,” “unitary” or “combined” Tax
Return provided for under the law of the United States, any foreign jurisdiction
or any state or locality with respect to Taxes for any taxable period for which
the statute of limitations has not expired. The basis of any depreciable assets,
and the methods used in determining allowable depreciation (including cost
recovery) of each Seller Company, are, to the best knowledge of Seller
Companies, correct and in compliance with the Code.

     

    (h) There are
no tax sharing, allocation, indemnification or similar agreements in effect as
between any Seller Company or any predecessor or Affiliate thereof and any other
party (including Parent or any predecessors or Affiliates thereof) under which
Purchaser or any Seller Company could be liable for any Taxes or other Claims of
any party.

     

    (i) Neither
Parent nor any Seller Company is a “foreign person” within the meaning of
Section 1445 of the Code.

     

    
      
         

      

      
        - 18
-

        
          

        

      

      
         

      

    

    (j) Neither
Parent nor any Seller Company has been a “United States real property holding
corporation” within the meaning of Section 897(c)(2) of the Code at any time
during the five-year period ending on the date hereof.

     

    (k) No
indebtedness of any Seller Company consists of “corporate acquisition
indebtedness” within the meaning of Section 279 of the Code.

     

    (l) No Seller
Company has applied for, been granted, or agreed to any accounting method change
for which such Seller Company will be required to take into account any
adjustment under Section 481 of the Code or any similar provision of the Code or
the corresponding tax laws of any nation, state or locality.

     

    (m) No Seller
Company is a party to any agreement that would require Parent, such Seller
Company or any Affiliate thereof to make any payment that would constitute an
“excess parachute payment” for purposes of Sections 280G and 4999 of the
Code.

     

    (n) Seller
Companies have delivered or made available to Purchaser copies of each of the
Tax Returns for income Taxes filed on behalf of each Seller Company since
January 1, 2006.

     

    (o) Seller
Companies have not engaged in a “reportable transaction” within the meaning of
Treasury Regulations Section 1.6011-4(b).

     

    (p) No power
of attorney has been granted by any Seller Company with respect to any matter
relating to Taxes that is currently in force.

     

    2.14 Banking
Arrangements.  Schedule 2.14
attached hereto sets forth the name of each bank in or with which each Seller
Company or, to Seller Companies’ knowledge, the PA, has an account, credit line
or safety deposit box, and a brief description of each such account, credit line
or safety deposit box, including the names of all persons currently authorized
to draw thereon or having access thereto.

     

    2.15 Liens;
Indebtedness; Collateral.  Except as disclosed in Schedule 2.15
attached hereto (a) there are no Liens, Claims or Orders on or with respect to
the Business or any of the Acquired Assets or the Equity Interests, (b) Seller
Companies have no Indebtedness or liabilities of any nature, whether accrued,
absolute, contingent or otherwise with respect to the Business and the Acquired
Assets, (c) no Seller Company has pledged any of its accounts receivable or
Acquired Assets with respect to any liability, obligation or Indebtedness of
such Seller Company or otherwise to any Person, and (d) Parent has not pledged
any of the Equity Interests with respect to any liability, obligation or
Indebtedness of any Seller Company or otherwise to any Person.  Except
as disclosed in Schedule 2.15
attached hereto, there are no facts in existence on the date hereof known or
that should be known to any Seller Company or Parent that might reasonably serve
as the basis for any Lien, Claim or Order of any Seller Company or
Parent.

     

    2.16 Licenses.  Each
Seller Company and the PA has at all times had all material Permits needed or
required by law to operate the Business (collectively, the “Licenses”).  Schedule 2.16
attached hereto is an accurate list and summary description of all such Licenses
owned or held by Seller Companies relating to the ownership, development or
operations of the Business or any of the Acquired Assets, all of which are now
and as of Closing Date shall be in good standing and full force and effect and
not subject to meritorious challenge, and to the knowledge of Parent and Seller
Companies, no suspension or cancellation of any such Licenses is threatened and
there is no basis for believing that any such Licenses will not be renewable
upon expiration.

     

    
      
         

      

      
        - 19
-

        
          

        

      

      
         

      

    

    2.17 Compliance
with Law.  

     

    2.17.1 Parent,
Seller Companies and the PA are and have at all times been in material
compliance with all applicable statutes, rules, Regulations, Orders and
requirements of all federal, state, and local commissions, boards, bureaus, and
agencies having jurisdiction over Parent, Seller Companies, the PA and the
Business and the operations of the Business at each Location, including, but not
limited to, the false claims, false representations, anti-kickback and all other
provisions of the Medicare/Medicaid fraud and abuse laws (42 U.S.C. § 1320a-7 et
seq.), the physician self-referral provisions of the Stark Law (42 U.S.C. §
1395nn) and the Health Insurance Portability and Accountability Act of 1996
(“HIPAA”), including the
final regulations promulgated thereunder. Parent, Seller Companies and the PA
have timely and accurately filed all material reports, returns, data, and other
information required by federal, state, municipal or other governmental
authorities that control, directly or indirectly, Parent’s, Seller Companies’ or
the PA’s activities to be filed with any commissions, boards, bureaus, and
agencies and has paid all sums heretofore due with respect to such reports and
returns.  No such report or return has been inaccurate, incomplete or
misleading. Parent, Seller Companies and the PA have timely and accurately filed
all requisite reimbursable claims and other reports required to be filed or
otherwise filed in connection with all state and federal Medicare and Medicaid
programs in which Parent, Seller Companies and/or the PA participate that are
due on or before the Closing Date or that relate to services provided at the
Locations on or before the Closing Date.  There are no Claims pending
or, to the knowledge of Parent and Seller Companies, threatened or scheduled
before any authority, including without limitation any intermediary, carrier, or
other state or federal agency with respect to any Medicare and Medicaid claim
filed by Parent, Seller Companies and/or the PA on or before the Closing Date,
or program compliance matters, that could have a detrimental effect on Parent,
Seller Companies and/or the PA, the operations or utility thereof, or the
transactions contemplated pursuant to this Agreement and the agreements,
documents and transactions contemplated hereby and thereby.  Except
for routinely scheduled Medicare and Medicaid program participation and
certification surveys pursuant to Seller Companies’ and the PA’s Medicare and
Medicaid contracts and filings, no valid program integrity review related to
Parent, Seller Companies or the PA has been conducted by any authority in
connection with the Medicare or Medicaid programs, and no such review is
scheduled, pending, or, to Parent’s or Seller Companies’ knowledge, threatened
against or affecting Seller Companies, the PA the Business, the Acquired Assets,
or the consummation of the transactions contemplated pursuant to this Agreement
and the agreements, documents and transactions contemplated hereby and
thereby.

     

    2.17.2 With
respect to HIPAA, each Seller Company and the PA has in place plans, policies
and or procedures designed to comply with the Standards for Privacy of
Individually Identifiable Health Information, the Security Standards for the
Protection of Electronic Protected Health Information and the Standards for
Electronic Transactions and Code Sets promulgated pursuant to HIPAA and any New
Jersey laws relating to patient privacy and/or the security, use or disclosure
of health care records (collectively, the “HIPAA
Regulations”).  Schedule 2.17.2
attached hereto describes all plans and other efforts of the PA and Seller
Companies to comply with the HIPAA Regulations, if and to the extent applicable,
whether such plans and efforts have been put into place or are in
process.  Schedule 2.17.2
attached  hereto includes but is not limited in any manner whatsoever
to any privacy compliance plan or security compliance plan of the PA and Seller
Companies (collectively or individually) in place or in development, and any
plans, analyses or budgets relating to information systems including but not
limited to necessary purchases, upgrades or modifications to further any of PA’s
and Seller Companies’ efforts to comply with the HIPAA
Regulations.  Seller Companies have provided Purchaser with true,
accurate and complete copies of the PA and Seller Companies’ manuals and plans
designed to comply with the HIPAA Regulations.

     

    
      
         

      

      
        - 20
-

        
          

        

      

      
         

      

    

    2.18 Rates and
Reimbursement Policies.  No Seller Company has any rate appeal
currently pending before any Authority or any administrator of any third-party
payor program.  No Seller Company nor Parent has any knowledge of any
applicable affecting rates or reimbursement procedures that has been enacted,
promulgated or issued within the eighteen (18) months preceding the Closing Date
or any such legal requirement proposed or currently pending in the State of New
Jersey or at the federal level that could have a Material Adverse Effect on any
Seller Company or may result in the imposition of additional Medicaid, Medicare,
charity, free care or welfare obligations, or other discounted or government
assisted patients of the Business.  No Seller Company nor Parent has
any knowledge of any impending proposed reduction in reimbursement from third
party or other payors.

     

    2.19 Physicians.  Schedule 2.19
attached hereto sets forth a list of each physician (the “Scheduled Physicians”) who has
or had a financial relationship (including without limitation, professional
reading, medical director, supervision, shared ancillary, and block lease
arrangement) with any Seller Company, the PA or the Imaging Centers within the
twenty four (24) calendar months immediately prior to Closing.  The
aggregate compensation, if any, paid to any physician set forth on Schedule 2.19
attached hereto is consistent with fair market value in arm’s length
transactions and the services contracted for do not exceed that which are
reasonably necessary to accomplish the commercially reasonable business purpose
of the services.  True, accurate and complete copies of any agreements
with the Scheduled Physicians have been provided to Purchaser.  Seller
Companies or the PA have properly disclosed to and obtained approval from CMS
for each physician who performs professional interpretations on behalf of Seller
Companies and any Imaging Center and for whom Seller Companies bill (the “Reading Physicians”) and has
caused each of the Reading Physicians to properly execute and file or cause to
be filed with the appropriate carrier or other Authority a Medicare 855-R
reassignment permitting Seller Companies or the PA to bill on behalf of such
physician or otherwise comply with the Medicare purchase diagnostic
interpretation rules.  Each Seller Company or the PA has properly
disclosed to and obtained approval from CMS for each physician who supervises
the provision of any diagnostic test at an Imaging Center (the “Supervising Physicians”, and,
together with the Reading Physicians and Scheduled Physicians, the “Physicians”), and each
Supervising Physician has properly executed a true, accurate and complete
Attachment 2 to the CMS 855-B application, which has been filed with the
appropriate carrier or other Authority.  To Parent’s and/or Seller
Companies’ knowledge, no Physician has threatened to discontinue or to terminate
his or her relationship with any Seller Company or the PA or otherwise not to
read for any Seller Company or the PA.  To Parent’s and/or Seller
Companies’ knowledge, none of the Physicians has expressed plans to retire from
the practice of medicine in the next five (5) years.  

     

    
      
         

      

      
        - 21
-

        
          

        

      

      
         

      

    

    2.19.1 During
the three (3) years preceding the Closing Date, to Seller Companies’ knowledge,
Kessler and all other Physicians have been duly licensed and registered, and in
good standing by the State of New Jersey to engage in the practice of medicine,
and said license and registration have not been suspended, revoked or restricted
in any manner;

     

    2.19.2 During
the three (3) years preceding the Closing Date, to Seller Companies’ knowledge,
Kessler and all other Physicians have had current controlled substances
registrations issued by the State of New Jersey and the United States Drug
Enforcement Administration, which registrations have not been surrendered,
suspended, revoked or restricted in any manner;

     

    2.19.3 Except as
disclosed in Schedule
2.19.3 attached hereto, neither Parent nor any Seller Company, as
applicable, has been a party or subject to:

     

    (a) Any
malpractice Claim (whether or not filed in court), settlement, settlement
allocation, judgment, verdict or decree;

     

    (b) Any
disciplinary, peer review or professional review investigation, proceeding or
action instituted by any licensure board, hospital, medical school, health care
facility or entity, professional society or association, third-party payor, peer
review or professional review committee or body, or governmental
agency;

     

    (c) Any
criminal complaint, indictment or criminal proceedings;

     

    (d) Any
investigation or proceedings, whether administrative, civil or criminal,
relating to an allegation of filing false health care Claims, violating
anti-kickback or fee-splitting laws, or engaging in other billing
improprieties;

     

    (e) Any
allegation, or any investigation or proceeding based on any allegation of
violating professional ethics or standards, or engaging in illegal, immoral or
other misconduct (of any nature or degree); or

     

    (f) Any
denial or withdrawal of an application in any state for licensure as a
physician, for medical staff privileges at any hospital or other health care
entity, for board certification or recertification, for participation in any
third-party payment program, for state or federal controlled substances
registration, or for malpractice insurance.

     

    2.19.4 With
respect to all operations, practices, real property, plants, structures,
machinery, equipment and other property, employees, products and services and
all other aspects of the Business, Seller Companies and the PA have continuously
operated in compliance with all applicable Regulations and Orders, including,
without limitation, all Regulations relating to the safe conduct of business,
environmental protection, quality and labeling, antitrust, consumer protection,
sanitation, fire, zoning, building and occupational safety, and in addition,
with respect to Seller Companies, in compliance with all applicable Regulations
and Orders relating to equal opportunity, discrimination and health. There are
no Claims pending, or, to the knowledge of Parent and Seller
Companies,  threatened, nor has any Seller Company nor Parent received
any written notice regarding any violations of any Regulations or Orders
enforced by any Authority claiming jurisdiction over Seller Companies, Parent,
the PA, the Business or the Acquired Assets.

     

    
      
         

      

      
        - 22
-

        
          

        

      

      
         

      

    

    2.19.5 Seller
Companies and the PA hold all material registrations, accreditations and other
certifications required for the conduct of the Business by any Authority or
trade group and Seller Companies and the PA have operated in compliance with the
terms and conditions of all such registrations, accreditations and
certifications.  Neither Parent, any Seller Company nor, to the
knowledge of Seller Companies and Parent, the PA has received any notice
alleging that any Seller Company or, to the knowledge of Seller Companies and
Parent, the PA has failed to hold any such material registration, accreditation
or other certification.

     

    2.20 Improper
and Other Payments.  (a) No Seller Company, nor any director,
manager, officer, key employee thereof, nor, to Parent’s or Seller Companies’
knowledge, any agent or representative of any Seller Company nor any Person
acting on behalf of any Seller Company or Parent, has made, paid or received any
unlawful bribes, kickbacks or other similar payments to or from any Person or
Authority, (b) no contributions have been made, directly or indirectly, to a
domestic or foreign political party or candidate, (c) no improper foreign
payment (as defined in the Foreign Corrupt Practices Act) has been made, and (d)
the internal accounting controls of Seller Companies are believed by Parent’s
and Seller Companies’ management to be adequate to detect any of the foregoing
under the circumstances of the Business currently and previously.

     

    2.21 Intellectual
Property.

     

    2.21.1 Schedule 2.21.1
attached hereto is a complete and accurate list of all Intellectual Property
used or held for use in the Business by Seller Companies or
Parent.  To the extent indicated on such schedule, the Intellectual
Property set forth on Schedule 2.21.1
attached hereto has been duly registered in, filed in or issued by the United
States Patent and Trademark Office, United States Copyright Office, a duly
accredited and appropriate domain name registrar, the appropriate offices in the
various states of the United States and the appropriate offices of other
jurisdictions (foreign and domestic), and each such registration, filing and
issuance remains in full force and effect as of the Closing
Date.  Copies of all items of Business Intellectual Property on Schedule 2.21.1
attached hereto and other material Intellectual Property used or held for use in
the Business, which
have been reduced to writing or other tangible form, have been delivered by
Seller Companies to Purchaser (including, without limitation true and complete
copies of all related licenses, and amendments and modifications
thereto).

     

    2.21.2 Except as
set forth in Schedule
2.21.2 attached hereto, no Seller Company is a party to any license or
Contract, whether as licensor, licensee, or otherwise with respect to any
Intellectual Property. To the extent any Intellectual Property is used under
license in the Business by Seller Companies, no notice of a material default has
been sent or received by any Seller Company under any such license that remains
uncured, and the execution, delivery or performance of Seller Companies’
obligations hereunder will not result in such a default.  Each such
license agreement is a legal, valid and binding obligation of Seller Companies
and each of the other parties thereto, enforceable in accordance with the terms
thereof.

     

    
      
         

      

      
        - 23
-

        
          

        

      

      
         

      

    

    2.21.3 Seller
Companies exclusively own or are licensed to use all of the Business
Intellectual Property used or held for use in the Business, free and clear of
any Liens, Orders and other adverse Claims, without obligation to pay any
royalty or any other fees with respect thereto.  Seller Companies do
not use any Intellectual Property other than the Business Intellectual Property
and other Intellectual Property licensed to Seller Companies pursuant to valid
and enforceable license agreements.  To the knowledge of Parent and
Seller Companies, Seller Companies’ use of the Business Intellectual Property
(including, without limitation, the manufacturing, marketing, licensing, sale or
distribution of products and the general conduct and operations of the Business)
does not violate, infringe, misappropriate or misuse any intellectual property
rights of any third party.  No Business Intellectual Property has been
cancelled, abandoned or otherwise terminated and all renewal and maintenance
fees in respect thereof have been duly paid.  There are no actions
that must be taken or payments that must be made by Seller Companies within 180
days following the Closing Date that, if not taken, will adversely affect
Business Intellectual Property.  Seller Companies have the exclusive
right to file, prosecute and maintain all applications and registrations with
respect to the Business Intellectual Property.

     

    2.21.4 Neither
Parent nor any Seller Company has received any written notice or Claim from any
third party challenging the right of any Seller Company to use any of the
Business Intellectual Property or other Intellectual Property.  The
Business Intellectual Property, together with the other Intellectual Property
licensed to Seller Companies pursuant to valid and enforceable license
agreements, constitutes all the Intellectual Property necessary to operate the
Business as of the Closing Date and thereafter, in the manner in which it is
presently operated and pursuant to the transactions contemplated pursuant to
this Agreement and the agreements, documents and transactions contemplated
hereby and thereby.

     

    2.21.5 Except as
set forth in Schedule
2.21.5 attached hereto, no Seller Company has made any Claim in writing
of a violation, infringement, misuse or misappropriation by any third party
(including, without limitation, any employee or former employee of such Seller
Company) of its rights to, or in connection with any Business Intellectual
Property, which Claim is still pending.  Except as set forth in Schedule 2.21.5
attached hereto, no Seller Company has entered into any Contract to indemnify
any other Person against any charge of infringement of any Intellectual
Property, other than indemnification provisions contained in purchase orders or
license agreements arising in the ordinary course of business.

     

    2.21.6 To the
best knowledge of Parent and Seller Companies, there are no pending or
threatened Claims by any Person or Authority of any violation, infringement,
misuse or misappropriation by Seller Companies of any Intellectual Property
owned by any third party, or of the invalidity of any patent or registration of
a copyright, trademark, service mark, domain name, or trade name included in
Business Intellectual Property.  No Seller Company nor Parent knows of
any valid basis for any such Claim(s).

     

    2.21.7 Seller
Companies have taken all necessary and reasonable steps to protect and preserve
the confidentiality of all trade secrets, know-how, source codes, databases,
customer lists, schematics, ideas, algorithms and processes and all use,
disclosure or appropriation thereof by or to any third party has been pursuant
to the terms of a written agreement between such third party and Seller
Companies.  No Seller Company has breached any Contracts of
non-disclosure or confidentiality.

     

    
      
         

      

      
        - 24
-

        
          

        

      

      
         

      

    

    2.21.8 None of
the Intellectual Property used, owned or licensed by HealthIXS Corporation, a
wholly-owned subsidiary of Parent, is used in, related to, licensed by or
necessary in any manner whatsoever for the operation of the Business or the
ownership of the Acquired Assets.

     

    2.21.9 For the
twelve (12) month period prior to the Closing Date, the Internet domain names
and URLs of Business Intellectual Property (together with any content and other
materials accessible and/or displayed thereon, the “Sites”) direct and resolve to
the appropriate Internet protocol addresses and are, and have been, maintained
and accessible to Internet users on those certain computers used by Seller
Companies to make the Sites so accessible (the “Server”) approximately
twenty-four (24) hours per day, seven (7) days per week (“24/7”) and are and have been
operational for downloading content from the Server on a 24/7
basis.  Seller Companies have fully operational back-up copies of the
Sites (and all related software, databases and other information), made from the
current versions of the Sites as accessible to Internet users on the Server (and
copied directly therefrom), which copies will have been made at least every two
weeks from the date hereof until the Closing Date.  Such back-up
copies are kept in a safe and secure environment, fit for the back-up of media,
and are not located at the same location of the Server.  Seller
Companies have no reason to believe that the Sites will not operate on the
Server or will not continue to be accessible to Internet users on a 24/7 basis
prior to, at the time of, and after the Closing Date.

     

    2.22 Employee
Benefit Plans.  

     

    2.22.1 Schedule 2.22
attached hereto sets forth a true, complete and correct list of all “employee
benefit plans”, as defined in § 3(3) of the Employee Retirement Security Act of
1974, as amended and the rules and regulations promulgated thereunder
(collectively, “ERISA”),
all benefit plans as defined in § 6039D of the Internal Revenue Code of 1986, as
amended, and the rules and regulations promulgated thereunder (the “Code”), and all other bonus,
incentive compensation, deferred compensation, profit sharing, ownership
interest option, severance, supplemental unemployment, layoff, salary
continuation, retirement, pension, health, life insurance, disability, group
insurance, vacation, holiday, sick leave, fringe benefit or welfare plan or
employment, consulting, change in control, independent contractor, professional
services, confidentiality, or non-competition agreement or any other similar
plan, agreement, policy or understanding (whether oral or written, qualified or
non-qualified) and any trust, insurance, escrow or other funding arrangement
related thereto (i) which is currently or has been at any time within the
last five (5) years maintained or contributed to by Parent, Seller Companies or
any ERISA Affiliate for the benefit of any Employee of the Business, or (ii)
with respect to which Parent, Seller Companies or any ERISA Affiliate has any
liability or obligations to any current or former Employee, or the dependents of
any current or former Employee, of the Business, regardless of whether funded,
or (iii) that could result in the imposition of liability or obligation of any
kind or nature, whether accrued, absolute, contingent, direct, indirect, known
or unknown, perfected or inchoate or otherwise and whether or not now due or to
become due, to Seller Companies (all of which are collectively referred to as
the “Benefit
Plans”).

     

    2.22.2 Neither
Parent, Seller Companies, nor any ERISA Affiliate have been liable at any time
within the last ten (10) years for contributions to a defined benefit pension
plan that is subject to Section 412 of the Code, Section 302 of ERISA and/or
Title IV of ERISA.  Parent and Seller Companies sponsor a money
purchase pension plan that is subject to Section 412 of the Code and Section 302
of ERISA.  There are no “accumulated funding deficiencies” within the
meaning of ERISA or the Code or any federal excise tax or liability on account
of any deficient fundings in respect of the Benefit Plans.  No
reportable event(s) (within the meaning of ERISA) or prohibited transaction(s)
(within the meaning of the Code) has occurred in respect of the Benefit
Plans.

     

    
      
         

      

      
        - 25
-

        
          

        

      

      
         

      

    

    2.22.3 Seller
Companies have heretofore provided to Purchaser, with respect to each of the
Benefit Plans, true, accurate and complete copies of the following documents as
applicable: (i) the Benefit Plan document and all amendments or a written
summary of any Benefit Plan not reduced to writing, (ii) the Form 5500 filings
(to the extent applicable) for each Benefit Plan for the 2007 calendar year;
(iii) the most recently issued IRS favorable determination, opinion, or
notification letter (to the extent applicable) for each Benefit Plan; (iv) all
personnel, payroll and employment manuals and policies related to any Employee
for the 2007 or the 2008 calendar year, and (v) such other documents, records or
other materials related thereto reasonably requested by Purchaser prior to the
Closing Date.

     

    2.22.4 There
have been no prohibited transactions, breaches of fiduciary duty or other
material breaches or violations of any law applicable to the Benefit Plans and
related funding arrangements that could subject Seller Companies or Purchaser to
any material liability.  Each Benefit Plan intended to be qualified
under Section 401(a) of the Code has a current favorable determination letter
(or, in the case of a standardized form or paired plan, a favorable opinion or
notification letter), and no event has occurred which could cause any Benefit
Plan to become disqualified for purposes of Section 401(a) of the
Code.  Each Benefit Plan has been operated in all material respects in
compliance with applicable law, including Section 401(a) of the Code and ERISA,
as applicable, and in accordance with its terms.

     

    2.22.5 All
required reports, tax returns, documents and plan descriptions of the Benefit
Plans have been timely filed with the Internal Revenue Service and the U.S.
Department of Labor (“DOL”) and/or, as appropriate,
provided to participants in the Benefit Plans.

     

    2.22.6 There are
no pending Claims relating to any Benefit Plan (other than ordinary course
Claims for benefits) and, to the best knowledge of Parent and Seller Companies,
none are threatened.  The Benefit Plans do not discriminate in
operating in favor of employees who are officers or highly
compensated.  The Benefit Plans have not been audited or investigated
by either the Internal Revenue Service, the Department of Labor or the Pension
Benefit Guaranty Corporation within the last five (5) years, and there are no
outstanding issues with reference to the Benefit Plans pending before said
governmental agencies.

     

    2.22.7 No
written or oral representations have been made to any Employee promising or
guaranteeing any employer payment or funding, and no Benefit Plans provide, for
the continuation of medical, dental, life or disability insurance coverage for
any former Employee or such former Employee’s beneficiaries for any period of
time beyond the end of the Employee’s termination date (except to the extent of
coverage required under Title I, Part 6, of ERISA (“COBRA”) and solely at the cost
of the former Employee).  The consummation of the transactions
contemplated pursuant to this Agreement and the agreements, documents and
transactions contemplated hereby and thereby will not accelerate the time of
vesting or payment, or increase the amount, of compensation to any Employee,
except to the extent required by the Code.  No Benefit Plans or other
contracts or arrangements provide for payments to any Employee that would be
triggered by the consummation of the transactions contemplated pursuant to this
Agreement and the agreements, documents and transactions contemplated hereby and
thereby would subject any person to excise tax under Section 4999 of the Code
(i.e., “golden parachute” taxes).  With respect to the Employees, no
Seller Company nor Parent has made any payments, is not obligated to make any
payments, and is not a party to any agreement that under certain circumstances
could obligate it to make any payments that will not be deductible under Section
280G of the Code.

     

    
      
         

      

      
        - 26
-

        
          

        

      

      
         

      

    

    2.22.8 Parent,
Seller Companies and each of their ERISA Affiliates have substantially complied
with the continuation coverage provisions of COBRA with respect to all
Employees.  Purchaser shall not assume responsibility for any current
COBRA beneficiary of Seller Companies or Parent.

     

    2.22.9 Neither
Parent, nor any Seller Company or any ERISA Affiliate nor any other employer who
has participated or is participating in any Benefit Plan (a “Sponsor”) has incurred any
liability to the DOL or the Internal Revenue Service in connection with any of
the Benefit Plans, and no condition exists that presents a risk to Parent,
Seller Companies or any Sponsor of incurring any material liability to the DOL
or the Internal Revenue Service in connection with any of the Benefit
Plans.

     

    2.22.10 Parent
and Seller Companies have paid in full or properly accrued on the appropriate
balance sheet all amounts that are required under the terms of each Benefit Plan
or funding arrangement to have been paid as of the date of this Agreement with
respect to periods prior to the Closing Date.  Further, on or prior to
the due date under applicable law, Seller Companies shall pay in full all
liabilities accrued as of the Closing Date with respect to each Employee in each
Benefit Plan.

     

    2.22.11 All
amounts required under any Benefit Plan or arrangement that provides for
severance payments to Employees will be paid on or prior to the completion of
the transactions contemplated herein.

     

    2.22.12 No lien,
security interests, encumbrances or other Liens exist with respect to the
Acquired Assets that were imposed pursuant to the terms of the Code or ERISA,
and no condition exists or could occur that would result in the imposition of
such liens, security interests, encumbrances or Liens with respect to the
Acquired Assets, Seller Companies, or the Business, arising from or relating to
the Benefit Plans.

     

    2.22.13 For the
purpose of this Section 2.22, the
term “ERISA Affiliate”
shall mean (i) any related company or trade or business that is required to be
aggregated with Seller Companies or Parent under Code Sections 414(b), (c), (m)
or (o); (ii) any other company, entity or trade or business that has adopted or
has ever participated in any Benefit Plan; and (iii) any predecessor or
successor company or trade or business of Parent, Seller Companies or any entity
described in Section 2.22.13(i)
and (ii)
immediately above.

     

    
      
         

      

      
        - 27
-

        
          

        

      

      
         

      

    

    2.23 Employees.  Schedule 2.23
attached hereto sets forth a list of all officers, directors, managers, and
employees of the Business (collectively, the “Employees”), together with
such Employees’ positions, a description of the rate and basis for their total
compensation and leave status (if applicable).  Except for those
Employees who are subject to Contracts described in Schedule 2.10.1(l)
attached hereto, all of the Employees are terminable at will.  To the
knowledge of Seller Companies and Parent, no executive, key employee, or group
of employees has given notice that they intend to terminate employment with the
Business prior to the Closing.  Under no circumstances will any
physician or other duly licensed health care provider that is not otherwise
permitted by applicable New Jersey laws to be an employee of
Purchaser.  Each Seller Company has conducted its business in
compliance with all Regulations and Orders affecting employment and employment
practices applicable to Seller Companies, including the payment of wages and
hours.  No Seller Company has ever been party to or bound by any
collective bargaining agreement, and none of the Employees are represented by
any labor organization.  To the knowledge of Seller Companies and
Parent, there is no organizational effort presently being made or threatened
(and none has been made or, to the knowledge of Parent and Seller Companies,
threatened within the last three (3) years) by or on behalf of any labor union
with respect to any Employee.  There have been no strikes, slowdowns,
work stoppages, other job actions, lockouts, material labor disputes, nor any
demands for collective bargaining by any union, labor organization or other
Person during the last three (3) years (nor, to the knowledge of Parent and
Seller Companies, has any such event been threatened).  There is no
dispute or controversy with any union or other organization of the Employees,
and no arbitration proceedings are pending or, to the best knowledge of Seller
Companies and Parent, threatened involving a dispute or controversy affecting
Seller Companies or the Business.  There are no complaints, charges,
or Claims against any Seller Company pending or, to the knowledge of Seller
Companies or Parent, threatened before any Authority based on, arising out of,
or in connection with, or otherwise relating to the employment or termination of
employment of any Employee.  At the Closing, Seller Companies will not
have any liability or obligation to any of their Employees or former employees,
officers or managers (including unaccrued year end bonuses) other than for the
payment of salaries to be paid in the ordinary course of
business.  Neither Parent nor any Seller Companies have taken any
action, or failed to take any action, that has resulted, or would reasonably be
likely to result in, any Claim by an Employee that the Employee has been
constructively terminated or due severance payments.  Upon the
consummation of the transactions contemplated pursuant to this Agreement and the
agreements, documents and transactions contemplated hereby and thereby, Seller
Companies will not have any “change in control,” bonus or other obligations to
any Employees, consultants or other Persons performing services for Seller
Companies or the Business.

     

    
      
         

      

      
        - 28
-

        
          

        

      

      
         

      

    

    2.24 Insurance
Coverage.  Each Seller Company and, to the knowledge of Seller
Companies and Parent, the PA has maintained in full force and effect, with no
premium arrearages as of the Closing Date, insurance policies bearing the
numbers, for the terms, with the insurance companies or other insurance
providers, in the amounts and providing the coverage set forth on Schedule 2.24
attached hereto.  True and correct copies of all such policies and all
endorsements thereto have been delivered to Purchaser.  Parent and
Seller Companies do not know of any state of facts, or of the occurrence of any
event which might reasonably (a) form the basis for any claim against the PA,
Parent or Seller Companies not fully covered by insurance for liability on
account of any express or implied warranty or tortious omission or commission,
or (b) result in material increase in insurance premiums of PA, Seller Companies
with respect to the Acquired Assets, or the Business as it operates prior to the
Closing Date or as it is contemplated to operate after Closing, pursuant to the
transactions contemplated pursuant to this Agreement and the agreements,
documents and transactions contemplated hereby and thereby.  Schedule 2.24
attached hereto contains a description of all current malpractice liability
insurance policies of Seller Companies and, to the knowledge of Seller Companies
and Parent, the PA.  Except as set forth on Schedule 2.24
attached hereto, to Parent’s and Seller Companies’ knowledge: (i) neither
Parent, any Seller Company nor the PA has during the three (3) years immediately
preceding the Closing Date, filed any written application for any insurance
coverage relating to the PA’s or Seller Companies’ business or property that has
been denied by an insurance agency or carrier; and (ii) Seller Companies and the
PA have been continuously insured for professional malpractice claims during the
same period.  Schedule 2.24
attached hereto also sets forth a list of all claims for any insured loss in
excess of $5,000 per occurrence filed by Parent, Seller Companies or, to the
knowledge of Seller Companies and Parent, the PA during the three (3) years
immediately preceding the Closing Date, including workers compensation, general
liability, environmental liability and professional malpractice liability
claims. With respect to each insurance policy listed in Schedule 2.24
attached hereto:  (i) each such policy is legal, valid, binding,
enforceable, and in full force and effect; (ii) each such policy will continue
to be legal, valid, binding, enforceable, and in full force and effect on
identical terms following the consummation of the transactions contemplated
pursuant to this Agreement and the agreements, documents and transactions
contemplated hereby and thereby; (iii) no Seller Company nor Parent nor, to the
knowledge of Seller Companies and Parent, the PA is in breach or default
(including with respect to the payment of premiums or the giving of notices),
and no event has occurred which, with notice or the lapse of time, would
constitute such a breach or default, or permit termination, modification, or
acceleration, under the policy; (iv) no party to such policy has repudiated any
provision thereof; (v) there is no claim pending under any such policy as to
which coverage has been questioned, denied or disputed by the underwriters of
such policies or any notice that a defense will be afforded with reservation of
rights; (vi) neither any Seller Company, Parent nor, to the knowledge of Seller
Companies and Parent, the PA has received: (A) any notice that any issuer of any
such policy has filed for protection under applicable bankruptcy laws or is
otherwise in the process of liquidating or has been liquidated, or (B) any other
indication that such policies are no longer in full force and effect or that the
issuer of any such policy is not longer willing or able to perform its
obligations thereunder; and (vii) neither any Seller Company, Parent, nor, to
the knowledge of Seller Companies and Parent, the PA has received any written
notice from or on behalf of any insurance carrier issuing such policies, that
there will hereafter be a cancellation, or a material increase in the premium or
deductible or non-renewal of existing policies. Seller Companies and, to the
knowledge of Seller Companies and Parent, the PA have been covered during the
past three (3) years by insurance in scope and amount customary and reasonable
for the business in which it has engaged during the aforementioned
period.

     

    2.25 Appraisal
Reports and Surveys.  To the knowledge of Parent and Seller
Companies, within the three (3) year period prior to the Closing Date, there
have been no appraisal reports, surveys or other documents that evaluate or
describe Seller Companies, the Business, the Locations or any of the Acquired
Assets or Acquired Assets that have not been delivered to
Purchaser.

     

    
      
         

      

      
        - 29
-

        
          

        

      

      
         

      

    

    2.26 Consents.  Schedule 2.26
attached hereto sets forth a complete list of consents of governmental and other
regulatory agencies or authorities, foreign or domestic, and non-governmental
Persons required to be received by or on the part of Parent, Seller Companies
or, to the knowledge of Seller Companies and Parent, the PA to enable them to
enter into and carry out this Agreement in all material respects.  All
such requisite consents have been, or prior to the Closing Date will have been,
obtained.

     

    2.27 Environmental
Matters.  Parent or Seller Companies have provided Purchaser
with, or access to, true and complete copies of all environmental reports
documenting the results of inspections, investigations, studies, or tests
conducted in relation to the Locations, Seller Companies or the Business,
including final Phase I and Phase II environmental site assessments,
if any, prepared by or on behalf of Seller Companies, Parent, any lender or
financing source of Parent or Seller Companies or otherwise in the possession or
control of Parent or Seller Companies, relating to Seller Companies, the
Locations, the operation of the Business or, to the knowledge of Seller
Companies and Parent, the PA. Except as disclosed in Schedule 2.27
attached hereto:

     

    2.27.1 Seller
Companies (i) hold and are in compliance with all Environmental Permits, and all
such Environmental Permits are in full force and effect; and (ii) currently
operate and have operated the Business, the Locations, and any other property
owned, leased or operated by Seller Companies or in connection with the Business
in compliance with applicable Environmental Laws and Environmental
Permits.

     

    2.27.2 Neither
Parent nor any Seller Company has received or has knowledge of any written
notice, citation, summons, order, request for information, notice of claim,
demand, complaint, penalty or notification that it is or may be potentially, and
no investigation or review currently is pending or, to Parent’s or Seller
Companies’ knowledge, threatened, by or from any Authority or other Person: (A)
with respect to any alleged violation of any Environmental Law or Environmental
Permits; (B) with respect to any failure to have any Environmental Permit;
(C) with respect to any possession, generation, treatment, storage,
recycling, transportation or Release of any Hazardous Substance, or (D) with
respect to any Remedial Action of any threatened or actual Release of any
Hazardous Substance generated by or on behalf of Seller Companies or their
predecessors at the Locations or in connection with Seller Companies’ past
operation of the Business.

     

    2.27.3 To the
knowledge of Seller Companies, no expenditure(s) in excess of $50,000 in the
aggregate with respect to Seller Companies, the Business or the Locations will
be necessary to achieve compliance with any Environmental Law.

     

    2.27.4 There
exists no Environmental Condition at, under or about any Location or any other
property now or formerly operated or used by Seller Companies and/or in
connection with the Business.

     

    2.27.5 There are
not now and there have not been Hazardous Substances used, generated or stored
by Seller Companies in the conduct of the Business or at the Locations; (b)
there are no and there have not been any Underground Storage Tanks or above
ground storage tanks at any Location; (c) there is no asbestos located at or on
any Location;  and (d) no Environmental Lien has attached to any
Location or any other property now or formerly operated or used by any Seller
Company or in connection with the Business.

     

    
      
         

      

      
        - 30
-

        
          

        

      

      
         

      

    

    2.27.6 No
Location nor any other property now or formerly operated or used by Seller
Companies or in connection with the Business is listed or proposed for listing
on the National Priorities List pursuant to CERCLA, or set forth on the
Comprehensive Environmental Response Compensation Liability Information System
List, or any similar state list of sites and, to the knowledge of Parent and
Seller Companies, no condition at such properties exists that, if known to an
Authority, would qualify such property for inclusion on any such
list.

     

    2.27.7 Seller Companies have no liability for costs associated with Remedial
Action or natural resource damages arising from an arrangement by Seller
Companies for the disposal of Hazardous Substances.

     

    2.27.8 The
transactions contemplated pursuant to this Agreement and the agreements,
documents and transactions contemplated hereby and thereby will not result in
any obligations for site investigation or cleanup, or consent of government
agencies or third parties, pursuant to any of the so called “transaction
triggered” or “responsible property transfer” Environmental Laws or any other
Environmental Law.

     

    2.28 Medical
Waste.  With respect to the generation, transportation,
treatment, storage, and disposal, or other handling of Medical Waste, Seller
Companies have complied with all Medical Waste Laws.

     

    2.29 Federal
Health Care Programs.  

     

    2.29.1 No Seller
Company participates in the Medicare program.  The PA is qualified for
participation in the Medicare program, and each Imaging Center is duly enrolled
in the Medicare program as an independent diagnostic testing
facility.  Complete and accurate copies of Seller Companies’ and/or
the PA’s existing Medicare contracts, Medicare 855-B applications, and Medicare
855-R applications have been furnished to Purchaser.  Each Seller
Company and the PA is presently in compliance with all of the terms, conditions
and provisions of such contracts, the noncompliance with which would have a
Material Adverse Effect on any such contract.

     

    2.29.2 No Seller
Company participates in the Medicaid program.  The PA is qualified for
participation in the Medicaid program.  Complete and accurate copies
of the PA’s existing Medicaid contracts for the Locations have been furnished to
Purchaser.  The PA is presently in compliance with all of the terms,
conditions and provisions of such contracts the noncompliance with which would
have a Material Adverse Effect on any such contract.

     

    2.29.3 No Seller
Company participates in the CHAMPUS program. The PA participates in the CHAMPUS
program and is presently in compliance, in all respects, with all of the terms
and conditions of such participation, the noncompliance with which would have a
Material Adverse Effect on any such participation.

     

    2.30 Capital
Expenditures and Investments.  Seller Companies
have outstanding Contracts and a budget for capital expenditures and Investments
that are Assumed Obligations as set forth in Schedule 2.30
attached hereto which includes a schedule of all monies disbursed on account of
capital expenditures and investments made by Seller Companies since the
Financial Statement Date.

     

    
      
         

      

      
        - 31
-

        
          

        

      

      
         

      

    

    2.31 Dealings
with Affiliates.  Schedule 2.31
attached hereto sets forth a complete and accurate list and description of the
economic terms, including the parties, of all Contracts to which any Seller
Company is, will be or has been a party, at any time from the Financial
Statement Date to the Closing Date, and to which any one or more of (a) Seller
Companies, (b) Parent, (c) a Seller Company’s Affiliate, (d) a Parent’s
Affiliate, or (e) any Person in which a Seller Company or Parent or any of their
respective Affiliates has, directly or indirectly, made an Investment, is also a
party.  Since the Financial Statement Date, no Seller Company has made
any payments, loaned or borrowed any funds or property or made any credit
arrangement or accommodation with Parent or an Affiliate or employee of any
Seller Company, except for the payment of employee salaries and manager
compensation in the ordinary course of business.

     

    2.32 Confidential
Information.  No Seller Company nor Parent has disclosed to any
Person, other than Purchaser, authorized representatives of Purchaser and
employees of Seller Companies, any proprietary confidential information related
to the Business.

     

    2.33 Brokerage.  There
are no Claims for brokerage commissions, investment banking or finders’ fees or
expenses or similar compensation in connection with the transactions
contemplated by this Agreement based on any arrangement or Contract binding upon
Seller Companies or Parent.

     

    2.34 Solvency.  Immediately
prior to, and immediately subsequent to, the consummation of the sale of the
Acquired Assets pursuant to the provisions of this Agreement, each Seller
Company will be a solvent entity with the ability to pay its debts as they
become due.  For purposes of this Agreement, solvent shall mean, with
respect to each Seller Company, that the present fair saleable value of such
Seller Company’s assets is greater than the amount that will be required to pay
its liability on its existing debts as they become absolute and
matured.

     

    2.35 Power of
Attorney.  There are no outstanding powers of attorney executed
on behalf of any Seller Company.

     

    2.36 Disclosures.  Neither this
Agreement nor any of the Contracts, exhibits, attachments, written statements,
documents, certificates or other items prepared for or supplied to Purchaser by
or on behalf of any Seller Company or Parent with respect to the transactions
contemplated hereby contains any untrue statement of a material fact or omits a
material fact necessary to make each statement contained herein or therein not
misleading.  There is no fact that any Seller Company or Parent has
not disclosed to Purchaser herein and of which any Seller Company or Parent, or
any of their respective officers, directors, managers or executive employees is
aware that could reasonably be anticipated to have a Material Adverse Effect on
the PA, Seller Companies, the Business, the Acquired Assets or the ability of
Purchaser to continue the businesses of the PA and Seller Companies in the same
manner as the PA and Seller Companies conducted the Business prior to the
Closing Date after consummation of the transactions contemplated pursuant to
this Agreement and the agreements, documents and transactions contemplated
hereby and thereby.  Seller Companies have disclosed to Purchaser all
material information relating to the Business, the Acquired Assets and the
transactions contemplated pursuant to this Agreement and the agreements,
documents and transactions contemplated hereby and thereby.

     

    
      
         

      

      
        - 32
-

        
          

        

      

      
         

      

    

    3. Representations And
Warranties Of Purchaser

     

    Purchaser
represents and warrants to Seller Companies and Parent as of the date hereof and
as of the Closing Date as set forth below in this Section
3.  Each of the representations and warranties shall be deemed
material, and Seller Companies and Parent, in executing, delivering and
consummating the transactions under this Agreement, have relied and will rely
upon the correctness and completeness of each of representation and warranty
notwithstanding any independent investigation and all representations and
warranties are provided by Purchaser to induce Seller Companies and Parent to
enter into this Agreement and to consummate the transactions contemplated
hereby.

     

    3.1 Corporate
Organization, Etc.  Purchaser is a limited liability company
duly organized, validly existing and in good standing under the laws of the
State of New Jersey with full corporate power and authority to carry on its
business as it is now being conducted and to own, operate and lease its
properties and assets.  Purchaser is duly qualified or licensed to do
business and is in corporate and Tax good standing in every jurisdiction in
which the conduct of its business, the ownership or lease of its properties,
require it to be so qualified or licensed.

     

    3.2 Authorization,
Etc.

     

    3.2.1 Purchaser
has full power and authority to enter into this Agreement and the agreements
contemplated hereby to which Purchaser is a party and to consummate the
transactions contemplated hereby and thereby.  The execution, delivery
and performance of this Agreement and all other agreements and transactions
contemplated hereby have been duly authorized by Purchaser, and no other
corporate proceedings on their part are necessary to authorize this Agreement
and the agreements contemplated hereby and the transactions contemplated hereby
and thereby.  This Agreement and all other agreements contemplated
hereby to be entered into by Purchaser each constitutes a legal, valid and
binding obligation of Purchaser enforceable against Purchaser in accordance with
its terms, except as the same may be limited by applicable bankruptcy,
insolvency, rehabilitation, moratorium or similar laws, now or hereafter in
effect, of general application relating to or affecting creditors’ rights,
including, without limitation, the effect of statutory or other laws regarding
fraudulent conveyances and preferential transfers, and for the limitations
imposed by general principles of equity.

     

    3.2.2 Except as
set forth in Schedule 3.2.2
attached hereto, the execution, delivery and performance by Purchaser of this
Agreement, and all other agreements contemplated hereby, and the fulfillment of
and compliance with the respective terms hereof and thereof by Purchaser, do not
and will not (a) conflict with or result in a breach of the terms, conditions or
provisions of, (b) constitute a default or event of default under (whether with
or without due notice, the passage of time or both), (c) result in a violation
of, or (d) require any authorization, consent, approval, exemption or other
action by, notice to, or filing with any third party or Authority pursuant to,
the organizational documents or operating agreement of Purchaser or any
applicable Regulation, Order or Contract to which Purchaser or its properties
are subject.  Purchaser has complied in all material respects with all
applicable Regulations and Orders in connection with the execution, delivery and
performance of this Agreement, the agreements contemplated hereby and the
transactions contemplated hereby and thereby.

     

    
      
         

      

      
        - 33
-

        
          

        

      

      
         

      

    

    3.3 Brokerage.  There
are no Claims for brokerage commissions, investment banking or finders’ fees or
expenses or similar compensation in connection with the transactions
contemplated by this Agreement based on any arrangement or Contract binding upon
Purchaser.

     

    4. Covenants
of Seller Companies and Parent.  

     

    Until the
Closing Date, except as otherwise consented to or approved by Purchaser in
writing, each of Seller Companies and Parent agree that they shall act, or
refrain from acting where required hereinafter, to comply (and in the case of
Parent, to cause Seller Companies to comply) with the following:

     

    4.1 Regular
Course of Business.  Each Seller
Company shall (a) operate its business diligently and in good faith, consistent
with past management practices; (b) maintain all of its properties in customary
repair, order and condition, reasonable wear and tear excepted;
(c) maintain (except for expiration due to lapse of time) all leases and
Contracts in effect without change except as expressly provided herein; (d)
comply with the provisions of all Regulations and Orders applicable to such
Seller Company and the conduct of the Business; (e) not cancel, release, waive
or compromise any debt, Claim or right in its favor having a value in excess of
$5,000 other than in connection with returns of inventory for credit or
replacement in the ordinary course of business; (f) not alter the rate or basis
of compensation of any of its officers, directors, managers or employees other
than in the ordinary course of business consistent with past practice and
immaterial in amount or otherwise adopt or modify any Benefit Plan; (g) maintain
insurance coverage up to the Closing Date with the coverage and in the amounts
set forth in Schedule
2.24 attached hereto; (h) maintain inventory, supplies and spare parts at
customary operating levels consistent with current practices, and replace in
accordance with past practice any inoperable, worn out or obsolete assets with
modern assets of comparable quality; (i) maintain  each Seller
Company’s books, accounts and records in accordance with past custom and
practice as used in the preparation of the Financial Statements; (j) maintain in
full force and effect the existence of all Business Intellectual Property
rights; (k) use its reasonable best efforts to preserve the goodwill and
organization of the Business and its relationships with its customers,
suppliers, employees and other Persons having business relations with it; (l)
not take or omit to take any action that would require disclosure under Section 2, or that
would otherwise result in a breach of any of the representations, warranties or
covenants made by Parent or Seller Companies in this Agreement or in any of the
agreements contemplated hereby; (m) not sell any of such Seller Company’s assets
other than in the ordinary course of business; and (n) not take any action or
omit to take any action which act or omission would reasonably be anticipated to
have a Material Adverse Effect.

     

    4.2 Ownership
Changes.  Seller Companies
shall not issue or sell any Equity Interests or securities convertible or
exchangeable into, or Options to subscribe for, any Equity Interests, and Seller
Companies shall not pledge or otherwise encumber any Equity
Interests.  Seller Companies shall not redeem, retire, purchase or
otherwise acquire directly or indirectly any Equity Interests.  Seller
Companies shall not declare, pay or set aside for payment any dividend or other
distribution in respect of its Equity Interests.  Seller Companies
shall not issue any additional Options or enter into any Contracts containing
any profit participation features, equity appreciation rights or phantom equity
option plans, or similar Contracts that allow any Person to participate in the
equity of any Seller Company.  No Seller Company shall amend its
organizational documents or operating agreement or merge into or consolidate
with any other Person or change the character of its business.  Parent
shall not sell, pledge or otherwise encumber its Equity Interests.  In
addition, Seller Companies shall not allow the transfer of any of their Equity
Interests on the ownership ledger or other books and records.

     

    
      
         

      

      
        - 34
-

        
          

        

      

      
         

      

    

    4.3 Capital
and Other Expenditures.  No Seller Company
shall make any Investments or capital expenditures, or commitments with respect
thereto, except as provided in its budget, and shall not make any Material
Adverse Change in business practices, such as reductions in capital
expenditures, advertising, etc., contemplated by the budget of Seller
Companies.  Seller Companies shall not make any loan or advance to any
Person (other than accounts receivable made in the ordinary course of business)
and shall collect in full any amounts outstanding now due from any
Affiliate.  Seller Companies shall not make any charitable or other
contributions to any Person, nor shall it make any commitments
therefor.

     

    4.4 Borrowing.  Seller Companies
shall not incur, assume or Guarantee any Indebtedness not reflected on the
Financial Statements except in the ordinary course of business under existing
credit facilities as such credit facilities exist on the date
hereof.

     

    4.5 Other
Commitments.  Except as set
forth in this Agreement, incurred or transacted in the ordinary course of
business, or permitted in writing by Purchaser, Seller Companies shall not enter
into any material Contract or transaction or make any commitment or incur any
material obligation or liability (including entering into any real property
leases).

     

    4.6 Interim
Financial Information and Audit.  Seller Companies
shall supply Purchaser with unaudited monthly operating statements within thirty
(30) days after the end of each month ending between the date hereof and the
Closing Date, certified by each Seller Company’s chief executive officer and
chief financial officer as having been prepared in accordance with procedures
employed by Seller Companies in preparing prior monthly operating statements and
certifying that such financial statements were prepared in accordance with GAAP
applied on a basis consistent with the Financial Statements and include all
adjustments (all of which were normal recurring adjustments) necessary to fairly
present Seller Companies’ financial position, results of operations and changes
in financial position at and for such periods.

     

    4.7 Full
Access and Disclosure.  Each Seller
Company shall afford to Purchaser and its counsel, accountants, agents and other
authorized representatives and to financial institutions specified by Purchaser
reasonable access during business hours to Seller Companies’ and (to the extent
Seller Companies have access) the PA’s facilities, books and records in order
that Purchaser may have full opportunity to make such reasonable investigations
as it shall desire to make of the affairs of Seller Companies and (to the extent
Seller Companies have access) the PA; provided that in each
case any visits by such Person to Seller Companies’ or the PA’s facilities shall
be approved by the applicable Seller Company or Parent and accompanied by a
representative of Seller Companies.  Seller Companies shall cause
their officers, employees, counsel and auditors to furnish such additional
financial, operating data and other information as Purchaser shall from time to
time reasonably request including, without limitation, any internal control
recommendations made by its independent auditors in connection with any audit of
Seller Companies.  From time to time prior to the Closing Date, Seller
Companies shall promptly supplement or amend information previously delivered to
Purchaser with respect to any matter hereafter arising which, if existing or
occurring at the date of this Agreement, would have been required to be set
forth or disclosed herein; provided, however, that such
supplemental information shall not be deemed to be an amendment to any schedule
hereto and shall not change the risk allocation of this Agreement as between
Purchaser, Parent and Seller Companies.

     

    
      
         

      

      
        - 35
-

        
          

        

      

      
         

      

    

    4.8 Fulfillment
of Conditions Precedent.  Parent and Seller
Companies shall use their best efforts to obtain at their expense all such
waivers, Permits, consents, approvals or other authorizations from third Persons
and Authorities, and to do all things as may be necessary or desirable in
connection with transactions contemplated by this Agreement.

     

    4.9 Minimum
Account Balance.  After the Closing, Purchaser shall maintain a
minimum aggregate cash balance equal to $150,000 in its bank accounts with
respect to the Business, which shall be funded solely by the operations of the
Business and utilized solely for the purposes of satisfying any payments to
Parent relating to a Working Capital Surplus, as determined pursuant to Section
1.8.

     

    4.10 SEC
Matters.  Within five (5) business days following the execution
of this Agreement, Parent shall file with the Securities Exchange Commission
(the “SEC) a preliminary
Schedule 14C information statement pursuant to Section 14C of the Securities
Exchange Act of 1934, as amended (the “Preliminary Information
Statement”) (and shall provide Purchaser with a copy thereof) describing
the transactions contemplated by this Agreement and notifying Parent's
stockholders that the holders of at least a majority of the issued and
outstanding shares of Parent's common stock have consented in writing to such
transactions. Parent shall provide Purchaser with a copy of such executed
written stockholder consent prior to filing the Preliminary Information
Statement with the SEC. In the event that the SEC provides Parent any comments
to the Preliminary Information Statement, Parent shall provide Purchaser with
all documents and communications related thereto (the “SEC Communications”) until
such time that the SEC has approved a definitive information statement for
filing with the SEC and mailing to Parent’s stockholders (the “Definitive Information Statement”, and
together with the Preliminary Information Statement and the SEC Communications,
the “SEC Documents”).
Parent shall file the Definitive Information Statement with the SEC, mail the
same to its stockholders and provide Purchaser with a copy thereof as soon as
practicable following the approval of the Definitive Information Statement by
the SEC as set forth above.

     

    5. Closing
Conditions

     

    5.1 Conditions
to the Obligations of
Purchaser.  Each and every obligation of Purchaser under this
Agreement shall be subject to the satisfaction at or prior to the Closing Date
of each of the following conditions, any of which may be waived, in writing,
exclusively by Purchaser:

     

    5.1.1 Representations
and Warranties; Performance.  The representations and
warranties of Seller Companies and Parent contained in this Agreement, and all
information contained in any exhibit or schedule hereto delivered by or an
behalf of Seller Companies or Parent to Purchaser, shall be true and correct
when made and on the Closing Date with the same force and effect as though the
same had been made on and as of the Closing Date, except for those
representations and warranties given as of a particular date, which shall be
true and correct on and as of such date.  Seller Companies and Parent
shall have performed and complied with all agreements, covenants, conditions and
obligations under this Agreement required to be performed and complied with by
such parties as of the Closing Date.  Purchaser shall have been
granted access to all of the materials and individuals reasonably requested and
shall have had full opportunity to complete its due diligence investigation with
the cooperation of all personnel of Parent and Seller Companies involved in the
Business and, if requested, outside professional consultants and professionals
retained by Seller Companies.

     

    
      
         

      

      
        - 36
-

        
          

        

      

      
         

      

    

    5.1.2 No
Material Adverse Change.  There shall have been no Material
Adverse Change since the Financial Statement Date.

     

    5.1.3 No
Litigation.  No action or proceeding shall have been instituted
against any Seller Company or Parent before any court or other governmental body
seeking to restrain or prohibit the consummation of the transactions
contemplated hereby or to make the consummation of the transactions contemplated
hereby illegal.

     

    5.1.4 No
Third-Party Claims.  No third party shall have made a Claim in
any forum for beneficial ownership of any of the Acquired Assets or the Equity
Interests.

     

    5.1.5 Schedules
and Exhibits. The
Schedules and Exhibits and all regulatory due diligence materials do not contain
any information that materially and negatively impacts the Business, or the
prospects, condition (financial or otherwise) or value of: (i) the Acquired
Assets, or (ii) the operations contemplated between Seller Companies and/or
Parent, on the one hand, and Purchaser, on the other hand, pursuant to the
transactions contemplated pursuant to this Agreement and the agreements,
documents and transactions contemplated hereby and thereby.

     

    5.1.6 Due
Diligence Review.  Purchaser shall have completed its business,
financial and legal due diligence review of Seller Companies, and Purchaser
shall be reasonably satisfied with the results of such review.

     

    5.1.7 Management
Agreement.  Purchaser and the PA shall have entered into a
Management Services Agreement reasonably satisfactory to Purchaser, in
substantially the same form as Exhibit 5.1.7
attached hereto (the “MSA”).

     

    5.1.8 Approvals
and Consents.  The Purchaser shall have approved the
transactions contemplated pursuant to this Agreement and the agreements,
documents and transactions contemplated hereby and thereby. Purchaser, each Seller
Company and Parent shall have obtained all
third-party consents, approvals, Order, Permits or other authorization required
by all applicable Regulations, Order and Contracts involving Seller Companies or
binding on their properties and assets to effectuate the transactions
contemplated pursuant to this Agreement and the agreements, documents and
transactions contemplated hereby and thereby, including, but not limited to, any
required consents to assignment from each Location’s landlord.

     

    
      
         

      

      
        - 37
-

        
          

        

      

      
         

      

    

    5.1.9 Regulatory
Approvals.  Parent and Seller Companies shall have obtained any
Regulatory approvals required as a result of the transactions contemplated
pursuant to this Agreement and the agreements, documents and transactions
contemplated hereby and thereby.

     

    5.1.10 Conditions
of Assets.  Seller Companies’ assets and properties shall not
have been damaged or destroyed, prior to the Closing Date, by fire or other
casualty, whether or not fully covered by insurance, in an aggregate amount
exceeding $25,000.

     

    5.1.11 Termination
of Affiliate Contracts.  Seller Companies and Parent shall have
caused all Contracts between any Seller Company, on the one hand, and Parent or
Affiliate of Parent, on the other hand, to terminate at Closing without any
further liability or obligation to any Seller Company.

     

    5.1.12 Financing.  Purchaser
shall have obtained financing, in amounts and on terms and conditions
satisfactory to Purchaser, to consummate the transactions contemplated by the
transactions contemplated pursuant to this Agreement and the agreements,
documents, instruments, and transactions contemplated hereby and thereby and
shall have obtained a written consent from KeyBank National Association, as a
lender and the agent for the lenders, under Purchaser’s senior credit facility,
to the transactions contemplated under this Agreement and the agreements,
documents, instruments, and transactions contemplated hereby.

     

    5.1.13 Closing
Deliveries.  Seller Companies and Parent shall have delivered
to Purchaser each of the items set forth under Section
6.2.

     

    5.1.14 Termination
of the Existing Services Agreement.  The Existing
Services Agreement shall have been terminated and no longer be of any force or
effect, and Seller Companies shall have delivered evidence of the same to
Purchaser.

     

    5.1.15 Governance
and Succession Plan.  Howard Kessler, M.D. shall have finalized
and delivered a governance and succession plan related to the PA and Dr.
Kessler, as the case may be, reasonably satisfactory to Purchaser.

     

    5.1.16 Other
Matters.  All corporate and other proceedings in connection
with the transactions contemplated pursuant to this Agreement and the
agreements, documents and transactions contemplated hereby and thereby at the
Closing Date shall be reasonably satisfactory in substance and form to Purchaser
and its counsel, and Purchaser and its counsel shall have received all such
counterpart originals or certified or other copies of such documents as they may
reasonably request.

     

    5.2 Conditions
to Obligations of Seller
Companies and Parent.  Each and every obligation of Seller
Companies and Parent under this Agreement shall be subject to the satisfaction
at or prior to the Closing Date of each of the following conditions, any of
which may be waived, in writing, exclusively by Seller Company:

     

    5.2.1 Representations
and Warranties; Performance .  The representations and
warranties of Purchaser contained in this Agreement and all information
contained in any exhibit or schedule hereto delivered by, or on behalf of
Purchaser, shall be true and correct when made and on the Closing Date with the
same force and effect as though the same had been made on and as of the Closing
Date, except for those representations and warranties given as of a particular
date, which shall be true and correct on and as of such
date.  Purchaser shall have performed and complied with all
agreements, covenants, conditions and obligations under this Agreement required
to be performed and complied with by Purchaser as of the Closing
Date.

     

    
      
         

      

      
        - 38
-

        
          

        

      

      
         

      

    

    5.2.2 No Litigation.  No
action or proceeding shall have been instituted against Purchaser before any
court or other governmental body, seeking to restrain or prohibit the
consummation of the transactions contemplated hereby or to make the consummation
of the transactions contemplated hereby illegal.

     

    5.2.3 Closing
Deliveries.  Purchaser shall have delivered to Seller Companies
each of the items set forth under Section
6.3.

     

    6. Closing

     

    6.1 Closing.  Unless
this Agreement shall have been terminated or abandoned pursuant to the
provisions of Section
9 hereof, the sale, purchase and other transactions provided for herein
(the “Closing”) shall be
consummated as soon as reasonably possible after satisfaction of the Closing
conditions and deliveries on such date and time as may be mutually agreed upon
by the Parties hereto (the “Closing Date”); provided that
the Closing shall not occur, in any event, after March 31, 2009.  The
Closing shall take place at the office of McDermott Will & Emery LLP located
at 340 Madison Avenue, New York, New York 10173, or via remote location as
coordinated by the Parties’ respective counsel.

     

    6.2 Deliveries
by Seller Companies and Parent.  At the Closing, Seller
Companies and Parent shall deliver or cause to be delivered, to Purchaser the
following, as applicable:

     

    6.2.1 Bill of
Sale duly executed by Seller Companies, as applicable;

     

    6.2.2 Assumption
Agreement duly executed by Seller Companies, as applicable;

     

    6.2.3 An
Assignment of Lease for each Location, duly executed by the applicable Seller
Company;

     

    6.2.4 The MSA
duly executed by the PA;

     

    6.2.5 The SEC
Documents;

     

    6.2.6 A payoff
letter (reasonably satisfactory to Purchaser) from each and every holder of
Seller Companies’ Indebtedness other than the Assumed Obligations, the Assumed
Indebtedness and as set forth on Schedule 6.2.6, in each case dated within three
(3) days prior to the Closing Date and stating the amounts owed in order for
such creditors to have been paid in full and to release all Liens in favor of
such creditors on the Closing Date.  Seller Companies and their
counsel shall cause such creditors to provide at Closing such UCC termination
statements, releases of mortgages and other releases of Liens as shall be
required by Purchaser and its lenders to release all Liens in favor of such
creditors on the Closing Date;

     

    
      
         

      

      
        - 39
-

        
          

        

      

      
         

      

    

    6.2.7 Resolutions
adopted by (i) the stockholders and (ii) the Board of Directors or the Board of
Managers, as applicable, of Parent and each Seller Company authorizing the
execution, delivery and performance of this Agreement and the consummation of
the transactions contemplated pursuant to this Agreement and the agreements,
documents and transactions contemplated hereby and thereby;

     

    6.2.8 All third
party or governmental consents and approvals required to consummate the
transaction contemplated hereby;

     

    6.2.9 A
certificate, executed by the secretary of Parent and each Seller Company,
certifying (i) as to the charter, articles of organization, bylaws and operating
agreement (or other similar constating documents), as applicable, of parent and
each Seller Company, (ii) that the resolutions delivered in connection with this
Agreement and to Purchaser pursuant to Section 6.2.7 are
true, correct and complete, and that such resolutions were duly adopted and have
not been amended or rescinded, (iii) as to the incumbency of certain officers of
Parent and Seller Companies, and (iv) as to the jurisdictions in which Parent
and Seller Companies are qualified to conduct business, in the form of Exhibit 6.2.9
attached hereto;

     

    6.2.10 Certified
documentation from the appropriate governmental Authority evidencing the good
standing with respect to the conduct of business of the PA and each Seller
Company as of a date not more than ten (10) days prior to the Closing Date as an
entity organized under the laws of the state and as a foreign entity authorized
to do business under the laws of the jurisdictions listed in the schedules
hereto;

     

    6.2.11 A
certificate, dated the Closing Date, executed by the President and the Chief
Financial Officer of Parent and each Seller Company certifying as to (i) the
satisfaction of the conditions set forth in Sections 5.1.1,
5.1.2 and 5.1.3, and (ii) as to
(a) Seller Companies’ Assumed Indebtedness as of the Closing Date, and (b) the
accuracy of all of the Financial Statements, in the forms designated as Exhibit 6.2.11(i)
attached hereto and Exhibit 6.2.11(ii)
attached hereto, respectively;

     

    6.2.12 An
opinion of Seller Companies’ and Parent’s counsel (which will be addressed to
Purchaser and its lenders), dated the Closing Date, in the form of Exhibit 6.2.12
attached hereto;

     

    6.2.13 A fund
flow statement, satisfactory to Purchaser, executed by Seller Companies (the
“Funds Flow Statement”);
and

     

    6.2.14 Such
other certificates, documents and instruments as Purchaser reasonably requests
related to the transactions contemplated hereby.

     

    6.3 Deliveries
by Purchaser.  At the Closing, Purchaser shall deliver to
Seller Companies the following:

     

    6.3.1 The
Purchase Price;

     

    6.3.2 Resolutions
adopted by Purchaser authorizing the execution, delivery and performance of this
Agreement and the consummation of the transactions contemplated pursuant to this
Agreement and the agreements, documents and transactions contemplated hereby and
thereby;

     

    
      
         

      

      
        - 40
-

        
          

        

      

      
         

      

    

    6.3.3 A
certificate by the secretary of Purchaser certifying (i) as to the certificate
of formation of Purchaser, (ii) that the resolutions delivered to Seller
Companies and Parent pursuant to Section 6.3.2 are
true, correct and complete, and that such resolutions were duly adopted and have
not been amended or rescinded, (iii) as to the incumbency of certain officers of
Purchaser, and (iv) as to the jurisdictions in which Purchaser is qualified to
conduct business, in the form of Exhibit 6.3.3
attached hereto;

     

    6.3.4 Certified
documentation from the appropriate governmental Authority evidencing the good
standing, with respect to both the conduct of business and the payment of all
Taxes, of Purchaser as of a date not more than seven (7) days prior to the
Closing Date as an entity organized under the laws of the state and as a foreign
entity authorized to do business under the laws of the jurisdictions listed in
the schedules hereto;

     

    6.3.5 The MSA
duly executed by Purchaser;

     

    6.3.6 A
certificate, dated the Closing Date, executed by Purchaser certifying as to the
satisfaction of the conditions set forth in Sections 5.2.1,
and 5.2.2;

     

    6.3.7 Funds
Flow Statement duly executed by Purchaser; and

     

    6.3.8 Such
other certificates, documents and instruments as Seller Companies reasonably
request in connection with the transactions contemplated pursuant to this
Agreement and the agreements, documents and transactions contemplated hereby and
thereby.

     

    7. Covenants.  

     

    7.1 No
Solicitation or Negotiation.  Seller Companies and Parent shall
not, and any of Parent’s and Seller Companies’ Affiliates, representatives,
officers, employees, directors, managers or agents shall not, directly or
indirectly (a) submit, solicit, initiate, encourage or discuss any proposal or
offer from any Person or enter into any Contract or accept any offer relating to
or to consummate any (i) reorganization, liquidation, dissolution or
recapitalization of any Seller Company; (ii) merger or consolidation involving
any Seller Company; (iii) purchase or sale of any of the assets or Equity
Interests, Options, stock appreciation rights, phantom stock options or other
similar equity based participations (or any rights to acquire, or securities
convertible into or exchangeable for, any such capital stock, Options, stock
appreciation rights, phantom stock options or other such securities) of any
Seller Company (other than a purchase or sale of inventory and worn-out or
obsolete assets in the ordinary course of business consistent with past custom
and practice and in accordance with the terms of this Agreement); (iv) similar
transaction or business combination involving any Seller Company or its assets;
or (v) acquisition by any Seller Company of other businesses, whether by the
purchase of assets or capital stock of another Person; or (b) furnish any
information with respect to, assist or participate in or facilitate in any other
manner any effort or attempt by any Person to do or seek to do any of the
foregoing; provided, however, that nothing
herein shall limit or restrict in any way Seller Companies or Parent from
communicating with their legal, accounting and other professional advisors or
lenders for the purpose of facilitating the transactions contemplated pursuant
to this Agreement and the agreements, documents and transactions contemplated
hereby and thereby. Seller Companies and Parent shall notify Purchaser
immediately if any Person makes any proposal, offer, inquiry or contact to any
Seller Company or Parent or, to Seller Companies’ or Parent’s knowledge, any
other Person, for the purpose of effectuating one or more of the foregoing
transactions.

     

    
      
         

      

      
        - 41
-

        
          

        

      

      
         

      

    

    7.2 Transfer
Tax.  Seller Companies and Parent shall pay on a timely basis
all applicable transfer, sales, use, recording, registration and other taxes
associated with the transactions contemplated pursuant to this Agreement and the
agreements, documents and transactions contemplated hereby and thereby,
including, but not limited to, the transfer of the Acquired Assets to
Purchaser.

     

    7.3 Agreement
to Defend.  In the event any action, suit, proceeding or
investigation of the nature specified in Section 5.1.3 or
Section 5.2.2
is commenced, whether before or after the Closing Date, all the parties hereto
agree to cooperate and use their best efforts to defend against and respond
thereto.

     

    7.4 Further
Acts and Assurances.  Seller Companies and Parent shall, at any
time and from time to time at and after the Closing, upon request of Purchaser,
take any and all actions necessary to place Purchaser in possession and
operating control of the Acquired Assets to be transferred hereunder, and will
do, execute, acknowledge and deliver, or will cause to be done, executed,
acknowledged and delivered, all such further acts, deeds, assignments,
transfers, conveyances, powers of attorney and assurances as may be reasonably
required for the transferring and confirming to Purchaser or to its successors
or permitted assigns, or for reducing to possession, the Acquired
Assets.  Subject to the terms and conditions of this Agreement, the
parties hereto and thereto shall use their best efforts to take, or cause to be
taken, all action, and to do, or cause to be done, all things necessary, proper
or advisable under applicable Regulations and Orders to consummate and make
effective as promptly as possible the transactions contemplated pursuant to this
Agreement and the agreements, documents and transactions contemplated hereby and
thereby, and to cooperate with each other in connection with the foregoing,
including without limitation using their best efforts (a) to obtain all
necessary waivers, consents, and approvals from other parties to loan
agreements, leases, mortgages and other Contracts; (b) to obtain all necessary
Permits, consents, approvals and authorizations as are required to be obtained
under any Regulation or Order; (c) to lift or rescind any injunction or
restraining order or other Order adversely affecting the ability of the parties
to consummate the transactions contemplated pursuant to this Agreement and the
agreements, documents and transactions contemplated hereby and thereby; (d) to
effect all necessary registrations and filings and submissions of information
requested by Authorities; and (e) to fulfill all conditions to the obligations
of the parties under this Agreement. Furthermore, Purchaser, Seller Companies
and Parent shall use their respective best efforts to prevent, with respect to a
threatened or pending preliminary or permanent injunction or other Regulation or
Order, the entry, enactment or promulgation thereof, as the case may
be.

     

    7.5 Deliveries
After Closing..  From time to time after the Closing, at
Purchaser’s request and without further consideration from Purchaser, Seller
Companies and Parent shall execute and deliver such other instruments of
conveyance and transfer and take such other action as Purchaser reasonably may
require to convey, transfer to and vest in Purchaser and to put Purchaser in
possession of any rights or property to be sold, conveyed, transferred and
delivered hereunder.

     

    
      
         

      

      
        - 42
-

        
          

        

      

      
         

      

    

    7.6 No
Termination of Seller Companies’ and Parent’s Obligations by Dissolution,
Etc..  Each Seller Company and Parent each specifically agrees
that the obligations of Seller Companies and Parent hereunder, including,
without limitation, obligations pursuant to Section 8 below,
shall not be terminated by the dissolution of Parent or any Seller Company or by
operation of law.

     

    7.7 Confidentiality.

     

    7.7.1 The
information, documents and instruments delivered to Purchaser by Seller
Companies, Parent or their respective agents and the information, documents and
instruments delivered to Seller Companies or Parent by Purchaser or its
respective agents are of a confidential and proprietary nature.  Each
of the Parties hereto agrees that both prior and subsequent to the Closing it
will maintain the confidentiality of all such confidential information,
documents or instruments delivered to it by each of the other Parties hereto or
their agents in connection with the negotiation of this Agreement or in
compliance with the terms, conditions and covenants hereof and will only
disclose such information, documents and instruments to its duly authorized
officers, directors, managers, representatives and agents.  Each of
the Parties hereto recognizes that any breach of this Section 7.7 would
result in irreparable harm to the other Parties to this Agreement and their
Affiliates and that, therefore each Party shall be entitled to an injunction to
prohibit any such breach or anticipated breach, without the necessity of posting
a bond, cash or otherwise, in addition to all other legal and equitable
remedies.  Nothing in this Section 7.7, however,
shall prohibit the use of such confidential information, documents or
information (a) that was, is now, or becomes generally available to the public
(but not as a result of a breach of any duty of confidentiality by which a Party
and its representatives and advisors are bound); (b) that was known to a Party
prior to its disclosure to such Party as demonstrated by such Party’s written
records; (c) that is disclosed to a Party by a third party not subject to any
duty of confidentiality prior to its disclosure to such Party; or (d) that, in
the reasonable opinion of Seller Companies’ counsel, Parent’s counsel or
Purchaser’s counsel, for governmental filings are (i) required by law or
governmental regulations or (ii) otherwise appropriate.

     

    7.7.2 The
Parties hereto agree that the terms and conditions of the transactions
contemplated pursuant to this Agreement and the agreements, documents and
transactions contemplated hereby and thereby shall remain
confidential.  Neither Purchaser, Seller Companies nor Parent or any
of their respective agents and representatives shall distribute any of the
documents in connection with the transactions contemplated pursuant to this
Agreement and the agreements, documents and transactions contemplated hereby and
thereby or any drafts thereof, nor any part thereof, to any third party unless
required by law to do so.

     

    7.8 Public
Announcements.  Each of the Parties agree that no Party hereto
shall release, publish or otherwise make available to the public in any manner
whatsoever any information or announcement regarding the transactions herein
contemplated without the prior written consent of Seller Companies and
Purchaser, except for information and filings reasonably necessary to be
directed to governmental agencies to fully and lawfully effect the transactions
herein contemplated or required in connection with applicable
laws.  Nothing herein shall allow any Party to respond to questions
presented by the press or media without first obtaining prior consent of Seller
Companies and Purchaser.

     

    
      
         

      

      
        - 43
-

        
          

        

      

      
         

      

    

    7.9 Non-Competition.

     

    7.9.1 For a
period commencing on the Closing Date and ending on the third (3rd) anniversary
of the Closing Date, no Seller Company nor Parent shall, without the prior
written consent of Purchaser, (a) directly or indirectly, own, manage, operate,
control or participate in any manner in the ownership, management, operation or
control of, or serve as a partner, director, employee, manager, principal,
agent, consultant or otherwise contract with, or have any financial interest in
or with, or aid or assist any other person or entity that operates imaging
equipment or an imaging facility or competes with an Imaging Center or the
Business within a twenty five (25) mile radius of any Imaging Center or any
other imaging centers managed by Purchaser, and (b) in any capacity, either
separately, jointly or in association with others, directly or indirectly do any
of the following:  (i) employ or seek to employ any Person or agent
who is then employed or retained by the Business, Purchaser or its Affiliates
(or who was so employed or retained at any time within the two (2) years prior
to the date a Seller Company or Parent employs or seeks to employ such Person);
(ii) solicit, induce, or influence any proprietor, partner, stockholder, lender,
director, officer, manager, employee, joint venturer, investor, consultant,
agent, lessor, supplier, customer or any other Person that has a business
relationship with the Business, Purchaser or its Affiliates, to discontinue or
reduce or modify the extent of such relationship with the Business, Purchaser or
its Affiliates; or (iii) submit, solicit, encourage or discuss any proposal,
plan or offer to acquire an interest in any of the Business’, Purchaser’s or its
Affiliates’ identified potential acquisition candidates.

     

    7.9.2 Each
Party understands and acknowledges that the provisions of this Section 7.9 are
designed to preserve the legitimate business interests and goodwill of the
Parties.  Accordingly, each Party hereby acknowledges that any breach
or threatened breach of the provisions of this Section 7.9 will
result in irreparable harm and injury to each of the other Parties and that
monetary damages will not provide an adequate remedy to a
Party.  Accordingly, each Party hereby agrees that in the event of a
breach or threatened breach of the provisions of this Section 7.9, the
non-breaching Party shall be entitled to (1) a temporary restraining order,
preliminary injunction and permanent injunction to enjoin such breach or
threatened breach; (b) any and all damages incurred or to be incurred by the
non-breaching Party; and (c) recover from the breaching Party the reasonable
attorneys’ fees and costs incurred by the non-breaching Party in enforcing the
provisions of this Section
7.9.

     

    7.9.3 The
provisions of this Section 7.9 shall
apply for the applicable periods as set forth above.  If any Seller
Company or Parent violates the restrictive covenant provisions set forth in this
Section 7.9,
and Purchaser, any of Purchaser’s successors and assigns or any of Purchaser’
Affiliates brings legal action for injunctive or other relief, such party
bringing the action shall not, as a result of the time involved in obtaining the
relief, be deprived of the benefit of the full period of the restrictive
covenant, unless a court of competent jurisdiction holds that the restrictive
covenant is not enforceable in whole or in part.  Accordingly, for any
time period that any Seller Company or Parent is in violation of the restrictive
covenant, such time period shall not be included in calculating the duration of
the restrictive covenant indicated above.

     

    
      
         

      

      
        - 44
-

        
          

        

      

      
         

      

    

    7.9.4 Each
Party hereby acknowledges that the restrictions set forth in this Section 7.9 are
minimal, reasonable in scope and duration and are necessary to protect the
legitimate business interests of the Parties and that any breach or threatened
breach of these restrictions will result in irreparable harm to the
non-breaching Party.  In the event any of the restrictions are found
by a court of competent jurisdiction to be too broad to permit enforcement to
its full extent, then such restriction shall be enforced to the maximum extent
allowable by law and the Parties hereby consent to and authorize the court to
modify these restrictions in a manner to permit their enforcement to the fullest
extent of the law.

     

    7.9.5 The
Parties also agree that the existence of any Claim by Parent or any Seller
Company against Purchaser, whether predicated upon this Agreement or otherwise,
shall not constitute a defense to the enforcement of the restrictive covenants
set forth herein, but shall be litigated separately.

     

    7.10 Employees.  Purchaser
shall provide employment to each of the Employees that meets Purchaser’s hiring
standards and criteria.  Nothing contained herein shall restrict
Purchaser or its subsidiaries in the future in the exercise of their independent
business judgment as to the terms and conditions under which the employment of
Employees shall continue, the duration of such employment, the basis on which
such employment is terminated, or the benefits provided to
Employees.  If the execution and delivery of this Agreement or the
consummation of the transactions contemplated hereby (a) results in any payment
becoming due to any current or former Employee, (b) increases any benefits under
any Benefit Plan, or (c) results in the acceleration of the time of payment,
vesting or other rights with respect to any such benefits, then Seller Companies
and Parent shall be solely liable for such payment, increase, or obligation, and
such amounts will not be Assumed Obligations. As of the Closing Date, Seller
Companies and Parent shall fully vest (100%) each Employee’s interest in any
pension plan sponsored by Seller Companies that is qualified under Section
401(a) of the Code. The cost to fully vest each Employee’s interests in any
pension plan sponsored by Seller Companies that is qualified under Section
401(a) of the Code shall be borne by Seller Companies and
Parent.  Within ten (10) days of the Closing Date, each Seller Company
and Parent shall payout any accrued but unused vacation or paid time off to all
Employees.  Seller Companies and Parent shall be responsible for
complying with all obligations under COBRA, with respect to Employees and other
“qualified beneficiaries” who incur a “qualifying event” on or prior to the
Closing Date (i.e., including a termination of employment).  Seller
Companies and Parent shall be responsible for all notifications and liability
associated with any terminations of employment on or prior to the Closing Date
under the worker Adjustment and Retraining Notification Act and any similar
state or local “mass layoff” or “plant closing” law.

     

    7.11 Schedules.  As
of the date of this Agreement, none of the schedules required by this Agreement
to be provided by Seller Companies have been delivered.  Seller
Companies agree to deliver to Purchaser for its approval all schedules to be
delivered by them within ten (10) days from the date of this Agreement (the
“Schedules Delivery
Date”); provided, that Seller
Companies and Parent shall supplement or amend the schedules in accordance with
the terms and conditions set forth in Section 4.7.  Purchaser shall
have the right to review the schedules and reject in writing any of the
schedules within (10) days from the Schedules Delivery Date (the “Schedules Acceptance
Date”).  In the event that Purchaser rejects in writing any
schedule on or before the Schedules Acceptance Date, Purchaser may terminate
this Agreement pursuant to Section 9.1.5.  If Purchaser does not
reject any schedule on or before the Schedules Acceptance Date, Purchaser shall
be deemed to have accepted all of the schedules and this Agreement shall be
binding on Purchaser, Parent and each of the Seller Companies in accordance with
its terms; provided, that, in the event that Purchaser, on the one hand, and
Seller Companies and/or Parent, on the other hand, are in dispute with respect
to any item or items set forth in the schedules hereto, the Schedules Acceptance
Date shall automatically be extended until such dispute is resolved or Purchaser
rejects such schedule and terminates this Agreement pursuant to Section
9.15.

     

    
      
         

      

      
        - 45
-

        
          

        

      

      
         

      

    

    7.12 Exhibits.  As
of the date of this Agreement, none of the exhibits required by this Agreement
to be attached hereto have been finalized or delivered.  Parent,
Seller Companies or Purchaser shall have the right to terminate this Agreement
prior to the Closing Date if Parent, Seller Companies or Purchaser, as the case
may be, do not accept and enter into any of the exhibits.

     

    8. Indemnification.

     

    8.1 Survival.  All of the terms
and conditions of this Agreement, together with the representations, warranties
and covenants contained herein or in any instrument or document delivered or to
be delivered pursuant to this Agreement, shall survive the execution of this
Agreement and the Closing Date until all obligations set forth therein shall
have been performed and satisfied notwithstanding any investigation heretofore
or hereafter made by or on behalf of any party hereto as follows: (a) the
representations and warranties in Section 2.13 (Taxes),
Section 2.22
(Employee Benefit Plans), and Section 2.23
(Employees) and their related schedules and the covenants contained in this
Agreement shall survive until sixty (60) days after the date as of which the
applicable statutes of limitations with respect to such matters expire (after
giving effect to any extensions or waivers thereof); (b) the representations and
warranties in Section
2.27 (Environmental Matters), Section 2.28 (Medical
Waste) and their related schedules shall terminate on the sixth (6th)
anniversary of the Closing Date; (c) the representations and warranties in Section 2.1
(Corporate Organization, Etc.), Section 2.2
(Ownership), Section
2.5 (Authorization, Etc.), Section 2.6 (Title
and Related Matters), Section 2.17
(Compliance with Law), Section 2.18 (Rates
and Reimbursement Policies), Section 2.19
(Physicians), Section
2.20 (Improper and Other Payments), Section 2.29 (Federal
Health Care Programs), Section 2.32
(Confidential Information), Section 2.33
(Brokerage), Section
3.1 (Corporate Organization, Etc.), Section 3.2
(Authorization, Etc.), Section 3.3
(Brokerage) and their related schedules (collectively, items (a), (b) and (c)
shall be referred to as the “Fundamental Representations and
Warranties”) shall survive indefinitely and not terminate; and (d) all
other representations and warranties in this Agreement and their related
schedules or in any of the written statements, certificates or other items
prepared and delivered hereunder or to induce the consummation of any of the
transactions contemplated hereby, shall terminate upon the thirty sixth (36th)
month anniversary of the Closing Date; provided that the
representations, warranties and indemnities for which an indemnification Claim
shall be pending as of the end of the applicable period referred to herein shall
survive with respect to such Claim until the final disposition
thereof.  The representations and warranties in this Agreement and the
schedules attached hereto or in any writing delivered in connection herewith
shall in no event be affected by any investigation, inquiry or examination made
for or on behalf of any party or be affected by the knowledge of any officer,
director, manager, stockholder, employee, partner or agent of any party seeking
indemnification hereunder or by the acceptance of any certificate or opinion
from any third party.  In addition, in no event will any disclosure of
any event or circumstance made after the date hereof and prior to the Closing
serve to amend any representation or warranty for any purpose of this
Agreement.

     

    
      
         

      

      
        - 46
-

        
          

        

      

      
         

      

    

    8.2 Limitations.

     

    8.2.1 No Party
shall be required to indemnify another Party under Sections 8.3.1 or
8.4.1 until the
indemnifiable damages, individually or in the aggregate, exceed $50,000 (the
“Hurdle Rate”), at which
point such indemnifying party shall be responsible for all indemnifiable damages
that may arise, irrespective of the Hurdle Rate; and provided that indemnifiable
damages shall accumulate until such time as they exceed the Hurdle Rate,
whereupon the party to be indemnified shall be entitled to seek indemnification
for the full amount of such damages from the first dollar.

     

    8.2.2 Absent
fraud, after the Closing, the aggregate amount of indemnifiable damages for
which Seller Companies and Parent shall be jointly and severally liable with
respect to breaches of the representations and warranties made by Seller
Companies and Parent in Section 2 (other than
the Fundamental Representations and Warranties or for knowing or intentional
misrepresentations or breaches of covenants and agreements) shall not exceed the
Purchase Price.

     

    8.2.3 In the
event the transactions contemplated pursuant to this Agreement and the
agreements, documents and transactions contemplated hereby and thereby are not
consummated as a result of a breach hereunder by Purchaser, the maximum
aggregate amount of indemnifiable damages for which Purchaser shall be liable
for hereunder shall equal the Purchase Price.  The Parties agree that
such amount is a fair estimate of the maximum amount of Seller Companies’ and
Parent’s potential damages and hereby agree not to assert any Claim in excess of
such amount.

     

    8.2.4 After the
Closing, the sole remedy of any party hereto with respect to indemnification
Claims pursuant to this Section 8 of this
Agreement shall be monetary damages determined pursuant to this Section 8; provided that nothing
herein shall prevent Purchaser from seeking equitable remedies for, among other
things, specific performance for breaches of Section 7.7
(Confidentiality), Section 7.8 (Public
Announcements), and Section 7.9
(Non-Competition).

     

    8.3 Indemnification
by Seller Companies and Parent.  Subject to Sections 8.1 and
8.2, each
Seller Company and Parent agree, jointly and severally, to indemnify Purchaser,
its subsidiaries and Affiliates and its officers, managers, employees, equity
holders, representatives, successors, assigns, and agents and hold each of them
harmless against and in respect of any and all damage, loss, deficiency,
liability, obligation, commitment, cost or expense (including the fees and
expenses of counsel) resulting from, or in respect of, any of the
following:

     

    8.3.1 Any
misrepresentation or breach of any representation or warranty on the part of
Seller Companies or Parent under this Agreement, any document relating hereto or
thereto or contained in any schedule to this Agreement or from any
misrepresentation in or omission from any certificate, schedule, other Contract
or instrument delivered by Seller Companies or Parent hereunder.

     

    
      
         

      

      
        - 47
-

        
          

        

      

      
         

      

    

    8.3.2 Any
breach of any covenant, agreement or non-fulfillment of any obligation on the
part of the applicable Seller Company or Parent under this Agreement, any
document relating hereto or thereto or contained in any schedule to this
Agreement or any certificate, schedule, other Contract or instrument delivered
by Seller Companies or Parent hereunder.

     

    8.3.3 Any and
all Excluded Liabilities.

     

    8.3.4 Any and
all Excluded Assets.

     

    8.3.5 (i) All
Taxes, losses, Claims and expenses resulting from, arising out of, or incurred
with respect to, any Claims that may be asserted by any party based on,
attributable to, or resulting from the failure of any representation or warranty
made pursuant to Section 2.13 to be
true and correct in all respects as of the date of this Agreement and as of the
Closing Date; and (ii) all Taxes (A) attributable to the Acquired Assets or the
Business with respect to any taxable period or portion thereof that ends on or
prior to the Closing Date or (B) imposed on Seller Companies or
Parent.

     

    8.3.6 Any and
all Claims with respect to Seller Companies, the Business or the Acquired Assets
arising out of or relating to any event, matter or circumstance occurring prior
to the Closing Date.

     

    8.3.7 All
environmental liability of Seller Companies, including federal, state and local
environmental liability, together with any interest or penalties thereon or
related thereto, that arises or accrues on or prior to the Closing
Date.

     

    8.3.8 Any
failure (i) of Seller Companies to have good, valid and marketable title to the
Acquired Assets, free and clear of all Liens, Claims and Orders other than
Permitted Liens and (ii) to obtain the signature of Seller Companies and Parent
in connection with the transactions contemplated pursuant to this Agreement and
the agreements, documents and transactions contemplated hereby and thereby, and
Seller Companies and Parent shall be responsible for all liability, fees and
expenses that may arise because such Person fails or refuses to agree to the
terms hereof.

     

    8.3.9 Any Claim
for transaction costs or expenses not paid through a reduction in the Purchase
Price on the Closing Date.

     

    8.3.10 Any Claim
made during the twelve (12) month period following the Closing Date related to
the termination, loss, expiration, suspension or limitation of or amendment or
other modification to any third party payor Contract resulting in a projected
loss of annualized revenue related thereto in excess of $250,000 (individually
or in the aggregate).  For purposes of this Section 8.3.10, the
measurement of any projected loss shall be based upon the projections of each
such third party payor Contract set forth on Schedule 8.3.10
attached hereto.

     

    
      
         

      

      
        - 48
-

        
          

        

      

      
         

      

    

    8.3.11 All
demands, assessments, judgments, costs and reasonable legal and other expenses
arising from, or in connection with, any action, suit, proceeding or Claim
incident to any of the foregoing.

     

    8.4 Indemnification
by Purchaser.  Subject to Sections 8.1 and
8.2, Purchaser
agrees to, and shall, indemnify Seller Companies and Parent and hold each of
them harmless, against and in respect of any and all damage, loss, deficiency,
liability, obligation, commitment, cost or expense (including the fees and
expenses of counsel) resulting from, or in respect of, any of the
following:

     

    8.4.1 Any
misrepresentation or breach of any representation or warranty on the part of
Purchaser under this Agreement, any document relating hereto or thereto or
contained in any schedule to this Agreement or from any misrepresentation in or
omission from any certificate, schedule, other Contract or instrument delivered
by Purchaser hereunder.

     

    8.4.2 Any
breach of any covenant, agreement or non-fulfillment of any obligation on the
part of Purchaser under this Agreement, any document relating hereto or thereto
or contained in any schedule to this Agreement or any certificate, schedule,
other Contract or instrument by Purchaser hereunder.

     

     

    8.4.3 Any and
all Assumed Obligations (including, but not limited to, the capital and
operating leases set forth on Schedule 1.2(a)
attached hereto) and the Assumed Indebtedness after the Closing
Date.

     

    8.4.4 Any and
all Acquired Assets after the Closing Date.

     

    8.4.5 All
demands, assessments, judgments, costs and reasonable legal and other expenses
arising from, or in connection with, any action, suit, proceeding or Claim
incident to any of the foregoing.

     

    8.5 Third-Party
Claims.

     

    8.5.1 The
following procedures shall be applicable with respect to indemnification for
third-party Claims.  Promptly after receipt by the party seeking
indemnification hereunder (hereinafter referred to as the “Indemnitee”) of notice of the
commencement of any (i) Tax audit or proceeding for the assessment of Tax by any
Taxing Authority or any other proceeding likely to result in the imposition of a
Tax liability or obligation or (ii) any action or the assertion of any Claim,
liability or obligation by a third party (whether by legal process or
otherwise), against which Claim, liability or obligation the other party to this
Agreement (hereinafter the “Indemnitor”) is, or may be,
required under this Agreement to indemnify such Indemnitee, the Indemnitee
shall, if a Claim thereon is to be, or may be, made against the Indemnitor,
notify the Indemnitor in writing of the commencement or assertion thereof and
give the Indemnitor a copy of such Claim, process and all legal
pleadings.  The Indemnitor shall have the right to (i) participate in
the defense of such action with counsel of reputable standing and (ii) assume
the defense of such action by agreeing to assume such defense within ten (10)
days of transmittal in writing of the notice of the Claim by the Indemnitee,
unless such Claim (A) may result in criminal proceedings, injunctions or other
equitable remedies in respect of the Indemnitee or its business; (B) may result
in liabilities which, taken with other then existing Claims under this Section 8, would not
be fully indemnified hereunder; (C) may have a Material Adverse Effect on the
business or financial condition of the Indemnitee after the Closing Date
(including an effect on the Tax liabilities, earnings or ongoing business
relationships of the Indemnitee); (D) is for an alleged amount of less than
$25,000; (E) upon petition by the Indemnitee, if an appropriate court rules that
the Indemnitor failed or is failing to vigorously prosecute or defend such
Claim, in which events the Indemnitee shall assume the defense; or
(F)  is with respect to Taxes, in which case Seller Companies shall
have the right to assume the defense or settlement of such third-party Claim
only if it solely relates to (i) Taxes with respect to the income or operations
of the Business or the ownership of the Acquired Assets for a taxable year or
other taxable period ending on or before the Closing Date or (ii) Taxes imposed
upon Seller Companies and Parent. Notwithstanding the immediately preceding
sentence, with respect to a third-party Claim for Taxes, neither Seller
Companies nor Parent shall consent to entry of any judgment or enter into any
settlement (or otherwise compromise) of such Claim without the written consent
of Purchaser, which consent shall not be unreasonably withheld or
delayed.

     

    
      
         

      

      
        - 49
-

        
          

        

      

      
         

      

    

    8.5.2 The
Indemnitor and the Indemnitee shall cooperate in the defense of any third party
Claims.  In the event that the Indemnitor assumes or participates in
the defense of such third party Claim as provided herein, the Indemnitee shall
make available to the Indemnitor all relevant records and take such other action
and sign such documents as are reasonably necessary to defend such third party
Claim in a timely manner.  If the Indemnitee shall be required by
judgment or a settlement agreement to pay any amount in respect of any
obligation or liability against which the Indemnitor has agreed to indemnify the
Indemnitee under this Agreement, the Indemnitor shall promptly reimburse the
Indemnitee in an amount equal to the amount of such payment plus all expenses
(including legal fees and expenses) incurred by such Indemnitee in connection
with such obligation or liability subject to this Section
8.  No Indemnitor, in the defense of any such Claim, shall,
except with the consent of the Indemnitee, consent to entry of any judgment or
enter into any settlement which does not include as an unconditional term
thereof the giving by the claimant or plaintiff to such Indemnitee of a release
from all liability with respect to such Claim.  In the event that the
Indemnitor does not accept the defense of any matter for which it is entitled to
assume as provided above, the Indemnitee shall have the full right to defend
such Claim.

     

    8.5.3 Prior to
paying or settling any Claim against which an Indemnitor is, or may be,
obligated under this Agreement to indemnify an Indemnitee, the Indemnitee must
first supply the Indemnitor with a copy of a final court judgment or decree
holding the Indemnitee liable on such Claim or failing such judgment or decree,
must first receive the written approval of the terms and conditions of such
settlement from the Indemnitor, which shall not be unreasonably withheld;
provided however, that no written approval is required from the Indemnitor as to
any third party Claim (i) that results solely in injunctions or other equitable
remedies in respect of the Indemnitee or its business; (ii) that settles
liabilities, or portions thereof, that are not subject to indemnification
hereunder; or (iii) is for an amount of less than $25,000.

     

    8.5.4 An
Indemnitee shall have the right to employ its own counsel in any case and the
fees and expenses of such counsel shall be at the expense of the Indemnitee
unless

     

    (a) the
employment of such counsel shall have been authorized in writing by the
Indemnitor in connection with the defense of such Claim;

     

    
      
         

      

      
        - 50
-

        
          

        

      

      
         

      

    

    (b) the
Indemnitor shall not have employed counsel in the defense of such Claim after
ten (10) days notice; or

     

    (c) such
Indemnitee shall have reasonably concluded that there may be defenses available
to it which are contrary to, or inconsistent with, those available to the
Indemnitor; in any of the foregoing events such fees and expenses shall be borne
by the Indemnitor.

     

    8.6 Payment
of Indemnification Amounts.  Each Indemnitor
shall pay the indemnification amount claimed by the Indemnitee in immediately
available funds promptly within ten (10) days after the Indemnitee provides the
Indemnitor with written notice of a Claim hereunder unless the Indemnitor in
good faith disputes such Claim.  If the Indemnitor disputes such Claim
in good faith, then promptly after the resolution of such dispute, the amount
finally determined to be due shall be paid by the Indemnitor to the Indemnitee
in immediately available funds within ten (10) days of such dispute
resolution.  In the event the Indemnitor fails to pay the Indemnitee
the amount of such indemnification Claim within such ten (10) day period, the
Indemnitor shall pay the Indemnitee interest on the amount of such
indemnification Claim at a rate of ten percent (10%) per annum, compounded
monthly from the date of the original written notice of such indemnification
Claim until the indemnification Claim is paid in full.  If any
Indemnitor fails to comply with its obligations to make cash payments to an
Indemnitee in an aggregate amount sufficient to reimburse the Indemnitee for all
losses resulting from an indemnified Claim, the Indemnitee may pursue any and
all rights and remedies against the Indemnitor available in law or in equity,
subject only to the limitations set forth in Section 8.2
above.

     

    8.7 Security
for the Indemnification Obligation; Right of Set-Off.  Each
Indemnitee shall have the right, with notice to each Indemnitor, to offset
amounts owed to it by such Indemnitor (including any indemnification payment
owed by such Indemnitor) against amounts owed by such Indemnitee or its
Affiliates to such Indemnitor pursuant to any other obligations, including,
without limitation, any indemnification payment owed by such Indemnitee to such
Indemnitor, but not prior to the time when it is finally determined that such
Indemnitee owes such Indemnitor the amount being offset by such Indemnitee
pursuant hereto.  Neither the exercise of, nor the failure to exercise
such right of set-off shall constitute an election of remedies or limit an
Indemnitee in any manner in the enforcement of other remedies that may be
available to such Indemnitee hereunder.

     

    8.8 Adjustment
to Purchase Price.  Any indemnification payable pursuant to
this Section 8
shall be, to the extent permitted by law, an adjustment to the Purchase
Price.

     

    8.9 Breach.  Notwithstanding
any other provision in this Agreement to the contrary, the Parties acknowledge
and agree that a breach by one Party of any representation, warranty, covenant,
agreement or obligation set forth in this Agreement or the documents entered
into or delivered in connection with this Agreement does not release the
non-breaching Party of its obligations hereunder, pursuant to the ancillary
documents hereto or in connection with the transactions contemplated pursuant to
this Agreement and the agreements, documents and transactions contemplated
hereby and thereby.

     

    
      
         

      

      
        - 51
-

        
          

        

      

      
         

      

    

    9. Termination, Amendment and
Waiver

     

    9.1 Termination.  Except
as provided in Section
9.2
hereof, this Agreement may be terminated and the transactions contemplated
herein abandoned at any time prior to the Closing:

     

    9.1.1 by mutual
written agreement of Seller Companies, Parent and Purchaser;

     

    9.1.2 by
Purchaser or Seller Companies if this Agreement is not consummated on or before
March 31, 2009; provided that if any Party has
breached or defaulted with respect to its obligations under this Agreement on or
before such date, such Party may not terminate this Agreement pursuant to this
Section 9.1.2,
and each other Party to this Agreement may at its option enforce its rights
against such breaching or defaulting Party and seek any remedies against such
party, in either case as provided hereunder and by applicable
Regulation;

     

    9.1.3 by
Purchaser if as of the Closing Date any of the conditions specified in Section 5.1 hereof
have not been satisfied or if Seller Companies or Parent are otherwise in
default under this Agreement or breach of any of their respective
representations, warranties or covenants or other agreements herein;
or

     

    9.1.4 by Seller
Companies if as of the Closing Date any of the conditions specified in Section 5.2 hereof
have not been satisfied or if Purchaser is otherwise in default under this
Agreement or breach of any of its respective representations, warranties or
covenants or other agreements herein.

     

    9.1.5 by
Purchaser if it rejects in writing Seller Companies’ schedules pursuant to
Section 7.11.

     

    9.1.6 by
Parent, Seller Companies or Purchaser if they reject in writing any of the
Exhibits pursuant to Section 7.12.

     

    9.2 Effect of
Termination.  In the event of termination of this Agreement as
provided in this Section 9, this Agreement
shall forthwith become void and there shall be no liability or obligation on the
part of any party; provided, however, that each
Party hereto shall remain liable for any material breaches of this Agreement
prior to its termination; and provided, further, however, that, the
provisions of Sections
7.7 and 7.8 and the
Confidentiality Agreement shall remain in full force and effect and survive any
termination of this Agreement.

     

    9.3 Extension;
Waiver.  Purchaser, on the one hand, and Seller Companies and
Parent, on the other hand, may, to the extent legally allowed, (i) extend
the time for the performance of any of the obligations of the other Party(ies)
hereto, (ii) waive any inaccuracies in the representations and warranties
made to such other Party(ies) contained herein or in any document delivered
pursuant hereto, and (iii) waive compliance with any of the agreements or
conditions for the benefit of such other Party(ies) contained
herein.  Any agreement on the part of a Party hereto to grant any such
extension or waiver shall be valid only if set forth in an instrument in writing
signed on behalf of such Party.

     

    
      
         

      

      
        - 52
-

        
          

        

      

      
         

      

    

    10. Definitions.  As
used herein, the following terms have the respective meanings set forth below or
set forth in the referenced Section of this Agreement:

     

    “24/7” shall have the meaning
referenced in Section 2.21.9.

     

    “Acquired Assets” shall have
the meaning referenced in Section 1.1.

     

    “Adjustment Statement” shall
have the meaning referenced in Section 1.8.2.

     

    “Affiliate” means, with regard
to any Person, (a) any Person, directly or indirectly, controlled by, under
common control of, or controlling such Person; (b) any Person, directly or
indirectly, in which such Person holds, of record or beneficially, five percent
(5%) or more of the equity or voting securities; (c) any Person that holds, of
record or beneficially, five percent (5%) or more of the equity or voting
securities of such Person; (d) any Person that, through Contract, relationship
or otherwise, exerts a substantial influence on the management of such Person’s
affairs; (e) any Person that, through Contract, relationship or otherwise, is
influenced substantially in the management of its affairs by such Person; (f)
any director, officer, manager, partner or individual holding a similar position
in respect of such Person; or (g) as to any natural Person, any Person related
by blood, marriage or adoption and any Person owned by such Persons, including
without limitation, any spouse, parent, grandparent, aunt, uncle, child,
grandchild, sibling, cousin or in-law of such Person.

     

    “Agreement” shall have the
meaning referenced in the preamble of this Agreement.

     

    “Assignment of Lease” shall
have the meaning referenced in Section 1.3(b).

     

    “Assumed Indebtedness” shall
have the meaning referenced in Section 1.6.

     

    “Assumed Obligations” shall
have the meaning referenced in Section 1.2.

     

    “Assumption Agreement” shall
have the meaning referenced in Section 1.2.

     

    “Authority” means any
governmental, regulatory or administrative body, agency, commission, board,
arbitrator or authority, any court or judicial authority, any public, private or
industry regulatory authority, whether international, national, federal, state
or local.

     

    “Benefit Plans” shall have the
meaning referenced in Section 2.22.1.

     

    “Bill of Sale” shall have the
meaning referenced in Section 1.3.

     

    “Business” shall have the
meaning referenced in the recitals to this Agreement.

     

    “Business Intellectual
Property” shall mean all Intellectual Property owned by Parent or any
Seller Company that is used or held for use in connection with the
Business.  Business Intellectual Property does not include any
Intellectual Property used, owned or licensed by HealthIXS Corporation, a
wholly-owned subsidiary of Parent.

     

    
      
         

      

      
        - 53
-

        
          

        

      

      
         

      

    

    “CERCLA” means Comprehensive
Environmental Response Compensation and Liability Act of 1980, as amended, and
the Regulations thereunder.

     

    “Claim” means any action, suit,
claim, lawsuit, demand, suit, inquiry, hearing, investigation, notice of a
violation or noncompliance, litigation, proceeding, arbitration, appeals or
other dispute, whether civil, criminal, administrative or
otherwise.

     

    “Closing” shall have the
meaning referenced in Section 6.1.

     

    “Closing Date” shall have the
meaning referenced in Section 6.1.

     

    “Closing Date Balance Sheet”
shall have the meaning referenced in Section 1.8.1.

     

    “Closing Date Working Capital”
shall mean the following from the Closing Date Balance Sheet:  (a) the
sum of (i) cash, and (ii) accounts receivable collected prior to the Closing
Date that otherwise satisfy the representation in Section 2.9, less (b) the sum
of Seller Companies’ (i) accounts payable, (ii) accrued expenses, and (iii)
other current liabilities, contingencies or reserves set forth on the Closing
Date Balance Sheet.

     

    “CMS” means Center for Medicaid
and Medicare Services.

     

    “COBRA” shall have the meaning
referenced in Section 2.22.7.

     

    “Code” shall have the meaning
referenced in Section 2.22.1.

     

    “Confidentiality Agreement”
means that certain Confidentiality Agreement, dated October 20, 2008, by and
between Seller Companies, Parent and Purchaser.

     

    “Contested Adjustment Notice”
shall have the meaning referenced in Section 1.8.2.

     

    “Contested Adjustments” shall
have the meaning referenced in Section 1.8.2.

     

    “Contract” means any agreement,
contract, commitment, instrument, document, certificate or other binding
arrangement or understanding, whether written or oral.

     

    “Definitive Information Statement” shall
have the meaning referenced in Section 4.10.

     

    “DOL” shall have the meaning
referenced in Section 2.22.5.

     

    “Employees” shall have the
meaning referenced in Section 2.23.

     

    “Environmental Condition” means a condition of the soil, surface waters,
groundwater, stream sediments, air and/or similar environmental media including
any Release or threatened Release of Hazardous Substances, either on or off a
property resulting from any activity, inactivity or operations occurring on such
property that, by virtue of Environmental Laws (i) requires notification,
investigatory, corrective or remedial measures, and/or (ii) comprises a basis
for Claims against, demands of and/or Liabilities of Seller Companies, Parent or
Purchaser or in respect of the Business or the Locations.

     

    
      
         

      

      
        - 54
-

        
          

        

      

      
         

      

    

     

     

    “Environmental Law” shall mean
any Regulation, Order, settlement agreement or Authority requirement, which
relates to or otherwise imposes liability or standards of conduct concerning the
environment, health, safety or Hazardous Substances, including without
limitation, discharges, emissions, releases or threatened releases of noises,
odors or any Hazardous Substances, whether as matter or energy, into ambient
air, water, or land, or otherwise relating to the manufacture, processing,
generation, distribution, use, treatment, storage, disposal, cleanup, transport
or handling of Hazardous Substances, including but not limited to CERCLA, the
Superfund Amendments and Reauthorization Act of 1986, the Hazardous Material
Transportation Act, the Resource Conservation and Recovery Act of 1976, the
Toxic Substances Control Act, the Federal Water Pollution Control Act, the Clean
Water Act, the Clean Air Act, the Occupational Safety and Health Act, any
so-called “Superlien” law, all as now or hereafter amended or supplemented, and
the Regulations promulgated thereunder, and any other similar Federal, state or
local Regulations.

     

    “Environmental Permit” shall
mean Permits, certificates, approvals, licenses, decrees, consents, Orders and
other authorizations relating to or required by Environmental Law and necessary
or desirable for Seller Companies’ business.

     

    “Equity Interests” shall have
the meaning referenced in Section 2.2.

     

    “ERISA” shall have the meaning
referenced in Section 2.22.1.

     

    “ERISA Affiliate” shall have
the meaning referenced in Section 2.22.13.

     

    “Escrow Agent” means American
Stock Transfer & Trust Company, LLC, located at 59 Maiden Lane, Plaza Level,
New York, New York 10038.

     

    “Escrow Agreement” shall have the meaning
referenced in Section 1.7.1.

     

    “Escrow Amount” shall have the
meaning referenced in Section 1.7.1.

     

    “Excluded Assets” shall have
the meaning referenced in Section 1.1.

     

    “Excluded Liabilities” shall
have the meaning referenced in Section 1.2.

     

    “Existing Services Agreement”
shall have the meaning referenced in the recitals to this
Agreement.

     

    “Financial Statement Date”
shall have the meaning referenced in Section 2.7.1.

     

    “Financial Statements” shall
have the meaning referenced in Section 2.7.1.

     

    “Fundamental Representations and
Warranties” shall have the meaning set forth in Section 8.1.

     

    “Funds Flow Statement” shall
have the meaning set forth in Section 6.2.13.

     

    
      
         

      

      
        - 55
-

        
          

        

      

      
         

      

    

    “GAAP” means United States
generally accepted accounting principles applied on a consistent
basis.

     

    “Guarantee” means any guarantee
or other contingent liability (other than any endorsement for collection or
deposit in the ordinary course of business), direct or indirect with respect to
any obligations of another Person, through a Contract or otherwise, including,
without limitation, (a) any endorsement or discount with recourse or undertaking
substantially equivalent to or having economic effect similar to a guarantee in
respect of any such obligations and (b) any Contract (i) to purchase, or to
advance or supply funds for the payment or purchase of, any such obligations,
(ii) to purchase, sell or lease property, products, materials or supplies, or
transportation or services, in respect of enabling such other Person to pay any
such obligation or to assure the owner thereof against loss regardless of the
delivery or nondelivery of the property, products, materials or supplies or
transportation or services or (iii) to make any loan, advance or capital
contribution to or other Investment in, or to otherwise provide funds to or for,
such other Person in respect of enabling such Person to satisfy an obligation
(including any liability for a dividend, liquidation payment or expense) or to
assure a minimum equity, working capital or other balance sheet condition in
respect of any such obligation.

     

    “Hazardous Substances” shall be
construed broadly to include any toxic or hazardous substance, material, or
waste, any petroleum or petroleum products, radioactive or nuclear materials,
asbestos in any form that has become friable, urea formaldehyde foam insulation,
dielectric fluid containing levels of polychlorinated biphenyls, and radon gas,
any chemicals, materials or substances defined or included in the definition of
“hazardous substances,” “hazardous wastes,” “restricted wastes,”, “medical
wastes,” “toxic substances,” “toxic pollutants,” or words of similar import,
under any applicable Environmental Law, any other chemical, material or
substance, exposure to which is prohibited, limited, or regulated by any
governmental Authority and any other contaminant, pollutant or constituent
thereof, whether liquid, solid, semi-solid, sludge and/or gaseous, including
without limitation, chemicals, compounds, by-products, pesticides, asbestos
containing materials, petroleum or petroleum products or by-products, and
polychlorinated biphenyls, the presence of which requires investigation or
remediation under any Environmental Law or which are or could reasonably be
expected to become regulated, listed or controlled by, under or pursuant to any
Environmental Law, or which has been or shall be determined or interpreted at
any time by any Authority to be a hazardous or toxic substance regulated under
any other Regulation or Order.

     

    “HIPAA” shall have the meaning
referenced in Section 2.17.1.

     

    “HIPAA Regulations” shall have
the meaning referenced in Section 2.17.2.

     

    “Hurdle Rate” shall have the
meaning set forth in Section 8.2.1.

     

    “Imaging Centers” shall have
the meaning referenced in the recitals to this Agreement.

     

    “Imaging Centers Capital
Expenditures” means a credit to Purchaser in the amount of $1,200,000 for
capital expenditures and leasehold improvements at the Imaging
Centers.

     

    “Improvements” shall have the
meaning set forth in Section 2.6.4.

     

    
      
         

      

      
        - 56
-

        
          

        

      

      
         

      

    

    “Indebtedness” with respect to
any Person means (a) any obligation of such Person for borrowed money, but in
any event shall include:  (i) any obligation or liabilities incurred
for all or any part of the purchase price of property or other assets or for the
cost of property or other assets constructed or of improvements thereto, other
than accounts payable included in current liabilities and incurred in respect of
property purchased in the ordinary course of business, (whether or not such
Person has assumed or become liable for the payment of such obligation) (whether
accrued, absolute, contingent, unliquidated or otherwise, known or unknown,
whether due or to become due); (ii) the face amount of all letters of credit
issued for the account of such Person and all drafts drawn thereunder;
(iii) obligations incurred for all or any part of the purchase price of
property or other assets or for the cost of property or other assets constructed
or of improvements thereto, other than accounts payable included in current
liabilities and incurred in respect of property purchased in the ordinary course
of business (whether or not such Person has assumed or become liable for the
payment of such obligation) secured by Liens; (iv) capitalized lease
obligations; (v) all Guarantees of such Person; and (vi) any outstanding
obligations or liabilities in connection with loans from Parent;
(b) equipment lease obligations; (c) accounts payable and accrued expenses
of such Person; (d) annual employee bonus obligations that are not accrued on
the Financial Statements; and (e) retroactive insurance premium
obligations.

     

    “Indebtedness Cap” shall have the meaning
referenced in Section 1.6.

     

    “Indemnification Escrow Amount”
shall have the meaning referenced in Section 1.7.1.

     

    “Indemnitee” shall have the
meaning set forth in Section 8.5.1.

     

    “Indemnitor” shall have the
meaning set forth in Section 8.5.1.

     

    “Independent Accountant” shall
have the meaning set forth in Section 1.8.2.

     

    “Intellectual Property” means
all domestic and foreign patents, patent applications, trademarks, service marks
and other indicia of origin, trademark and service mark registrations and
applications for registrations thereof, copyrights, copyright registrations and
applications for registration thereof, Internet domain names and universal
resource locators (“URLs”), trade secrets,
inventions (whether or not patentable), invention disclosures, moral and
economic rights of authors and inventors (however denominated), technical data,
customer lists, corporate and business names, trade names, trade dress, brand
names, know-how, show-how, maskworks, formulae, methods (whether or not
patentable), designs, processes, procedures, technology, source codes, object
codes, computer software programs, databases, data collectors and other
proprietary information or material of any type, whether written or unwritten
(and all good will associated with, and all derivatives, improvements and
refinements of, any of the foregoing).

     

    “Investment” shall mean (a) any
direct or indirect ownership, purchase or other acquisition by a Person of any
notes, obligations, instruments, capital stock, Options, securities or ownership
interests (including partnership interests and joint venture interests) of any
other Person; and (b) any capital contribution or similar obligation by a Person
to any other Person.

     

    “IRS” means the United States
Internal Revenue Service or any successor agency, and, to the extent relevant,
the United States Department of the Treasury.

     

    
      
         

      

      
        - 57
-

        
          

        

      

      
         

      

    

    “JV” means the joint venture
partnership between Parent and UIA commonly known as “Union Imaging Associates,
JV”.

     

    “Licenses” shall have the
meaning referenced in Section 2.16.

     

    “Lien” means any (a) security
interest, lien, mortgage, pledge, hypothecation, encumbrance, rights of first
refusal, Options, warrants, charges, pledges, voting agreements, trusts,
restrictions of any nature, Claim, easement, charge, restriction on transfer or
otherwise, or interest of another Person of any kind or nature, including any
conditional sale or other title retention Contract or lease in the nature
thereof; (b) any filing or agreement to file a financing statement as debtor
under the Uniform Commercial Code or any similar statute; (c) any subordination
arrangement in favor of another Person; and (d) any other encumbrances of any
nature whatsoever.

     

    “Locations” shall have the
meaning referenced in the recitals to this Agreement.

     

    “Material Adverse Change” means
any developments or changes that would have a Material Adverse
Effect.

     

    “Material Adverse Effect” means
any circumstances, state of facts or matters which might reasonably be expected
to have a material adverse effect in respect of any Location, the Business or
its operations, properties, assets, condition (financial or otherwise), results,
plans, strategies or prospects.

     

    “Medical Waste” includes, but
is not limited to, (a) pathological waste, (b) blood, (c) sharps, (d)
wastes from surgery or autopsy, (e) dialysis waste, including contaminated
disposable equipment and supplies, (f) cultures and stocks of infectious agents
and associated biological agents, (g) contaminated animals, (h) isolation
wastes, (i) contaminated equipment, (j) laboratory waste, and (k) various other
biological waste and discarded materials contaminated with or exposed to blood,
excretion, or secretions from human beings or animals.  “Medical
Waste” also includes any substance, pollutant, material, or contaminant listed
or regulated under MWTA.

     

    “Medical Waste Laws” means the
following, including regulations promulgated and orders issued thereunder, all
as may be amended from time to time: MWTA; the U.S. Public Vessel Medical Waste
Anti-Dumping Act of 1988, 33 USCA §§2501 et seq.; the Marine Protection,
Research, and Sanctuaries Act of 1972, 33 USCA §§1401 et seq.; the Occupational
Safety and Health Act, 29 USCA §§651 et seq.; the United States Department of
Health and Human Services, National Institute for Occupational Self-Safety and
Health Infectious Waste Disposal Guidelines, Publication No. 88-119 et seq. and
any other federal, state, regional, county, municipal, or other local laws,
regulations, and ordinances insofar as they purport to regulate Medical Waste,
or impose requirements relating to Medical Waste.

     

    “MSA” shall have the meaning
referenced in Section 5.1.7.

     

    “MWTA” means the Medical Waste
Tracking Act of 1988, 42 U.S.C. §§6992, et seq.

     

    “Option” means any
subscription, option, warrant, right, security, Contract, commitment,
understanding, equity appreciation right, phantom equity option, profit
participation or arrangement by which (a) with respect to any Seller Company,
such Seller Company is bound to issue any additional interest in the equity or
equity appreciation of such Seller Company or rights pursuant to which any
Person has a right to purchase an interest in the equity or equity appreciation
of Seller Company or (b) with respect to any Seller Company, such Seller Company
is bound to sell or allow another Person to vote, encumber or control the
disposition of any equity or rights pursuant to which any Person has a right to
purchase, vote, encumber or control the disposition of equity from such Seller
Company.

     

    
      
         

      

      
        - 58
-

        
          

        

      

      
         

      

    

    “Order” means any writ, decree,
order, judgment, injunction, rule, ruling, Lien, voting right, consent of or by
an Authority.

     

    “PA” shall have the meaning
referenced in the recitals to this Agreement.

     

    “Parent” shall have the meaning
referenced in the preamble of this Agreement.

     

    “Parties” means, collectively,
Purchaser, Seller Companies, Parent, and their respective successors and
permitted assigns.

     

    “Party” means, individually,
Purchaser, each Seller Company and Parent and their respective successors and
permitted assigns.

     

    “Permits” means all permits,
licenses, registrations, certificates, Orders, qualifications or approvals
required by any Authority or other Person.

     

    “Permitted Liens” means (a)
statutory Liens not yet delinquent and immaterial in amount; (b) such
imperfections or irregularities of title or Liens as do not materially detract
from or interfere with the present use of the properties or assets subject
thereto or affected thereby, otherwise impair present business operations at
such properties, or do not detract from the value of such properties and assets;
(c) Liens reflected in the Financial Statements or the notes thereto; (d) the
rights of customers of a Seller Company with respect to inventory or work in
progress under purchase orders or Contracts entered into by a Seller Company in
the ordinary course of business; (e) mechanics’, carriers’, workers’,
repairmen’s, warehousemen’s, or other similar Liens arising in the ordinary
course of business in respect of obligations not overdue and immaterial in
amount or that are being contested in good faith and covered by a bond in an
amount at least equal to the amount of the Lien; (f) deposits or pledges to
secure workmen’s compensation, unemployment insurance, old age benefits or other
social security obligations in connection with, or to secure the performance of,
bids, tenders, trade Contracts not for the payment of money or leases, or to
secure statutory obligations or surety or appeal bonds or other pledges or
deposits for purposes of like nature in the ordinary course of business and
immaterial in amount; and (g) the Assumed Indebtedness.

     

    “Person” means any corporation,
partnership, joint venture, limited liability company, organization, entity,
Authority or natural person.

     

    “PET” shall have the meaning
referenced in the preamble of this Agreement.

     

    “PET Center” shall have the meaning
referenced in the recitals to this Agreement.

     

    
      
         

      

      
        - 59
-

        
          

        

      

      
         

      

    

    “PET Location” shall have the
meaning referenced in the recitals to this Agreement.

     

    “Physicians” shall have the
meaning referenced in Section 2.19.

     

    “Preliminary Information
Statement” shall have the meaning referenced in Section
4.10.

     

    “Purchase Price” shall have the
meaning referenced in Section 1.4.

     

    “Purchaser” shall have the
meaning referenced in the preamble of this Agreement.

     

    “Reading Physicians” shall have
the meaning referenced in Section 2.19.

     

    “Regulation” means any rule,
law, code, statute, regulation, ordinance, requirement, announcement, policy,
guideline, rule of common law or other binding action of or by an Authority and
any judicial interpretation thereof.

     

    “Release” means any manner of
spilling, leaking, dumping, discharging, releasing, migrating or emitting, as
any of such terms may further be defined in any Environmental Law, into or
through any medium including, without limitation, ground water, surface water,
land, soil or air.

     

    “Remedial Action” shall mean
actions to clean up the environment, including soil, surface water or
groundwater, in response to a Release, spill or discharge of Hazardous
Substances, including the following activities: (a) monitoring, investigation,
assessment, treatment, cleanup, containment, removal, mitigation, response or
restoration work; (b) obtaining any permits, consents, approvals or
authorizations of any Governmental Authority necessary to conduct any such
activity; (c) preparing and implementing any plans or studies for any such
activity; (d) the use, implementation, application, installation, operation or
maintenance of remedial technologies applied to the surface or subsurface soils,
excavation and treatment or disposal of soils, systems for long-term treatment
of surface water or groundwater, engineering controls or institutional controls;
and (e) any other activities reasonably determined to be necessary or
appropriate or required under Environmental Laws to address a release of
Hazardous Substances.

     

    “Scheduled Physicians” shall
have the meaning referenced in Section 2.19.

     

    “SEC” shall have the meaning
referenced in Section 4.10.

     

    “SEC Communications” shall have
the meaning referenced in Section 4.10.

     

    “SEC Documents” shall have the
meaning referenced in Section 4.10.

     

    “Seller Companies” shall have
the meaning referenced in the preamble to this Agreement.

     

    “Seller Companies’ knowledge”,
“knowledge of Seller
Companies” “Parent’s
knowledge”, “knowledge
of Parent” or correlative terms shall be deemed to mean the knowledge of
Parent, Seller Companies or any of Seller Companies’ officers, directors,
managers or owners, after due and diligent inquiry (which shall include
conversations with such managers, officers and employees of Seller Companies
having responsibility for, and review of the files of Seller Companies relating
to, the subject matter to which the representation and warranty relates) of
their respective direct reports and management of Seller Companies.

     

    
      
         

      

      
        - 60
-

        
          

        

      

      
         

      

    

    “Server” shall have the meaning
referenced in Section 2.21.9.

     

    “Settlement Amount Certificate”
shall have the meaning referenced in Section 1.8.2.

     

    “Settlement Date” shall have
the meaning referenced in Section 1.8.3.

     

    “Sites” shall have the meaning
referenced in Section 2.21.9.

     

    “Sponsor” shall have the
meaning referenced in Section 2.22.9.

     

    “Storage Location” shall have the
meaning referenced in the recitals to this Agreement.

     

    “Supervising Physicians” shall
have the meaning referenced in Section 2.19.

     

    “Tax Returns” shall have the
meaning referenced in Section 2.13.1.

     

    “Taxes” shall mean all taxes,
assessments, charges, duties, fees, levies or other governmental charges,
including, without limitation, all Federal, state, local, foreign and other
income, franchise, profits, gross receipts, capital gains, capital stock,
transfer, net proceeds, alternative or add-on minimum, ad valorem, turnover,
personal property (tangible and intangible), leasing, lease, user, employment,
fuel, excess profits, interest equalization, property, sales, use, value-added,
occupation, property, excise, severance, windfall profits, stamp, license,
payroll, social security, withholding and other taxes, assessments, charges,
duties, fees, levies or other governmental charges of any kind whatsoever
(whether payable directly or by withholding and whether or not requiring the
filing of a Tax return), all estimated taxes, deficiency assessments, additions
to tax, penalties and interest and shall include any liability for such amounts
as a result either of being a member of a combined, consolidated, unitary or
Affiliated group or of a contractual obligation to indemnify any person or other
entity.

     

    “Taxing Authorities” means
Internal Revenue Service and any other Federal, state, or local Authority which
has the right to impose Taxes on Seller Companies or Parent.

     

    “UIA” shall have the meaning
referenced in the preamble of this Agreement.

     

    “UIC” shall have the meaning
referenced in the preamble of this Agreement.

     

    “UIC Center” shall have the meaning
referenced in the recitals to this Agreement.

     

    “UIC Location” shall have the
meaning referenced in the recitals to this Agreement.

     

    
      
         

      

      
        - 61
-

        
          

        

      

      
         

      

    

    “Underground Storage Tank”
shall have the meaning ascribed to such term in Section 6901 et seq., as
amended, of RCRA, or any applicable Regulation, Order governing underground
storage tanks.

     

    “Working Capital Escrow Amount”
shall have the meaning referenced in Section 1.7.1.

     

    “Working Capital Shortfall”
shall mean the amount by which the Closing Date Working Capital is less than
$525,000.

     

    “Working Capital Surplus” shall
mean the amount by which the Closing Date Working Capital exceeds
$525,000.

     

    11. Miscellaneous.  

     

    11.1 Schedules
and Other Instruments.  Each Schedule and Exhibit to this
Agreement shall be considered a part hereof as if set forth herein in
full.

     

    11.2 Additional
Assurances.  The provisions of this Agreement shall be
self-operative and shall not require further agreement by the Parties except as
may be herein specifically provided to the contrary; provided, however, at the
reasonable request of a Party, the other Party or Parties shall execute such
additional instruments and take such additional actions as the requesting Party
may deem necessary to effectuate this Agreement.  In addition and from
time to time after Closing, Parent and the applicable Seller Companies shall
execute and deliver such other instruments of conveyance and transfer, and take
such other actions as Purchaser reasonably may request, to effectively convey
and transfer full right, title and interest to, vest in, and place Purchaser in
legal, equitable and actual possession of the Business and the Acquired
Assets.  Seller Companies and Parent shall also furnish Purchaser with
such information and documents in that Party’s possession or under that Party’s
control, or which Seller Companies and Parent can execute or cause to be
executed, as will enable Purchaser to prosecute any and all petitions,
applications, Claims and demands relating to or constituting a part of the
Acquired Assets. Additionally, Seller Companies, Parent and Purchaser shall
cooperate and use their respective reasonable efforts to have their respective
present managers, directors, officers and employees cooperate with each other on
and after Closing in furnishing information, evidence, testimony and other
assistance in connection with any action, proceeding, arrangement or dispute of
any nature with respect to matters pertaining to all periods prior to Closing in
respect of the items subject to this Agreement.

     

    11.3 Consented
Assignment.  Anything contained herein to the contrary
notwithstanding, this Agreement shall not constitute an agreement to assign any
Claim, right, Contract, license, lease, commitment, sales order or purchase
order if an attempted assignment thereof without the consent of the other Party
thereto would constitute a breach thereof or in any material way affect the
rights of Seller Companies and Parent, as appropriate, thereunder, unless such
consent is obtained.  If such consent is not obtained, or if an
attempted assignment would be ineffective or would materially affect the rights
thereunder of any Seller Company or Parent so that Purchaser would not in fact
receive all such rights, then the Parties shall cooperate in any reasonable
arrangement designed to provide for the Parties the benefits under any such
Claim, right, Contract, license, lease, commitment, sales order or purchase
order, including, without limitation, enforcement of any and all rights of
Seller Companies and Parent, against the other party or parties thereto arising
out of the breach or cancellation by such other party or otherwise.

     

    
      
         

      

      
        - 62
-

        
          

        

      

      
         

      

    

    11.4 Legal
Fees and Costs.  In the event a Party elects to incur legal
expenses to enforce or interpret any provision of this Agreement, the agreements
contemplated hereby, or the transactions contemplated hereby or thereby by
judicial proceedings or otherwise, the prevailing Party in whose favor a final
non-appealable judgment is rendered will be entitled to recover such legal
expenses, including, without limitation, reasonable attorney’s fees, costs and
necessary disbursements at all court levels, in addition to any other relief to
which such Party shall be entitled.

     

    11.5 Benefit;
Assignment.  Subject to provisions herein to the contrary, this
Agreement shall inure to the benefit of and be binding upon the Parties hereto
and their respective legal representatives, successors and assigns; provided,
however, that no Party may assign this Agreement without the prior written
consent of the other Party, which consent shall not be unreasonably withheld;
provided, further, however, that Purchaser may, without the prior written
consent of the other Party, assign its rights and delegate its duties hereunder
to one or more entities that are under common ownership or control of Purchaser.
This Agreement is intended solely for the benefit of the Parties hereto and is
not intended to, and shall not, create any enforceable third party beneficiary
rights.

     

    11.6 Cost of
Transactions.  Except as otherwise provided herein, whether or
not the transactions contemplated hereby shall be consummated, the Parties agree
as follows:  (i) each Seller Company and Parent shall bear its own
fees, expenses and disbarments, including without limitation, those related to
its respective agents, representatives, accountants, and counsel incurred in
connection with the subject matter hereof and any amendments hereto on or prior
to the Closing Date; and (ii) Purchaser shall bear its own fees, expenses and
disbursements, including, without limitation, those related to its agents,
representatives, accountants and counsel incurred in connection with the subject
matter hereof and any amendments hereto.

     

    11.7 Waiver of
Breach.  The waiver by any Party of a breach or violation of
any provision of this Agreement shall not operate as, or be construed to
constitute, a waiver of any subsequent breach of the same or any other provision
hereof.

     

    11.8 Notice.  All
notices, requests, demands and other communications under this Agreement shall
be in writing and shall be deemed to have been duly given or made as follows:
(a) if sent designated for overnight delivery by nationally recognized
overnight air courier (such as Federal Express or UPS), one (1) business day
after mailing; (b) if sent by facsimile transmission before 5:00 p.m. on a
business day (sender’s time), when transmitted and receipt is confirmed through
a delivery report; (c) if sent by facsimile transmission after 5:00 p.m. or on a
day that is not a business day (sender’s time) and receipt is confirmed through
a delivery report, on the following business day; (d) the date such notice,
request, demand or other communication is rejected; or (e) upon actual receipt
by the party to whom such notice, request, demand or other communication is
required to be given; provided that such notices, requests, demands and other
communications are delivered to the address or facsimile number set forth below,
or to such other address or facsimile number as any party shall provide by like
notice to the other parties:

     

    
      
         

      

      
        - 63
-

        
          

        

      

      
         

      

    

    Parent
or any Seller Company:

     

    c/o
Modern Medical Modalities Corporation

    439
Chestnut Street

    Union,
New Jersey 07083

    Attention:
Barry Hayut, Chairman and Chief Executive Officer

    Facsimile:  908-845-0385

     

    With a
simultaneous copy to:

     

    Richardson
& Patel LLP

    The
Chrysler Building

    405
Lexington Avenue, 26th
Floor

    New York,
NY 10174

    Facsimile:
212-907-6687

    Attention:
Kevin Friedmann, Esq.

                       Jody
Samuels, Esq.

    


    Purchaser:

     

    Health
Diagnostics of New Jersey, L.L.C.

    c/o
Health Diagnostics LLC

    200 Park
Avenue, 44th Floor

    New York,
NY 10166

    Attention:  Bradford
Peters

     

    With a
simultaneous

    copy
to                      :

     

    McDermott,
Will & Emery

    201 South
Biscayne Boulevard, Suite 2200

    Miami,
Florida 33131-4336

    Attention:   Joshua
Kaye, Esq.

                        
Frederic
L. Levenson, Esq.

                         J. Gerard
Legagneur, Esq.

     

    11.9 Performance.  If
the due date for any notice, request, demand or other communication under this
Agreement occurs on a Saturday, Sunday or United States federal holiday, then
the due date for such notice, request, demand or communication shall be the next
business day following such Saturday, Sunday or federal holiday.

     

    11.10 Severability.  In
the event any provision of this Agreement is held to be invalid, illegal or
unenforceable for any reason and in any respect, such invalidity, illegality, or
unenforceability shall in no event affect, prejudice or disturb the validity of
the remainder of such provision or the remaining provision of this Agreement,
which shall be and remain in full force and effect, enforceable in accordance
with its terms.

     

    
      
         

      

      
        - 64
-

        
          

        

      

      
         

      

    

    11.11 Gender
and Number.  Whenever the context of this Agreement requires,
the gender of all words herein shall include the masculine, feminine and neuter,
and the number of all words herein shall include the singular and
plural.

     

    11.12 Divisions
and Headings.  The divisions of this Agreement into sections
and subsections and the use of captions and headings in connection therewith are
solely for convenience and shall have no legal effect in construing the
provisions of this Agreement.

     

    11.13 Entire
Agreement; Amendment.  This Agreement, including the schedules
and exhibits hereto and the Contracts, documents, certificates and instruments
referred to herein, embodies the entire agreement and understanding of the
parties hereto in respect of the transactions contemplated by this Agreement and
supersedes all previous Contracts, representations, warranties, promises,
covenants, arrangements, communications and understandings, oral or written,
express or implied, between the parties with respect to such transactions and
constitutes the entire agreement of whatsoever kind or nature existing between
or among the Parties respecting the within subject matter and no Party shall be
entitled to benefits other than those specified herein.  There are no
Contracts, representations, warranties, promises, covenants, arrangements or
understandings between the parties with respect to the transactions contemplated
hereby, other than those expressly set forth or referred to
herein.  As between or among the Parties, no oral statements or prior
written material not specifically incorporated herein shall be of any force and
effect.  All prior representations or agreements, whether written or
verbal, not expressly incorporated herein are superseded and no changes in or
additions to this Agreement shall be recognized unless and until made in writing
and signed by all Parties hereto.

     

    11.14 Counterpart.  This
Agreement may be executed in two or more counterparts (including by means of
telecopied or PDF signature pages), each and all of which shall be deemed an
original and all of which together shall constitute but one and the same
instrument.  Counterpart signatures need not be on the same page and
shall be deemed effective upon receipt.

     

    11.15 No Third
Party Beneficiaries.  This Agreement is for the sole benefit of
the Parties and their permitted successors and assigns and nothing herein
express or implied shall be construed to give any Person, other than the Parties
of such permitted successors and assigns, any legal or equitable rights
hereunder.

     

    11.16 Schedules.  No
exceptions to any representations or warranties disclosed on one schedule shall
constitute an exception to any other representation or warranties made in this
Agreement unless the substance of such exception is disclosed as provided herein
on each such applicable schedule or a specific cross reference to a disclosure
on another schedule is made.  All schedules and exhibits attached
hereto or referred to herein are hereby incorporated in and made a part of this
Agreement as if set forth in full herein.

     

    11.17 Injunctive
Relief.  The Parties hereto agree that in the event of a breach
of any provision of this Agreement or a failure by a party to perform in
accordance with the specific terms herein, the aggrieved party or parties may be
damaged irreparably and without an adequate remedy at law. The Parties therefore
agree that in the event of a breach of any provision of this Agreement, the
aggrieved Party or Parties may elect to institute and prosecute proceedings in
any court of competent jurisdiction to enforce specific performance or to enjoin
the continuing breach of such provision without the requirement of a posting of
a bond, as well as to obtain damages for breach of this Agreement.  By
seeking or obtaining any such relief, the aggrieved Party shall not be precluded
from seeking or obtaining any other relief to which it may be
entitled.

     

    
      
         

      

      
        - 65
-

        
          

        

      

      
         

      

    

    11.18 Delays or
Omissions.  No delay or omission to exercise any right, power
or remedy accruing to any Party hereto, upon any breach or default of any other
Party under this Agreement, shall impair any such right, power or remedy of such
party nor shall it be construed to be a waiver of any such breach or default, or
an acquiescence therein, or of any similar breach or default thereafter
occurring; nor shall any waiver of any single breach or default be deemed a
waiver of any other breach or default theretofore or thereafter
occurring.  Any waiver, permit, consent or approval of any kind or
character on the part of any Party hereto of any breach or default under this
Agreement, or any waiver on the part of any Party of any provisions or
conditions of this Agreement must be made in writing and shall be effective only
to the extent specifically set forth in such writing.  All remedies,
either under this Agreement or by law or otherwise afforded to any Party, shall
be cumulative and not alternative.

     

    11.19 Waiver of
Jury Trial.  EACH PARTY HERETO HEREBY IRREVOCABLY WAIVES ANY
AND ALL RIGHTS IT MAY HAVE TO DEMAND THAT ANY ACTION, PROCEEDING OR COUNTERCLAIM
ARISING OUT OF OR IN ANY WAY RELATED TO THIS AGREEMENT OR ANY SCHEDULES OR
EXHIBIT HERETO OR THE RELATIONSHIPS OF THE PARTIES HERETO OR ANY COURSE OF
DEALING OR COURSE OF CONDUCT OR STATEMENTS (WHETHER VERBAL OR WRITTEN) BE TRIED
BY JURY.  THIS WAIVER EXTENDS TO ANY AND ALL RIGHTS TO DEMAND A TRIAL
BY JURY ARISING FROM ANY SOURCE INCLUDING, BUT NOT LIMITED TO, THE CONSTITUTION
OF THE UNITED STATES OR ANY STATE THEREIN, COMMON LAW OR ANY APPLICABLE STATUTE
OR REGULATIONS.  EACH PARTY HERETO ACKNOWLEDGES THAT IS KNOWINGLY,
INTENTIONALLY AND VOLUNTARILY WAIVING ITS RIGHTS TO DEMAND TRIAL BY
JURY.

     

    11.20 Choice of
Law; Venue.  THE PARTIES AGREE THAT THIS AGREEMENT SHALL BE
GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW
JERSEY.  THE PARTIES DESIGNATE ALL FEDERAL AND STATE COURTS OF RECORD
SITTING IN THE STATE OF NEW JERSEY AS FORUMS WHERE ANY CLAIMS IN RESPECT OF OR
ARISING OUT OF THIS AGREEMENT, OR THE TRANSACTIONS CONTEMPLATED BY THIS
AGREEMENT SHALL BE PROSECUTED AS TO ALL PARTIES, THEIR SUCCESSORS, ASSIGNS, AND
BY THE FOREGOING DESIGNATIONS THE PARTIES CONSENT TO THE JURISDICTION AND VENUE
OF SUCH COURTS.

     

    11.21 Tax
Advice and Reliance.  Except as expressly provided in this
Agreement, none of the Parties (nor any of the Parties’ respective counsel,
accountants or other representatives) has made or is making any representations
to any other Party (or to any other Party’s counsel, accountants or other
representatives) concerning the consequences of the transactions contemplated
hereby under applicable tax laws.  Each Party has relied solely upon
the tax advice of its own employees or of representatives engaged by such Party
and not on any such advice provided by any other Party hereto.

     

    
      
         

      

      
        - 66
-

        
          

        

      

      
         

      

    

    11.22 No Strict
Construction.  The Parties have participated jointly in the
negotiation and drafting of this Agreement.  In the event an ambiguity
or question of intent or interpretation arises, this Agreement shall be
construed as if drafted jointly by the parties, and no presumption or burden of
proof shall arise favoring or disfavoring any party by virtue of the authorship
of any of the provisions of this Agreement.

     

    11.23 Interpretation.  In
this Agreement, unless the context otherwise requires references to (a) a
judgment shall include references to any order, writ, injunction, decree,
determination or award of any court or tribunal or (b) time are references to
Eastern Standard Time.

     

     

    [SIGNATURES
APPEAR ON NEXT PAGE]

     

    
      
         

      

      
        - 67
-

        
          

        

      

      
         

      

    

     

    IN WITNESS WHEREOF, the
Parties hereto have duly executed this Asset Purchase Agreement as of the date
first above written.

     

    
      
        
          
            
              
                
                  
                    
                      
                        
                          
                            
                              
                                
                                  
                                    
                                      
                                        
                                          
                                            
                                              
                                                
                                                  
                                                    
                                                      
                                                        
                                                          
                                                            
                                                              
                                                                
                                                                  
                                                                    
                                                                      
                                                                        
                                                                          
                                                                            
                                                                              
                                                                                	 
      	
                                                                                        PURCHASER:

                                                                                      
	 	 
	 
      	
                                                                                        HEALTH
      DIAGNOSTICS OF NEW JERSEY, L.L.C.

                                                                                      
	 
      	 
      	 
      	 
      
	 
      	 
      	 
      	 
      
	 
      	
                                                                                        By:

                                                                                      	
                                                                                        /s/
      Bradford Peters

                                                                                      
	 
      	
                                                                                         

                                                                                      	
                                                                                        Bradford
      Peters, Chief Executive Officer

                                                                                      
	 
      	 
      	 
      	 
      
	 
      	 
      	 
      	 
      
	 
      	
                                                                                        PARENT:

                                                                                      
	 	 
	 
      	
                                                                                        MODERN
      MEDICAL MODALITIES CORPORATION

                                                                                      
	 
      	 
      	 
      	 
      
	 
      	 
      	 
      	 
      
	 
      	
                                                                                        By:

                                                                                      	
                                                                                        /s/
      Baruh Hayut

                                                                                      
	 
      	
                                                                                         

                                                                                      	
                                                                                        Baruh
      Hayut, Chief Executive Officer

                                                                                      
	 
      	 
      	 
      	 
      
	 
      	 
      	 
      	 
      
	 
      	
                                                                                        SELLER
      COMPANIES:

                                                                                      
	 	 
	 
      	
                                                                                        UNION
      IMAGING ASSOCIATES, INC.

                                                                                      
	 	 
	 	 
	 
      	
                                                                                        By:

                                                                                      	
                                                                                        Baruh
      Hayut

                                                                                      
	 
      	
                                                                                         

                                                                                      	
                                                                                        Baruh
      Hayut, Chief Executive Officer

                                                                                      
	 	 
	 	 
	 
      	
                                                                                        UNION
      IMAGING CENTER, LLC

                                                                                      
	 	 
	 	 
	 
      	
                                                                                        By:

                                                                                      	
                                                                                        Modern
      Medical Modalities Corporation, its sole member

                                                                                      
	 	 	 	 
	 	 	 	 
	 
      	
                                                                                         

                                                                                      	
                                                                                        By:

                                                                                      	
                                                                                        /s/
      Baruh Hayut

                                                                                      
	 
      	
                                                                                         

                                                                                      	
                                                                                         

                                                                                      	
                                                                                        Baruh
      Hayut, Chief Executive
Officer

                                                                                      


                                                                              

                                                                            

                                                                          

                                                                        

                                                                      

                                                                    

                                                                  

                                                                

                                                              

                                                            

                                                          

                                                        

                                                      

                                                    

                                                  

                                                

                                              

                                            

                                          

                                        

                                      

                                    

                                  

                                

                              

                            

                          

                        

                      

                    

                  

                

              

            

          

        

      

    

    


     

    


     

    [SIGNATURES
CONTINUED ON NEXT PAGE]

     

    
      
         

      

      
        - 68
-

        
          

        

      

      
         

      

    

     

     

    
      
        
          
            
              
                
                  
                    
                      	 
      	
                              PET
      SCAN AT UNION IMAGING, LLC

                            
	 	 	 
	 
      	
                              By:

                            	
                              Modern
      Medical Modalities Corporation, its sole member

                            
	 	 	 	 
	 	 	 	 
	 
      	
                               

                            	
                              By:

                            	
                              /s/
      Baruh Hayut

                            
	 
      	
                               

                            	
                               

                            	
                              Baruh
      Hayut, Chief Executive
Officer

                            


                    

                  

                

              

            

          

        

      

    

    


     

    


     

    
      
         

      

      
        - 69
-